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ABSTRACT 
Halonium-Induced Reactions for the Synthesis of Diverse Molecular Scaffolds 
Alexandria P. Brucks 
 
Chapter 1. Introduction 
A vast number of halogenated natural products have been isolated to date that 
contain unique structural and electronic characteristics due to the installed halogen.  
These properties not only aid in their bioactivity, but also put into question nature’s 
biosynthesis of these complex molecules.  Nature’s ability to install halogens in a direct 
and concise manner has inspired our group to seek out chemical transformations that 
accomplish the same efficiency in the context of synthesizing complex natural products.  
Specifically, our group has targeted challenges in the areas of halonium-induced polyene 
cyclization, asymmetric halonium addition to alkenes, and medium-sized bromoether 
formation, as having access to such transformations would further facilitate total 
syntheses of these halogenated isolates. 
 
Chapter 2. Discovery of IDSI and Iodonium- and Chloronium-Induced Polyene 
Cyclizations 
 Only a few electrophilic iodonium reagents have proven capable of inducing 
polyene cyclization of linear terpene precursors, though, to date, these only include 
substrates with electron rich functional groups.  Due to this, we targeted development of a 
new iodonium reagent, IDSI.  This easily synthesized, isolable solid has promoted 
cyclization of both electron rich and poor linear polyene precursors in good yields and 
diastereoselectivities.  The produced iodinated cores allow for further diversification as 
demonstrated in the formal synthesis of loliolide, stemodin, and K-76.  In general, the use 
of IDSI in previous routes decreases step count, increases overall yields, and avoids the 
use of stoichiometric amounts of toxic metals.  In addition, the chloronium variant, 
CDSC, completed the first polyene cyclization ever to be initiated by a chloronium 
electrophile. 
 
Chapter 3. Enantioselective Iodohydrin Formation using Simple Alkenes 
With the development of our halonium reagents, BDSB (the bromonium variant), 
IDSI, and CDSC, we next varied the synthesis of each reagent to include an asymmetric 
component.  While their use in polyene cyclization only produced racemic materials, the 
iodohydroxylation of simple alkenes provided up to 63% ee with only a select substrate.  
Yet, this chiral IDSI reagent is one of only a handful of strategies capable of transferring 
an iodonium electrophile with moderate enantioselectivity (above 50% ee). 
 
Chapter 4. Discovery and Development of a Bromonium-Induced Ring Expansion to 
Rapidly Produce Laurencia Medium-Sized Bromoethers 
 By analyzing the hypothesized biosynthesis of the Laurencia natural isolates, we 
realized the proposed direct 8-membered bromoetherification from a linear precursor was 
most likely an unfavorable event, leading us to investigate an alternative idea.  Discovery 
of a unique bromonium-induced ring expansion method generated 8-membered 
bromoethers diastereoselectively in a single step in good yields.  From easily prepared 
tetrahydrofuran precursors, a variety of diastereomers of 8-endo and 8-exo bromoethers 
were generated selectively, modeling the cores of over half of the medium-sized isolates.  
This method was then expanded to include diastereoselective synthesis of 9-membered 
bromoethers, also found in the Laurencia family. 
 
Chapter 5. Formal Total Synthesis of Laurefucin and Evaluation of the Proposed 
Biosynthesis of Medium-Sized Laurencia Bromoethers 
 The BDSB-induced ring expansion strategy was then used as the key step in the 
completed formal total synthesis of laurefucin, an 8-endo bromoether in the Laurencia 
natural products.  By utilizing this method, we have developed the shortest synthesis of 
any 8-membered bromoether isolate in the family to date.  Due to the breadth of products 
this transformation has generated, we believe this bromonium-induced ring expansion 
may have biosynthetic relevance.  Our proposed biosynthesis could account for 
generation of not only the 8-membered bromoethers, but also additional 5-, 7- and 9-
membered ethers found in the family.  Additional experiments were completed to support 
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1.1 Halogenated Natural Products 
 To date, there are over 4,500 isolated natural products that contain at least one 
halogen atom.1  Moreover, their positioning within these frameworks is quite diverse, 
alpha to carbonyls, or attached to arenes, sp3 rings, or even linear precursors, with some 
examples shown in Figure 1.2  Chlorine and bromine are the most abundant overall, 
present in over 98% of these halogen-containing isolates.  There are a few examples of 
iodine- and fluorine-containing natural products, though comparatively they are few and 
far between.  These isolates typically contain a broad range of biological activity, and in 
general the installed halogen is responsible for the unique structural and electronic 
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 As one example of this halogen-dependent bioactivity, rebeccamycin (2) requires 
its chloride substituents to display its potent cytotoxicity against melanoma and leukemia 
lines; synthesized derivatives that lack these halogens are magnitudes less active and, in 
some cases where additional structural changes have been made, completely inactive in 
the same assay.3  Likewise, neomangicol A and B (3 and 4), the first examples of 
halogenated sesterterpenoid natural products, show cytotoxicity against human colon 
tumor cell lines.4  Yet, this effect was lost when the non-halogenated derivative of these 
natural products was tested, demonstrating the unique and important properties that these 
functional groups possess. 
 Critically, in these cases, the non-halogenated derivatives could not have been 
accessed without the power of total synthesis; in addition, total synthesis allows for the 
preparation of larger quantities of a given molecule of interest for testing.  Overall, for 
most halogenated targets, their synthesis requires the addition of the halogen atom via an 
SN2 reaction (Scheme 1).  Nucleophilic bromide (or other halide) displacement of a 
leaving group or an epoxide thus incorporates the desired halide with stereoinversion (8 
to 9 and 10 to 11).  Typically, the presence of a bromide, chloride, or iodide atom is 
considered a reactive handle, allowing for further diversification of complex molecules; 
yet, when this halide is desired in the final product, late stage installation is often 
required, a task that can be accomplished by nucleophilic addition through careful 
planning.  An alternate mode of halogen inclusion is electrophilic halonium addition to an 
alkene.  In this case, following halonium addition to an olefin, the reactive intermediate 
could be quenched by an intermolecular halide or heteroatom to yield derivatives of 13, 
3
 
or instead by an intramolecular nucleophile in a net halonium-induced cyclization 
reaction (i.e. 14 to 15), the topic of discussion for Chapters 2, 4, and 5. 
 
 While in a laboratory flask halides are great nucleophiles, in nature, there are few 
carbon electrophiles, making nucleophilic halogenation a rare event.5  Instead, nature 
turns to a two-electron oxidation of these halide anions to the corresponding electrophilic 
halonium ions, accounting for the abundant halonium-induced cyclizations found in 
biosynthetic hypotheses via nucleophilic attack of substrates onto these materials.6  My 
work in Prof. Scott Snyder’s research group at Columbia University has been focused on 
the discovery of novel reagents and transformations to access halogenated motifs found 
in natural products, with the main topics: 
 •  Halonium-induced polyene cyclizations 
 •  Asymmetric halonium addition to unfunctionalized alkenes 
 •  Formation of Laurencia medium-sized haloethers 
The main objectives have been to develop robust reactions with high regio- and 
stereocontrol which are capable of completing total syntheses of complex molecules in a 
concise and efficient manner, often mimicking nature’s biogenesis of these materials, but 
making use of the first approaches that have proven broadly successful. 

































1.2 Halonium-Induced Polyene Cyclization 
The intramolecular cyclization example shown in Scheme 1 in Section 1.1 uses a 
heteroatom as the nucleophile to generate final products such as lactones, lactams, ethers, 
and cyclic amines (i.e. 14 to 15).  These processes, in general, are well-studied with 
numerous comprehensive reviews covering these halonium-induced cyclization 
reactions.7  However, when the internal nucleophile is an alkene, a new C-C bond could 
be formed (i.e. 16 to 17 or 18, Scheme 2i).  The generation of this newly formed 
carbocycle is termed polyene cyclization, a reaction that allows multiple stereocenters to 
be constructed at once in a controlled fashion.8  While polyene cyclizations initiated by 
epoxides or Brønsted acids are well known in multiple formats, little success has been 
achieved in the halonium-induced variant of the process.9  If this technology were 
available, chemists would have access to the over 200 isolates derived from, or believed 




While total syntheses of these halogen-containing isolates have been completed, 
very few generate the core carbocycle via a direct halonium-induced cyclization reaction; 
instead, cyclization with stoichiometric Hg(II), followed by stereoretentive replacement, 
has afforded these substrates.11  The reason for this is due to poor yields and selectivities 
using known halonium reagents, a topic that will be discussed further in Chapter 2.  
Additionally, while bromonium-12 or iodonium-initiated13 cyclizations are known (though 
only when using electron rich alkenes), there has yet to be a reported example of a direct 
chloronium-induced polyene cyclization.14  As such, no general solution exists in which 
each halonium variant (Cl, Br, and I) is capable of generating carbocycles 
diastereoselectively in good yields.  The targeted goal in this project was to develop a 





Scheme 2: A Representative Example of Polyene Cyclization and 






































ii. Polyene Cyclization in Nature
6
 
both electron rich and poor linear polyene precursors, thereby affording more efficient 
access to an array of bioactive natural products and analogs. 
 
1.3 Enantioselective Halonium Addition 
 When analyzing the collection of known halonium-induced polyene cyclization 
discussed in the previous section, only a single example generates enantioselective 
products in any level of ee.13a  Nevertheless, most of the isolated halogen-containing 
natural products are chiral; suggesting that nature installs these halogens asymmetrically 
since the rest of the structure is produced following halonium introduction.  More 
generally, while X2 addition to alkenes was discovered over 100 years ago,15 chemists are 
still challenged by achieving asymmetry in this process.16  Even if chiral halonium 
sources are developed, there are major factors that can erode enantioselectivity in ways 
not typical for other electrophiles, a topic to be discussed in further detail in Chapter 3.  
Chemists have solved this problem in some instances through the use of a bifunctional 
chiral catalyst that coordinates both the nucleophile and electrophile.  Although high 
asymmetry can be achieved, only modest substrate scopes and a single halogen atom 
typically can be used for each given set of conditions.  Additionally, the substrates 
generally need a nearby functional group for chelation to the chiral catalyst; only one 
example of enantioselective X2 addition with high ee to an unfunctionalized alkene is 
known.17  Due to the lack of successful literature precedent on this topic, we pursued 
approaches for the asymmetric halogenation with the hope that new classes of highly 
reactive halonium reagents would be unique in their ability to add X2 to a variety of 
7
 
alkenes and generate enantiopure 1,2-dihalides and/or related materials such as 
halohydrins.  
 
1.4 Laurencia Medium-Sized Bromoether Cores 
While the direct asymmetric halogenation of alkenes is noticeably absent in the 
literature, numerous methods exist to generate halolactones and haloethers with 
synthetically useful enantioselectivities.16  These halocyclization reactions may have 
utility in synthesis of the Laurencia medium-sized bromoethers.  The Laurencia C15 
acetogenins are one of the largest groups of halogenated natural products comprising of 
over 100 compounds.18  Within this family, the medium-sized rings (i.e. 7-, 8-, and 9-
membered ethers) make up over half of these molecules, with the 8-membered ethers 




The proposed biosynthesis for these compounds in nature involves a direct 
bromoetherification of a linear precursor to a medium-sized bromoether (Scheme 3ii);19 
yet in the over 30 total syntheses of these isolates, none generate the core via the same 
direct process.20  The challenge here lies in the formation of medium-sized rings, difficult 
because of both entropic and enthalpic barriers;21 only a small number of 
haloetherifications to generate medium-sized rings exist in the literature.22  Additionally, 
that halogen electrophile must add regioselectively to a substrate with multiple 
nucleophilic sites (such as in 26).  We hoped to follow nature’s lead in using a direct 
bromonium-induced cyclization event to complete a more expedient synthesis of these 
isolates.  If we could effect this transformation, an entire class of halogenated natural 
products would be readily accessible.  Additionally, the synthesis of these natural 







































products via a direct bromonium-induced reaction may provide further support for their 
biosynthesis as well as new biogenetic hypotheses.  And, given the role that halogens 
have on biological activity, as discussed above in Section 1.1, their biosynthesis has been 
a topic of interest for numerous decades. 
 
1.5 Conclusion 
Whether it is polyene cyclization, asymmetric halonium addition, or the general 
synthesis of Laurencia medium-sized bromoethers, each of these separate topics in 
halogenation chemistry has been a challenge that chemists have yet to solve in an 
efficient manner.  The multiple step routes used to circumvent each problem led us to 
believe that there is a more direct pathway towards each of these motifs made smoothly 
in nature.  Our goal was to match nature’s selectivity using newly developed tools and 
concepts focused on polyene cyclization as well as medium-sized bromoether formation.   
This thesis will cover the discovery of a new class of highly reactive halonium 
reagents, materials that are isolable, air stable solids.23  These unique halonium reagents 
have allowed us to synthesize previously unobtainable isolates as well as streamline the 
synthesis of multiple additional compounds.  Specifically, we have been able to complete 
seven different total and formal syntheses using halonium-induced polyene cyclization.23  
The transformation of these halonium reagents into enantiopure derivatives has allowed 
the asymmetric addition of X2 to certain unfunctionalized alkenes.24  Lastly, studies 
focused on the Laurencia natural products have uncovered a powerful halonium-induced 
ring expansion transformation capable of synthesizing the isolated medium-sized 
haloether cores; we believe this process may have biogenetic relevance.25  Using nature’s 
10
 
biosynthetic pathway as inspiration, we have been able to mimic halonium-induced 
transformations which nature can complete in a regio- and stereoselective manner in a 
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 The polyene cyclization reaction of linear terpenes is a transformation with great 
power in its ability to rapidly assemble molecular complexity.  To date, there have been 
numerous variants of polyene cyclizations with multiple reagent and substrate classes in 
both racemic and enantioselective formats,1 though the use of halonium electrophiles to 
promote such cascades has shown little progress until recently.  Such a reaction would be 
of great value considering there are over 135 bromine-containing cores and over 35 
isolates that possess a chlorine.2  Figure 1 provides four examples of these materials, 
compounds known to derive biosynthetically from a polyene cyclization. 
 
Scheme 1 presents two mechanistic examples of halonium-induced polyene 
cyclization reactions, one accomplished in nature with chemo- and facial-selectivity 
using either vanadium- or heme-based haloperoxidases.3  The first displays a bromonium 
electrophile, while the second is activated by a chloronium ion.  Based on Stork and 
Eschenmoser’s original hypothesis for the stereocontrol observed in polyene cyclization,4 
the stereoselectivity probably results from a preorganized all-chair like transition state 




























 While nature can synthesize these compounds selectively, mimicking this reaction 
in a laboratory setting has proven quite challenging.  Examining a simpler system in 
Scheme 2, treatment of this linear precursor (10) with a halonium source should generate 
11.  Here, an intramolecular cyclization would generate 12 and/or 13 based on whether 
the process is terminated by an elimination or external nucleophilic attack.  Alternatively, 
if the internal alkene is relatively non-nucleophilic or a competing nucleophile/base is 
available in solution, 14 and/or 15 could potentially form alongside 12 and/or 13, again 
via direct elimination or nucleophilic attack.  Because of these multiple possible 
pathways, in addition to the potential for further reactions of the alkenes within 12, 14, 
and 15 with additional electrophile in solution, attempts to control this collection of 





































Bromine is the most common halogen found within these natural products and 
therefore has attracted the most attention from the synthetic community.  Despite much 
effort, yields and selectivity are poor at best.5  Scheme 3 provides a few representative 
examples of common bromonium sources being deployed for this transformation, 
including TBCO (2,4,4,6-tetrabromo-2,5-cyclohexadienone),5f NBS (N-
bromosuccinimide),5a Br2/Ag (I),5c and NBS/Lewis base.9c  In the case of Br2/Ag(I), the 
bromide counterion is removed from solution due to the formation of AgBr.  While these 
bromonium sources typically are competent at providing the needed electrophilic 
bromine atom, the counterion used to stabilize that electrophile is typically also highly 
nucleophilic and/or basic, leading primarily to the low yields and unwanted byproducts 
such as those described above (i.e. 14 or 15, Scheme 2).  Outside of the bromide, to the 
best of our knowledge there are no known chloronium sources capable of inducing 
polyene cyclization in any yield, highlighting an even greater challenge in accessing 
































 The first significant breakthrough in this field came from the Snyder group in 
2009 in the form of a new reagent developed by my colleague, Dr. Daniel Treitler.7  He 
set out to create new bromonium sources, trying to stabilize the bromonium electrophile 
with a Lewis base as well as to add a Lewis acid to sequester the potentially nucleophilic 
bromide counterion.  A thorough search of the literature, combined with an array of pilot 
experiments, led to the ideal combination of molecular bromine, diethyl sulfide, and 
SbCl5 (Scheme 4).  This orange crystalline solid was called BDSB, an acronym for 
bromodiethylsulfonium bromopentachloroantimonate.  Its utility in polyene cyclization 
was quickly realized, as a variety of geraniol, nerol, and farnesol derivatives were 
cyclized in good to excellent yields as single diastereomers.  A single example is shown 
in Scheme 4 in which farnesol cyanide (16) was cyclized in a 72% yield to the desired 
product 25, an intermediate previously used to accomplish a total synthesis of aplysin-
20.7b  This same intermediate (i.e. 25) was accessed by the Murai group starting from the 
same linear precursor, though a three step sequence of bromohydrin formation, acylation, 
and Lewis acid promoted polyene cyclization was required (generating the same product 
in a diminished yield) because direct bromonium cyclization of this electron deficient 







































 With BDSB’s capability of cyclizing both electron rich and poor linear polyene 
precursors established, we hoped to use this installed bromide as a functional handle to 
access an even greater array of natural products via elimination, substitution, or coupling.  
Unfortunately, the elimination of this installed equatorial bromine proved quite 
challenging.  Numerous conditions were varied to attempt the transformation of 26 
(Scheme 5) into alkene 27, though typically only trace elimination to 27, recovered 
starting material, and/or decomposition occurred.  As such, we wanted to see if the 
elimination could be achieved with its iodinated counterpart (28) since its larger size 
might make it more readily manipulated.  To accomplish this goal, however, a method to 
synthesize compound 28 would be required. 
 
 While iodinated natural products derived from polyene cyclizations do not occur 
in nature, there are several iodonium sources known to be capable of performing this 







































bis(pyridine)iodonium tetrafluoroborate (Ipy2BF4), in combination with HBF4, was 
capable of performing a similar reaction, though initially not based on a terpene structure 
(29 to 30 and 31 to 32, Scheme 6).9b  This preliminary finding was expanded in a follow 
up publication in 2004 to include linear polyene precursors such as 33.9a  In the drawn 
example, it is quite impressive that 34 was generated in 41% yield as a single 
diastereomer (74% yield per ring formation), though drawbacks of this methodology 
include the need for long reaction times at cryogenic temperatures.  However, to date it is 
worth noting that only electron rich terpene precursors have been shown to undergo the 
desired transformation, revealing that room for additional solutions exists. 
 
Shortly thereafter, in 2007, the Ishihara group developed an iodonium-induced 
polyene cyclization reaction using NIS and a Lewis base (Scheme 7).9c  The Lewis base 
chosen was a chiral phosphoramidite (35), now able to render this reaction 
enantioselective.  Treatment of 22 with stoichiometric amounts of both NIS and 35 at  
+
Ipy2BF4, HBF4
































-40°C for 24 h yielded both fully cyclized and partially cyclized products.  This mixture 
then underwent a second acid promoted step to complete the final cyclization of 37, 
overall producing 36 in 57% yield with 95% ee.  While this transformation is remarkable, 
only three substrates are proven to work using these conditions, all of which are electron 
rich arenes as displayed in Scheme 7. 
 
Looking globally at these two developed methodologies, both enable the 
cyclization of electron rich polyene precursors, though require the use of cryogenic 






















36, 57% yield, 95% ee
38
OMe
1. NIS, 35, PhMe
-40 °C, 24 h
H
I
39, 58% yield, 91% ee
OMe
2. ClSO3H, iPrNO2




1. NIS, 35, PhMe
-40 °C, 24 h
2. ClSO3H, iPrNO2
    -78oC, 4 h
41, 52% yield, 99% ee40




step to complete the cyclization.  The lack of general methodology to cyclize a variety of 
linear polyene precursors with halonium electrophiles has encouraged us to pursue this 
topic, with the main goals of my project being the development of reagents and/or 
strategies capable of cyclizing both electron rich and poor linear precursors using a single 
iodonium source.  The installation of this iodide would not be for the purpose of residing 
in a final product, but rather in the ability to use that iodine atom as a functional handle 
for further transformations.  Additionally, since there have been no reported polyene 
cyclizations induced by a chloronium electrophile, we also wished to see if any 
successful designs with the iodine could extend to this system as well, to afford a global 
solution to halonium-induced polyene cyclizations. 
 
2.2 Discovery of IDSI 
 Although the synthesis of BDSB was readily achieved, direct extension of that 
procedure for the synthesis of the iodinated variant proved to be far from trivial, 
particularly in terms of generating a crystalline material.7b  To begin, I2 was dissolved in 
DCE and Et2S was added; at this point, a color change was observed, suggesting the 
probable formation of iodosulfonium iodide intermediate.  Next, SbCl5 was added and 
further stirring at 25°C for 2 h yielded a dark reddish brown solution.  If the reaction was 
placed in the freezer, only excess I2 crystallized from the solution.  However, addition of 
a small layer of hexanes (a solvent I2 is soluble in) allowed for crystallization of the 
desired product as dark reddish orange crystals.  Typically these were grown overnight, 





At the onset, we named these crystals IDSI in the hope that they would react like 
BDSB, though the actual name of solid 42 based on IUPAC rules would be 
diethyliodosulfonium pentachloroiodoantimonate.  These crystals had to be stored at 
-20°C, as IDSI is stable for only a short period of time at 25°C.  Yet, IDSI is stable 
enough at 25°C for the crystals to be isolated and weighed out in air.  IDSI is soluble in 
MeNO2, EtNO2, MeCN, CH2Cl2, DMSO, DMF, acetone, and EtOAc; slightly soluble in 
dioxane and CHCl3; and insoluble in benzene, toluene, and hexanes.  The dimethyl 
variant of 42 was prepared by Minkwitz and Prenzel, though only IR analysis of this 
structure had been previously completed.10 
 
However, it was in obtaining a crystal structure of this material that we discovered 
that IDSI actually exists as a chloride linked dimer in the solid state.  This dimer moiety 
could possibly be contributing to its instability, since ICl could be lost upon warming.  
Structurally, the I-Cl bond lengths in 43 are 2.814 and 2.714 Å, values much larger than 
that of molecular I-Cl at 2.553 Å.11   Because of this, we expect a more reactive iodonium 
electrophile due to the increased bond length.  Additionally, a NIS chloride-linked dimer 






DCE, 0oC, 10 min;
25 oC, 2 h
I2   +   Et2S   +   SbCl5
78% yield




dimer has shown to previously behave as an equivalent of ICl.12  This was a characteristic 
we were hesitant about on the onset of the project, as hopefully our reagent would not 
quench the reaction with the chloride ion prior to ring formation.  As will be shown in the 
following section, IDSI once dissociated seems to behave as a source of one equiv each 
of I+, ICl, SbCl6-, and 2 equiv of Et2S. 
 
2.3  Iodonium-Induced Polyene Cyclization 
 With our iodonium source in hand, our next efforts were to examine whether IDSI 
was capable of promoting polyene cyclization of a variety of terpenes.  Pleasingly, simple 
treatment of homogeranyl benzene (44) with IDSI in nitromethane (0.05 M) for 5 min at -
25°C yielded the trans-decalin core of 28 (Table 1), although these initial results were 
obtained prior to the crystal structure analysis of IDSI (thus at this point, Entry 2 of Table 
1 was considered 1 equivalent of 42).  While a 73% yield of product was observed, the 
remainder of the material balance was H-cyclized byproduct 45.  Mechanistically, the 
reaction terminates by regaining aromaticity via loss of a proton, a species that could 
initiate a proton-induced polyene cyclization of any residual 44 to generate 45.  However, 
once receiving the corrected structure of IDSI, use of an appropriate amount of the 






Not only was IDSI capable of performing this desired transformation, it also does 
so with greater efficiency than other known iodonium sources, namely those used by 
Barluenga and co-workers (Ipy2BF4, HBF4)9a and the Ishihara group (NIS, PPh3)9c (Table 
2).  Under Barluenga’s standard conditions (Entry 1), compound 28 was obtained in 41% 
yield along with 14% of partially cyclized 46.  The excess pyridine (from the Ipy2BF4 
reagent) present in the reaction mixture most likely quenched the proton generated from 
regaining aromaticity, removing the acid which could further catalyze the cyclization of 
46 to 28.  With this idea in hand, the conditions of Entry 2 were designed with excess 
acid present to aid in completing the final cyclization.  Here, unfortunately, too much 
acid was present; generating byproduct 45 in approx 15% yield with no improvement on 
the yield of 28.  When decreasing the temperature, multiple inseparable diastereomers of 
28 were produced.  Interestingly, the use of Ipy2BF4 without HBF4 typically yielded 
unreacted starting material (Entry 4).  We hypothesize that the need for HBF4 is to help 
activate the iodonium species, likely by protonating one of the pyridine rings to facilitate 
its departure and generate the “active” iodonium reagent in situ as the monopyridine 











40.2 mg = 0.5 equiv
64.3 mg = 0.8 equiv
80.4 mg = 1.0 equiv
96.5 mg = 1.2 equiv
1.6:1 28:45, 4:1 28+45:44















43, mw = 804 g/mol




Under Ishihara’s conditions (Entry 5),9c only 50% conversion was observed after 
24 h at -40°C.  And, in our hands, none of the fully cyclized material was produced; only 
partially cyclized 46 was observed.  This product again can be taken forward to desired 
28 in a second acidic step, an additional step that IDSI does not require.  When using 
NIS/PPh3, the proton lost is most likely quenched by the succinimide anion.  IDSI differs 
from both conditions, as the most basic atom in solution is likely the sulfur of diethyl 
sulfide, a compound much less basic and therefore more easily deprotonated.  In fact 
treatment of diethylsulfide with HCl and SbCl5 makes the protonated variant of IDSI 
(Et2SH•SbCl6), a crystalline solid capable of transforming 44 into 45 in quantitative yield 
(Entry 6). 
 
Given that these initial results looked promising, IDSI was explored next for its 
ability to cyclize both electron rich and poor linear polyene precursors.  Scheme 9 shows 
numerous substrates that IDSI successfully transformed into cyclized adduct.  Electron 
rich arenes such as 38 and 47 both underwent full cyclization in good yields.  


















41% 28, 14% 46
~40% 28, ~15% 45
multiple diast of 28
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reaction conditions; 47 instead reacted chemoselectively only at the desired alkene.  
Substrate 49 shows oxygen trapping the resultant carbocation, here losing the MOM 
group during the termination of the reaction to afford 50 in an 85% yield.  While these 
examples show slight diversity in functional groups, addition of a nitrogen in the context 
of a nitrile can be used as well.  Compound 51 generated three different regioisomeric 
alkenes in good yields, as there is no nucleophilic trapping group in this example.  
Additionally, differentially protected alcohols in the form of 53 were produced in 45% 
yield starting from linear acetate 18.  The yield in this particular case was moderate, as 
the competing side product was the iodochloride 54.  This unwanted by product was not 
especially surprising considering that IDSI structurally is a chloride linked dimer, now 
showing that IDSI can behave as a source of ICl if the competing intramolecular 
nucleophile is only modest in overall quality (in this example due to the sigma 





This pathway of halogen addition proved to be a general trend for most electron 
deficient linear polyenes.  As shown in Scheme 10, the tert-butyl carbonate terminated 
polyenes 55 and 58 were cyclized in 57% and 48% yields respectively, with the major 
byproduct resulting again from ICl addition to the most electron rich alkene.  
Nevertheless, what is key to note from these successful cyclizations is that these 
examples differ in their alkene geometry, with 55 being synthesized from geraniol and 58 
being a nerol derivative.  This stereochemical information was then relayed into the 


























































generated the cis-disposed alternative.  Based on the established mechanism for polyene 
cyclization, these results suggest the intermediacy of chair-chair intermediates 56 or 59 in 
leading to the single diastereomer observed for each product.  Critically, substrates 18, 
55, and 58 are the first examples of any electron deficient linear terpene precursor 
undergoing polyene cyclization initiated by an iodonium source, illustrating the unique 
power of IDSI. 
 
 The substrates shown thus far have afforded only bicyclic products; however, if 
an additional terpene unit is included in the starting material, tricyclic cores can be 
produced as well.  As shown in Scheme 11, farnesol derivative 40 was treated with IDSI 
at -25°C for a longer period of time (30 min) to generate tricycle 41 in 26% yield.  The 
major by product was the partially cyclized material 61.  Here, IDSI was not able to fully 
cyclize the linear precursor, but by the addition of MeSO3H into the reaction mixture 
after 30 min, a greater mass balance of the desired product was achieved.  Most likely the 
added acid was capable of completing the final cyclization, transforming 61 into 41 in 
situ, similar to the conditions used by Ishihara and co-workers in Scheme 7,9c though the 












0 to 25oC, 30 min
IDSI, MeNO2



















 This section has outlined the utility of IDSI to cyclize linear polyenes in a single 
step in good yields to a single diastereomer.  While a diverse array of cyclized products 
can be produced, the utility of these iodinated substrates lies principally in their ability to 
be easily manipulated as, to the best of our knowledge, there are no natural products that 
contain an iodinated decalin core.  The next section will describe the value of these 
products in context of several total syntheses. 
 
 
2.4 Formal Syntheses of K-76, Stemodin, and Loliolide 
 As noted in the introduction to this chapter, the real advantage of the installed 
iodide is that it can be eliminated, coupled, or substituted.  As one example, treatment of 
28 with DBU in pyridine at 80°C yielded the eliminated product in 86% yield.  The 
elevated temperatures are likely required because the installed iodide atom is equatorial, 
rendering E2 elimination much more challenging to achieve.13  Under the same 
conditions, the brominated variant of this material (i.e. 26) gave largely recovered 
starting material with a trace amount of eliminated product.  Since this transformation 
















41, 60% yield, 2:1 dr
+
a. IDSI, MeNO2
    -25oC, 30 min
40
b. MeSO3H
    -25 to 25oC, 1 h




targeted to determine if this new two step approach could afford decreased step counts 
and increased yields, overall streamlining synthetic efforts with non-toxic and readily 
handled reagents. 
 
As one example, K-7614 was synthesized by McMurry and Erion in 1985 with the 
trans-decalin core deriving from a mercury(II)-promoted polyene cyclization of a linear 
terpene precursor.15  As shown in Scheme 13, α,β-unsaturated ester 16 (R = Et) was 
cyclized with stoichiometric Hg(OTFA)2, with the resultant organomercurial then treated 
with stoichiometric (PhSe)2 to generate intermediate 64.  After oxidation and double 
bond migration, the desired diene intermediate 65 was generated in four steps and overall 



























Using the same starting material (varied only in the ester, though this should have 
no effect on the transformation shown), 16 (R = Me) was treated with IDSI under 
standard conditions to afford the desired bicycle 63 in 77% yield.  It is quite remarkable 
that IDSI performed this desired transformation, as, to the best of our knowledge, the 
only electrophiles capable of generating the desired bicycle are Hg(II) salts.  As shown in 
Scheme 14, other iodonium sources such as Ipy2BF4/HBF4 and NIS/PPh3 produced only 
partially cyclized material 67; the decreased nucleophilicity of the α,β-unsaturated alkene 





























IDSI 2 steps 66% yield
Hg2+ 4 steps 53% yield
86% yield
65, R = Me or Et64
63
Reagents and Conditions: a. IDSI (1.2 equiv), MeNO2, -25
oC, 5 min, 77%; b. DBU (20 equiv), 
pyridine, 120oC, 12 h, 86%.





BDSB proved incapable of fully cyclizing the desired linear precursor, producing 
only partially cyclized material (a brominated variant of 67, not shown).  The ability of 
IDSI to complete this transformation, whereas BDSB cannot, must lie in the iodonium 
atom itself.  Iodine is soft and easily polarizable, making it quite similar to Hg(II), 
features that can facilitate complete cyclization.  A higher energy transition state was 
likely seen with the bromonium case, not allowing the final electron deficient alkene to 
organize and react before termination occurred.  Additionally, IDSI contains an 
equivalent of ICl, which, under the reaction conditions, could lead to the generation of HI 
or HCl, materials which may have the capability of cyclizing 67 to 16. 
To complete the formal synthesis of K-76, the iodine atom within 63 was 
eliminated in 86% yield using the previously developed conditions to generate the same 
bicyclic diene synthesized by McMurry and Erion (Scheme 13).  Overall, IDSI avoids the 
use of stoichiometric amounts of mercury and selenium reagents and generates the same 
desired compound in two steps with a 66% yield, thereby streamlining the synthesis of 



























Reagents and Conditions: a. Ipy2BF4 (1 equiv), HBF4 (1 equiv), CH2Cl2, -40
oC, 30 min; b. NIS (1 equiv), 
PPh3 (0.1 equiv), CH2Cl2, -78 for 30 min then -40
oC for 24 h.





As a second example shown in Scheme 15, loliolide16 was synthesized by 
Rouessac and coworkers in 1983, with the key step in the synthesis being a cyclization of 
acid 70 using Hg(OTFA)2.17  The so-produced organomercurial 69 was then transformed 
into the corresponding iodide and eliminated with LiCl in DMF.  Overall, Rouessac’s 
sequence from 70 to 72 was three steps and produced 72 in 25% yield.  Avoiding the use 
of mercury, IDSI transformed the same starting carboxylic acid into 71 in 79% yield 
(with a 19:1 dr at the methyl bridgehead).  An additional step circumvented this modest 
erosion in dr by cyclizing instead the tert-butyl ester derivative (68).  This reaction led to 












































Reagents and Conditions: a. TFAA (5 equiv), tBuOH, 0 to 25oC, 20 min, 
68%; b. IDSI (1.2 equiv), MeNO2, -25
oC, 5 min, 79%; c. IDSI (1.2 equiv), 
MeNO2, 0
oC, 5 min, 88%; d. LiCl (50 equiv), DMF, 80oC, 12 h, 97%.




route to the use of IDSI, the synthesis was shortened by a step with a three-fold boost in 
yield using IDSI. 
 
 Using the tert-butyl ester derivative 68, the desired iodinated bicycle 71 could be 
produced using other iodonium sources, though in decreased yields (Scheme 16).  Use of 
Ipy2BF4 with HBF4 yielded approximately 50% of the desired product with an additional 
30% yield of unreacted starting material.  Similarly, NIS and catalytic PPh3 were lower 
yielding, though they produced 71 in 15% yield; here, the majority of the mass balance 
was recovered starting material.  Although we must note that the shown procedures for 
these reagents were clearly not optimized for this direct transformation, since only 


























Reagents and Conditions: a. Ipy2BF4 (1 equiv), HBF4 (1 equiv), CH2Cl2, -40
oC, 
30 min; b. NIS (1 equiv), PPh3 (0.1 equiv), CH2Cl2, -78 for 30 min then -40
oC 
for 24 h.






















Reagents and Conditions: a. IDSI (1.2 equiv), MeNO2, 25
oC, 5 min; b. H2SO4 (15 equiv), 
PhMe, 0oC, 30 min, 40% over 2 steps.




As a final cationic cyclization, the total synthesis of stemodin18 was accomplished 
in 1980 by Corey and co-workers (Scheme 17).19  Enol phosphate 74 was cyclized using 
Hg(OTFA)2, after which the intermediate organomercurial was then displaced with 
iodine in 60% yield (with a 5:1 dr at the iodine center).  Access to the same intermediate 
could also be achieved using IDSI, though treatment of enol phosphate 74 with IDSI 
typically produced only partially cyclized material.  Here, a second acid-promoted step 
proved necessary to facilitate complete cyclization.  Overall, IDSI provided 75 over two 
steps in 40% yield as a single diastereomer, where the mercury (II) variant also two steps 
but with a higher 60% overall yield.  While IDSI was not able to increase the yield here, 
it still avoids the need to use stoichiometric amounts of mercury. 
 
 Looking more closely at this cyclization reaction, Entry 1 of Table 3 demonstrates 
that cyclization of phosphate 74 without the acidic step afforded only 5% of the desired 







































Step 1 and add H2SO4
Step 1, concentrate, Step 2
Step 2: HCl/dioxane
Step 2: ClSO3H/PhMe







5% 75 + 53% 77
27% 75 + 64% 78
<10% 75





24% combined 1:1.5 75:77




    25oC, 5 min
2. H2SO4, PhMe










resulted in a large amount of proton-induced polyene cyclized product 78 (Entry 2).  
Without a workup in between the reactions (i.e. if they were done as a “single step”), 
mostly decomposition resulted (Entry 3).  Entries 4 and 5 illustrate that other acids 
yielded only partially cyclized product and/or decomposition.  Additionally, the reaction 
temperature appeared to play a critical role, as performing the reaction at -78°C also 
yielded decomposition (Entry 6).  Other iodonium sources such as I2/PPh3 only afforded 
unreacted starting material (Entry 7).  With the highest yield achieved at 40% over two 
steps, another approach was targeted (was the enol phosphate was too deactivated to 
participate in the full cyclization?).  Therefore, other enol derivatives were prepared.  
Entries 8-10 demonstrate that silyl enol ethers had similar problems, typically affording 
poor mass recovery with the major product being partially cyclized 77.  Additionally, the 
MOM- and methyl-enol ethers both led to decomposition under the reaction conditions 
(Entries 11 and 12).  Thus, while several efforts were taken to increase the yield of the 
desired transformation, none of these alternative conditions or approaches actually 
increased the overall yield of the produced 75 above 40%. 
 
Other cyclized natural products retain the alkene motif, including (+)-shonanol 
(79, Scheme 18).20  This compound was isolated in 1965 and has only been synthesized 
from derivatization of a similar natural product.20c  Looking at our proposed 

















the α,β-unsaturated ketone from 80, a compound that we believed could derive from 
polyene cyclization of 81 with IDSI.  Here, because we believed strongly that IDSI would 
prove capable of performing the polyene cyclization, we focused our efforts on the 
requisite allylic oxidation of the alkene needed post-cyclization.   
 
Table 4 provides a subset of examples of oxidations attempted to achieve the 
desired transformation to the α,β-unsaturated ketone 82.  All entries favored benzylic 
oxidation to 83 over allylic oxidation to 82, likely due to both steric and electronic 
factors.  When each of these conditions was varied to favor allylic oxidation based on 
published procedures,21 the only case where the desired oxidation was observed was in 
Entry 1, using CuI and tert-butylhydrogen peroxide (TBHP).  Interestingly, Entry 2 was 
quite clean, a great method to generate 83.  Because the desired product was never 
formed in a good yield, we pursued further oxidation of 83, hoping it would undergo a 
second oxidation to generate diketone 84 (Table 5).  At this point, the installed allylic 


















































hopefully be an easier transformation.  While this task seemed achievable, unfortunately 
no allylic ketone was ever observed.  As shown in Entries 1 and 2, only recovered 
unreacted 83 was observed, and using more forcing conditions generated ketoenol 85.  
Since the desired allylic oxidation was a challenge at this point and benzylic oxidation 
was an easier task, we shifted our focus to a new target molecule. 
 
Specifically, that target was celahypodiol (86),22 a molecule which has a uniquely 
substituted ring system, containing two vinyl methyl groups and a benzylic ketone 
(Scheme 19).23  Based on our previous oxidation work, the benzylic ketone should be 
easily prepared.  Thus, retrosynthetically, 86 could be derived from a methyl migration 
and oxidation of substrate 87.  In turn, compound 87 would derive from IDSI cyclization 
of the corresponding linear precursor, an example shown previously in Scheme 9 (though 
the methyl ether protecting group would likely need to be altered for ease of late-stage 
target delivery).  At the onset of this total synthesis endeavor, the only undeveloped step 































Table 6 shows initial efforts towards this proposed rearrangement.  The general 
idea was to treat the iodinated polyene cyclized product with a silver (I) source, inducing 
a methyl shift following carbocation formation (i.e. 90), which upon loss of a proton 
would then generate the desired substitution in 91.  While the desired group for migration 
should be one of the two methyls, a ring contraction is possibility, funneling material to 
the now exocyclic alkene 93.  The listed silver salts in different solvents typically led to 
decomposition (Entries 2, 5, 10) or unreacted starting material (Entries 3, 4, and 9).  
However, under the conditions detailed in Entries 1, 6, and 7, a new product was 
observed, one that had a promising 1H NMR spectrum revealing loss of the ipso-I proton 
and shift of the methyl peaks downfield due to their allylic or benzylic positioning.  Both 
91 and 93 showed these key 1H NMR peaks, so derivatization was preformed to 
determine the exact structure.  Oxidative cleavage of this new compound produced a new 
material that lacked the two methyl groups, confirming the structure as 93.  While this 
product was not the desired one, this ring contraction most likely occurs due to the 
alignment of the highlighted C-C sigma bond with the antibonding I-C.24  In the chair-
chair conformation of the decalin framework, the methyl groups are not properly aligned 




















2.5 Chloronium-Induced Polyene Cyclization 
 While BDSB and IDSI were the first halonium reagents developed by our group, 
the chloronium variant also has great merit as numerous natural products are derived 
from a chloronium-induced polyene cyclization as described in Section 2.1.  Synthesis of 
the chloronium reagent followed a similar experimental protocol, now using chlorine gas 
as the halogen source, and was readily crystallized like BDSB.  The isolated white 
crystalline solid was termed CDSC (94), following the same naming scheme as the other 






























































25°C and stored at -20°C to prevent decomposition.  The dimethyl sulfide variant of 
CDSC had been previously synthesized.25   
 
With the new reagent in hand, a variety of polyene cyclizations were examined.  
As shown in Scheme 21, treatment of homogeranyl benzene (44) with 1 equiv of CDSC 
in nitromethane at -25°C for 5 min yielded a mixture of products.  The major product was 
the desired 97, but the reaction was not diastereoselective as previously observed with the 
other two XDSX reagents.  This outcome may reflect the propensity for the 3-membered 
chloronium intermediate 95 to preferentially exist in the open tertiary carbocation form 
(i.e. 96).26  Because of this preference, intramolecular attack from the remaining alkene 
occurs through an open transition state, allowing attack from either face of the 
carbocation and producing both diastereomers of the product at the chlorine center.  In 
support of such an intermediate (96), a number of byproducts, including 98, 99, and 100, 







Cl2   +   Et2S   +   SbCl5
91% yield





Looking at additional substrates, CDSC proved capable of cyclizing 18, 70, and 
68 (Scheme 22).  Though, similar to the previous example, poor yields and 
diastereoselectivity were observed.  While substrate 101 was diastereomeric about the 
chloride, the cyclic lactone 102 had two products about the bridgehead methyl.  
Diastereomers of each product about the other chiral centers are possible, as the low 
yields observed may be due to additional diastereomers that were difficult to isolate and 
purify after work-up.  Overall, CDSC is the first chloronium reagent that generates to 
some degree polyene cyclized products; yet, the alternative mechanism occurring for 









97b, 23% yield98 99 100
+
+++
(~50% yield combined 98, 99, and 100)






2.6 Enantioselective Polyene Cyclization 
 With such success in polyene cyclization using our developed BDSB, IDSI, and 
CDSC halonium reagents, we hoped to be able to translate these findings into an 
asymmetric variant (work done in collaboration with coworker Dr. Daniel Treitler).27  For 
instance, replacement of the diethyl sulfide backbone of the XDSX reagents with a chiral 
sulfide could potentially generate a chiral XDSX variant.28   At the onset of this work, we 
focused on synthesizing simple chiral sulfides, such as dimethyl thiolane 104 (Scheme 
23).  2,5-Hexadione was enzymatically reduced in an asymmetric manner to produce diol 
103 in a 63% yield and 95% ee.29  This chiral diol was bismesylated and treated with 
Na2S, which underwent two SN2 substitutions, to afford thiolane 104 in a 65% yield.  The 
enantiomeric excess of this prepared thiolane was only 65% (measured by optical 
rotation), implying that racimazation had occurred during this sequence; potentially an 





































 Nevertheless, despite the loss of some ee, we continued to push forward.  Upon 
iodonium formation under standard conditions as shown in Scheme 24; though these 
reagents 105a and 105b are identical because of the C2-symmetry of the thiolane.30  
Crystallographic analysis of compound 105 confirmed a monomeric structure in the solid 
state, differing from achiral IDSI crystals.   
 
With the chiral iodonium reagent in hand, polyene cyclization using homogeranyl 
benzene was again tested (Scheme 25).  While the linear polyene underwent cyclization 
quite smoothly to generate the iodinated bicycle 28 in 78% yield, unfortunately the 
product was racemic.  Work done by my colleague, Dr. Daniel Treilter, proved that the 
other reagents containing bromine and chlorine also underwent polyene cyclization, but 
without any induced chirality.  However, while polyene cyclization was not rendered 
enantioselective, as will be described in the next chapter, these chiral halonium reagents 
















Reagents and Conditons: a. yeast, glucose, water, 35oC, 12 h, 63%; b. MsCl (4
equiv), Et3N (6 equiv), CH2Cl2, -20 to 0
oC, 1 h; c. Na2S•9H2O (2 equiv), EtOH, 25
oC, 
30 min, 65%.







The discovery of IDSI, a new iodonium reagent, has enabled the first cyclization 
reactions of electron rich and poor linear polyene precursors in good yield, typically 
affording only a single product diastereomer.  While the utility of the installed iodine is 
not necessarily in the atom itself, it does afford a new handle capable of being converted 
into new functionality.  The benefit of the installation of an iodine atom was highlighted 
in its ability to streamline total syntheses of K-76, loliolide, and stemodin by decreasing 
step count and boosting yields of previous technologies.  Moreover, IDSI has proven a 
suitable alternative for the mercury (II) salts, thereby offering a green replacement for the 
use of stoichiometric amounts of highly toxic reagents.  While I have discovered IDSI 





























unique features highlighted in the total synthesis of a member of the resveratrol family of 
polyphenols31 as well as in stereoselective polyketide synthesis.32  The chloronium 
reagent, CDSC, was developed and similarly used to perform the first reported polyene 
cyclization of both electron rich and deficient alkenes.  These XDSX reagents (BDSB, 
IDSI, and CDSC) appear unique in their ability to act as a “naked” halonium sources 
without a nucleophilic or basic counterion present in solution.  This property could lead 
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2.9 Experimental Section 
 General Procedures.  All reactions were carried out under an argon 
atmosphere with dry solvents under anhydrous conditions, unless otherwise noted.  Dry 
methylene chloride (CH2Cl2), benzene, toluene, diethyl ether (Et2O) and tetrahydrofuran 
(THF) were obtained by passing commercially available pre-dried, oxygen-free 
formulations through activated alumina columns; acetonitrile (MeCN) was dried over 3 Å 
molecular sieves, distilled, and stored over 3 Å molecular sieves; pyridine was distilled 
from CaH2 and stored over 3 Å molecular sieves; triethylamine (Et3N) was distilled from 
KOH; N,N-dimethylformamide (DMF) was stored over 3 Å molecular sieves; 1,2-
dichloroethane, acetone, and methanol (MeOH) were purchased in anhydrous form from 
Sigma-Aldrich and used as received.  Yields refer to chromatographically and 
spectroscopically (1H and 13C NMR) homogeneous materials, unless otherwise stated.  
Reagents were purchased at the highest commercial quality and used without further 
purification, unless otherwise stated.  Reactions were magnetically stirred and monitored 
by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck silica gel plates 
(60F-254) using UV light as visualizing agent and an aqueous solution of 
phosphomolybdic acid and cerium sulfate, and heat as developing agents.  Preparative 
thin-layer chromatography was carried out on 0.50 mm E. Merck silica gel plates (60F-
254).  SiliCycle silica gel (60, academic grade, particle size 0.040–0.063 mm) was used 
for flash column chromatography.  NMR spectra were recorded on Bruker DRX-300 and 
DRX-400 instruments and calibrated using residual undeuterated solvent as an internal 
reference.  The following abbreviations were used to explain the multiplicities: s = 




app = apparent.  IR spectra were recorded on a Nicolet Avatar 370 DTGS series FT-IR 
spectrometer. High-resolution mass spectra (HRMS) were recorded in the Columbia 
University Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB 
(Fast Atom Bombardment) and EI (Electron Ionization) techniques.  All enantiomeric 
excess (e.e.) values were obtained by HPLC using a Daicel CHIRALCEL OD column. 
 Abbreviations.  AcOH = acetic acid, AgOAc = silver (I) acetate, DBU = 1,8-
diazabicyclo[5.4.0]undec-7-ene, EtOH = ethanol, Et2S, diethyl sulfide, HBF4•Et2O = 
tetrafluoroboric acid diethyl ether complex, MeLi = methyl lithium, Me3OBF4 = 
trimethyloxonium tetrafluoroborate, Mn(OAc)3•2H2O = manganese (III) acetate 
dihydrate, MOMCl = chloromethyl methyl ether, MsCl = methanesulfonyl chloride, n-
BuLi = n-butyl lithium, TBDPSCl = tert-butyldiphenylsilyl chloride, TBHP = tert-butyl 
hydrogen peroxide, TBSOTf = tert-butyldimethylsilyl trifluoromethanesulfonate, t-BuLi 
= tert-butyl lithium. 
 
Note.  Synthetic procedures, complete characterization, and 1H and 13C NMR spectra of 
18, 38, 40, 44, 49, 51, 55, 68, and 70 are available in the preliminary publication on 
polyene cyclization using BDSB: Snyder, S. A.; Treitler, D. S. Angew. Chem. Int. Ed. 
2009, 48, 7899–7903. 
 
 IDSI (43).  Et2S (0.54 mL, 5.0 mmol, 2.0 equiv) was added dropwise to a solution 
of I2 (0.64 g, 2.5 mmol, 1.0 equiv) in 1,2-dichloroethane (15 mL) at 0 °C.  The mixture 
was stirred for 5 min at 0 °C.  SbCl5 (1.0 M in CH2Cl2, 5.0 mL, 5.0 mmol, 2.0 equiv) was 




over 30 min, then stirred for an additional 2 h at 25 °C.  Upon completion, and in order to 
collect IDSI crystals, hexanes (4 mL) was carefully pipetted onto the top of the solution 
and the layered solution was cooled to –20 °C for 24 h.  The resulting orange crystals 
were isolated by decanting off the liquid, rinsing with hexanes (2 x 1 mL), and then 
drying under vacuum prior to use in cation-p cyclizations (1.26 g, 78% yield).   
 
 
[Note from crystallographer: The iodine thermal parameters are elongated in the direction 
of the bond, and this implies that there may be a chlorine impurity. This can therefore 
artificially change the observed bond lengths and angles. The atoms have been assigned 
based on the information of the synthetic chemists]. 
 
 28.  A solution of IDSI (0.097 g, 0.120 mmol, 1.2 equiv) in nitromethane (0.5 
mL) was quickly added via syringe to a solution of homogeranylbenzene (44, 0.023 g, 
0.100 mmol, 1.0 equiv) in nitromethane (1.5 mL) at –25 °C.  After stirring for 5 min at –
25 °C, the resulting mixture was poured into a solution of saturated aqueous NaHCO3:5% 
aqueous Na2SO3 (1:1, 10 mL) and the resultant biphasic mixture was stirred vigorously 
for 15 min at 25 °C.  The reaction contents were then extracted with CH2Cl2 (3 × 10 mL), 
and the combined organic layers were dried (MgSO4), filtered, and concentrated.  The 
resultant residue was purified by flash column chromatography (silica gel, hexanes: 




28: Rf = 0.49 (silica gel, hexanes: CH2Cl2, 9:1); IR (film) νmax 3058, 2965, 2945, 1488, 
1475, 1377, 762, 723, 670 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.20–7.03 (m, 4 H), 4.28 
(dd, J = 13.2, 4.0 Hz, 1 H), 2.92–2.87 (m, 2 H), 2.57 (dq, J = 3.6, 13.6 Hz, 1 H), 2.45 (dq, 
J = 14.0, 3.6 Hz, 1 H), 2.17 (dt, J = 13.2, 3.6 Hz, 1 H), 2.00 (m, 1 H), 1.82 (m, 1 H), 
1.62–1.54 (m, 2 H), 1.25 (s, 3 H), 1.13 (s, 3 H), 1.09 (s, 3 H); 13C NMR (75 MHz, 
CDCl3) δ 148.8, 134.8, 129.2, 126.0, 125.7, 124.6, 53.5, 50.0, 41.9, 39.7, 38.3, 34.5, 33.2, 
31.0, 25.0, 21.8, 21.3; HRMS (EI) calcd for C17H23I [M]+ 354.0845, found 354.0840. 
 
 Polyene Cyclization of 44 Using Ipy2BF4/HBF4. Prepared according to: 
Barluenga, J.; Trincado, M.; Rubio, E.; González, J. M. J. Am. Chem. Soc. 2004, 126, 
3416–3417. A suspension of bis(pyridine)iodonium tetrafluoroborate (0.037 g, 0.100 
mmol, 1.0 equiv) in CH2Cl2 (0.1 mL) was stirred for 5 min at 25 °C until the solid 
dissolved.  The reaction contents were then cooled to –40 °C and HBF4•Et2O (0.014 mL, 
0.100 mmol, 1.0 equiv) was added.  After stirring for 10 min at –40 °C, 
homogeranylbenzene (44, 0.023 g, 0.100 mmol, 1.0 equiv) was added as a solution in 
CH2Cl2 (0.8 mL).  The reaction mixture was kept at –40 °C for 3 h with constant stirring.  
Upon completion, the reaction contents were quenched with ice-cold water (10 mL), 
Na2S2O3 (0.100 g) was added, and the materials were extracted with CH2Cl2 (3 × 10 mL).  
The combined organic layers were washed with water (10 mL), dried (MgSO4), filtered, 
and concentrated.  The resultant brown oil was purified by flash column chromatography 
(silica gel, hexanes:CH2Cl2, 9:1) to afford bicycle 28 (0.015 g, 41% yield) as a colorless 
amorphous solid. [Note:  Since the partially-cyclized compounds are difficult to isolate, 




on 1H NMR ratios of diagnostic signals.  The remaining mass balance was divided 
between incorrect diastereomers and other unknown products. The proton-cyclized 
product 45 was spectroscopically identical to previously reported material: (a) Rosales, 
V.; Zambrano, J. L.; Demuth, M. J. Org. Chem. 2002, 67, 1167–1170. (b) Banick, B. K.; 
Chakraborti, A. K.; Ghatak, U. R. J. Chem. Res. Miniprint 1986, 3391.] 
 Using the above conditions with substrate 16 afforded 47% isolated yield of the 
tetra-substituted partially-cyclized product 67a. The remaining mass was assigned as a 
mixture of di- and tri-substituted alkene isomers (partially-cyclized material), as well as 
trace starting material. Product 63 was not observed under these conditions. 
 Using the above conditions with substrate 68 afforded approx a 50% isolated 
yield of the cyclized product 71. The remaining mass was starting material.  
 
 Polyene Cyclization of 44 Using PPh3/NIS. Prepared according to: Sakakura, 
A.; Ukai, A.; Ishihara, K. Nature 2007, 445, 900–903.  A solution of 
homogeranylbenzene (44, 0.023 g, 0.100 mmol, 1.0 equiv) in CH2Cl2 (0.5 mL) was 
added to a solution of triphenylphosphine (7.9 mg, 0.0030 mmol, 30 mol %) in CH2Cl2 
(0.5 mL) at -78 °C. N-Iodosuccinimide (0.023 g, 0.100 mmol, 1.0 equiv) was added to 
the reaction mixture, which was kept at -78 °C for 24 h. The reaction mixture was then 
warmed to –40 °C and kept at -40 °C for 6 h with constant stirring.  The reaction contents 
were then quenched with 20% aqueous Na2S2O3 (5 mL) and the materials were extracted 
with hexanes (3 × 10 mL).  The combined organic layers were washed with brine (10 
mL), dried (MgSO4), filtered, and concentrated.  Since the partially-cyclized compounds 




material based on 1H NMR ratios of diagnostic signals.  The desired product 45 was 
observed in trace amounts. 
 Using the above conditions with substrate 16 afforded a 3.5:1.0 starting 
material:partially-cyclized material based on the crude 1H NMR. The desired product 63 
was not observed under these conditions. 
 Using the above conditions with substrate 68 afforded approx 15% yield of the 
desired cyclized product 71 with the remainder of the mass balance being recovered 
starting material. 
 
Preparation of Polyene Cyclization Precursors 
 47.   Procedure  adapted  from:  Pouységu, L.; Chassaing, S.; Dejugnac, D.; 
Lamidey, A.-M.; Miqueu, K.; Sotiropoulos, J.-M.; Quideau, S. Angew. Chem. 2008, 47, 
3552–3555.  First, t-BuLi (1.7 M in pentane, 0.690 mL, 1.17 mmol, 3.0 equiv) was added 
dropwise to solution of 38 (0.100 g, 0.390 mmol, 1.0 equiv) in THF (1.5 mL) at –40 °C.  
The reaction mixture was then stirred at –40 °C for 1 h.  Next, trimethylborate (0.135 
mL, 1.17 mmol, 3.0 equiv) was added in a single portion at –40 °C, and the reaction 
mixture was then allowed to warm to 0 °C over the course of 1 h.  A solution of 1 M 
NaOH: aqueous 30% H2O2 (1:1, 0.6 mL) was then carefully added at 0 °C and the 
reaction mixture was stirred for an additional 30 min at 0 °C.  The reaction contents were 
then quenched with saturated aqueous Na2SO3 (5 mL) and the resultant biphasic mixture 
was stirred for 10 min at 25 °C.  The mixture was then extracted with EtOAc (3 × 20 mL) 
and the combined organic layers were washed with water (50 mL), dried (MgSO4), 




chromatography (silica gel, hexanes:EtOAc, 9:1) to give the desired phenol (0.096 g, 
90% yield) as a colorless oil.  Next, to a solution of a portion of the newly prepared 
phenol (0.063 g, 0.230 mmol, 1.0 equiv) and methanesulfonic acid (0.044 mL, 0.260 
mmol, 2.0 equiv) in THF (1 mL) at 0 °C was slowly added NaH (60% dispersion in 
mineral oil, 0.040 g, 1.00 mmol, 4.3 equiv).  The resulting suspension was allowed to 
warm to 25 °C and stirred for 3 h.  Upon completion, the reaction contents were poured 
into water (10 mL) and extracted with Et2O (5 × 15 mL).  The combined organic layers 
were then dried (MgSO4), filtered, and concentrated.  The resulting yellow oil was 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 20:1) to afford 
cyclization precursor 47 (0.063 g, 95% yield) as a light yellow oil.  47: Rf = 0.29 (silica 
gel, hexanes:EtOAc, 9:1); IR (film) νmax 2928, 2854, 1516, 1464, 1263, 1236, 1156, 1032 
cm–1; 1H NMR (400 MHz, CDCl3) δ 6.79 (dd, J = 6.4, 2.0 Hz, 1 H), 6.73 (dd, J = 6.8, 2.0 
Hz, 2 H), 5.18 (tt, J = 7.2, 1.2 Hz, 1 H), 5.09 (tt, J = 6.8, 1.2 Hz, 1 H), 3.87 (s, 3 H), 3.86 
(s, 3 H), 2.59 (t, J = 7.2 Hz, 2 H), 2.29 (q, J = 7.6 Hz, 2 H), 2.11–1.94 (m, 4 H), 1.69 (s, 3 
H), 1.60 (s, 3 H), 1.57 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 148.9, 147.3, 135.8, 135.3, 
131.4, 124.5, 123.8, 120.4, 112.0, 111.4, 56.1, 55.9, 39.8, 35.8, 30.2, 26.9, 25.8, 17.8, 
16.2; HRMS (EI) calcd for C19H28O2 [M]+ 288.2094, found 288.2089. 
 
 58.  Prepared according to: Alonso, E.; Guijarro, D.; Martínez, P.; Ramón, D. J.; 
Yus, M. Tetrahedron 1999, 55, 11027–11038.  0.546 g (85% yield) as a yellow viscous 
oil.  58: Rf = 0.66 (silica gel, hexanes:EtOAc, 19:1); IR (film) νmax 2972, 2933, 1739, 
1369, 1277, 1254, 1166 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.37 (dt, J = 1.2, 6.8 Hz, 1 




1.75 (s, 3 H), 1.68 (s, 3 H), 1.59 (s, 3 H), 1.47 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 
153.7, 142.8, 132.3, 123.7, 119.1, 81.9, 63.6, 32.3, 27.9 (3 C), 26.8, 25.8, 23.6, 17.8; 
HRMS (FAB) calcd for C15H25O3 [M-H]+ 253.1804, found 253.1794. 
 
Standard Procedure for Small-Scale Polyene Cyclizations with IDSI 
 A solution of IDSI (0.0965 g, 0.120 mmol, 1.2 equiv) in nitromethane (0.5 mL) 
was quickly added to a solution of the substrate (0.100 mmol, 1.0 equiv) in nitromethane 
(1.5 mL) at the temperature indicated.  After stirring the reaction contents for the 
indicated time, the mixture was poured into a solution of saturated aqueous NaHCO3:5% 
aqueous Na2SO3 (1:1, 10 mL) and the resultant biphasic mixture was vigorously stirred 
for an additional 15 min at 25 °C.  Upon completion, the reaction contents were extracted 
with CH2Cl2 (3 × 10 mL) and the combined organic layers were dried (MgSO4), filtered, 
and concentrated.  The resultant residue was purified either by flash column 
chromatography or preparative TLC to yield the desired cation-π cyclization products in 
the amount and yields indicated below.  
 39. White crystalline solid, 0.035 g, 90% yield; Rf = 0.35 (silica gel, 
hexanes:EtOAc, 19:1); IR (film) νmax 2949, 2924, 2851, 1609, 1502, 1463, 1264, 1044, 
870, 669 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.96 (d, J = 8.4 Hz, 1 H), 6.72 (d, J = 2.4 
Hz, 1 H), 6.67 (dd, J = 8.0, 2.4 Hz, 1 H), 4.27 (dd, J = 12.8, 4.0 Hz, 1 H), 3.77 (s, 3 H), 
2.90–2.77 (m, 2 H), 2.54 (dq, J = 3.6, 13.4 Hz, 1 H), 2.44 (dq, J = 14.0, 4.0 Hz, 1 H), 
2.11 (dt, J = 13.2, 3.6 Hz, 1 H), 1.98 (m, 1 H), 1.79 (m, 1 H), 1.60 (dd, J = 13.2, 4.0 Hz, 1 
H), 1.53 (m, 1 H), 1.25 (s, 3 H), 1.13 (s, 3 H), 1.08 (s, 3 H); 13C NMR (75 MHz, CDCl3) 




30.4, 25.2, 22.2, 21.6; HRMS (EI) calcd for C18H25IO [M]+ 384.0950, found 384.0952. 
 48.  Yellow amorphous solid, 0.030 g, 73% yield; Rf = 0.29 (silica gel, 
hexanes:EtOAc, 9:1); IR (film) νmax 2947, 2847, 1510, 1463, 1256, 1146 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 6.67 (s, 1 H), 6.51 (s, 1 H), 4.28 (dd, J = 13.2, 4.4 Hz, 1 H), 3.83 (s, 
6 H), 2.82 (dd, J = 8.8, 4.4 Hz, 2 H), 2.56 (dq, J = 3.2, 13.2 Hz, 1 H), 2.44 (dq, J = 14.0, 
4.0 Hz, 1 H), 2.10 (dt, J = 13.2, 3.6 Hz, 1 H), 1.98 (m, 1 H), 1.80 (m, 1 H), 1.62–1.51 (m, 
2 H), 1.24 (s, 3 H), 1.13 (s, 3 H), 1.07 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 147.4, 
147.2, 140.9, 127.0, 111.6, 111.5, 50.3 (2 C), 42.2, 39.6, 38.0, 34.5, 33.2 (2 C), 30.8, 
25.0, 24.9, 21.9, 21.3; HRMS (EI) calcd for C19H27IO2 [M]+ 414.1056, found 414.1068. 
 50.  Yellow crystalline solid, 0.042 g, 85% yield; Rf = 0.64 (silica gel, hexanes: 
EtOAc, 4:1); IR (film) νmax 2946, 2866, 2825, 1482, 1388, 1195, 1151, 1134, 1011, 964, 
738 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.96 (s, 1 H), 6.86 (s, 1 H), 5.13 (s, 2 H), 4.23 
(dd, J = 12.8, 4.0 Hz, 1 H), 3.53 (s, 3 H), 2.77 (dd, J = 16.8, 5.6 Hz, 1 H), 2.67 (dd, J = 
16.4, 12.8 Hz, 1 H), 2.45 (dq, J = 14.0, 4.0 Hz, 1 H), 2.29 (dq, J = 3.6, 13.6 Hz, 1 H), 
1.87–1.69 (m, 3 H), 1.21 (s, 3 H), 1.12 (s, 3 H), 1.04 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 148.3, 147.4, 122.0, 121.4, 117.8, 111.4, 96.2, 76.3, 56.5, 49.1, 46.5, 42.4, 39.0, 
34.3, 32.2, 25.8, 19.9, 19.7; HRMS (FAB) calcd for C18H24BrIO3 [M]+ 493.9954, found 
493.9931. 
 52.  Colorless viscous oil, 0.025 g of a 8.5:1.4:1.0 mixture of alkene isomers 
(trisubstituted:tetrasubstituted:disubstituted), 85% combined yield; Major alkene isomer 
of 52b: Rf = 0.33 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2969, 2935, 2858, 2246, 
1445, 1372, 1139, 844 cm–1;  Diagnostic 1H NMR signals (400 MHz, CDCl3) δ 5.32 (br 




17.2, 5.6 Hz, 1 H), 1.80 (s, 3 H), 1.19 (s, 3 H), 1.04 (s, 3 H);  13C NMR  (100 MHz, 
CDCl3)  δ 132.7, 125.2, 119.9, 46.9, 45.4, 37.7, 34.1, 28.0, 21.6, 18.1, 18.0; HRMS (EI) 
calcd for C11H16IN [M]+ 289.0328, found 289.0315. [Diagnostic 1H NMR signals for 
other isomers: tetrasubstituted δ 4.41 (dd, J = 9.6, 4.4 Hz, 1 H), 3.07 (AB, J = 44.4, 17.6 
Hz, 2 H), 1.74 (s, 3 H), 1.26 (s, 3 H), 1.23 (s, 3 H); disubstituted δ 5.06 (s, 1 H), 4.78 (s, 1 
H), 1.22 (s, 3 H), 0.88 (s, 3 H)]. 
 53.  White crystalline solid, 0.015 g, 45% yield; Rf = 0.42 (silica gel, hexanes: 
EtOAc, 1:1); IR (film) νmax 3394 (br), 2971, 2947, 1736, 1372, 1244, 1140, 1028, 913 
cm–1; 1H NMR (400 MHz, CDCl3) δ 4.45 (dd, J = 12.0, 4.8 Hz, 1 H), 4.31 (dd, J = 12.0, 
5.2 Hz, 1 H), 4.16 (dd, J = 12.8, 4.0 Hz, 1 H), 2.53 (br s, 1 H), 2.36 (dq, J = 14.0, 4.0 Hz, 
1 H), 2.20 (dq, J = 4.0, 13.6 Hz, 1 H), 2.06 (s, 3 H), 1.77 (t, J = 5.2 Hz, 1 H), 1.66 (dt, J = 
13.2, 3.6 Hz, 1 H), 1.56 (dt, J = 4.0, 13.6 Hz, 1 H), 1.23 (s, 3 H), 1.14 (s, 3 H), 1.02 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 171.1, 72.0, 64.1, 54.3, 49.5, 44.9, 39.6, 34.9, 32.9, 
23.8, 21.3, 20.5; HRMS (EI) calcd for C12H21IO3 [M]+ 340.0535, found 340.0540. 
54. Colorless viscous oil, 0.014 g, 39% yield, contaminated with ~15% of an 
inseparable, unidentified impurity; Rf = 0.28 (silica gel, hexanes: EtOAc, 20:1); IR (film) 
νmax 2980, 2934, 1784, 1370, 1232, 1023 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.47 (t, J = 
7.2 Hz, 1 H), 4.63 (d, J = 6.8 Hz, 2 H), 4.16 (dd, J = 11.2, 1.2 Hz, 1 H), 2.40 (m, 1 H), 
2.28 (m, 1 H), 2.15 (m, 1 H), 2.08 (s, 3 H), 1.92 (m, 1 H), 1.88 (s, 3 H), 1.75 (s, 6 H); 13C 
NMR (100 MHz, CDCl3) δ 171.2, 140.1, 120.2, 72.5, 61.3, 48.6, 39.4, 35.6, 34.2, 28.4, 
21.2, 16.5; HRMS (FAB) calcd for C12H19ClIO2 [M-H]+ 357.0118, found 357.0135. 
 57.  Light yellow crystalline solid, 0.018 g, 57% yield; Rf = 0.26 (silica gel, 




MHz, CDCl3) δ 4.51 (dd, J = 10.8, 5.6 Hz, 1 H), 4.42 (dd, J = 12.7, 10.8 Hz, 1 H), 4.14 
(dd, J = 12.8, 4.0 Hz, 1 H), 2.47 (dq, J = 14.4, 4.0, 1 H), 2.21 (m, 1 H), 2.11 (dd, J = 12.8, 
5.6 Hz, 1 H), 1.85 (dt, J = 13.2, 3.6 Hz, 1 H), 1.75 (dt, J = 4.4, 0.8 Hz, 1 H), 1.52 (s, 3 
H), 1.11 (s, 3 H), 1.01 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 148.4, 81.0, 68.4, 45.7, 
45.1, 41.2, 37.8, 33.8, 31.2, 20.9, 20.1; HRMS (FAB) calcd for C11H18IO3 [M+H]+ 
325.0301, found 325.0290. 
 60.  White amorphous solid, 0.016 g, 48% yield; Rf = 0.26 (silica gel, hexanes: 
EtOAc, 3:2); IR (film) νmax 2971, 2946, 1742, 1214, 1112 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 4.74 (dd, J = 12.4, 6.0 Hz, 1 H), 4.52 (br s, 1 H), 4.47 (d, J = 12.0 Hz, 1 H), 
2.28–2.11 (m, 2 H), 2.01 (m, 1 H), 1.94–1.88 (m, 2 H), 1.55 (s, 3 H), 1.28 (s, 3 H), 1.19 
(s, 3 H); 13C NMR (75 MHz, CDCl3) δ 149.1, 80.7, 66.4, 50.7, 40.1, 37.1, 35.5, 35.1, 
28.8, 28.1, 20.1; HRMS (EI) calcd for C11H17IO3 [M]+ 324.0222, found 324.0205. 
 41.  In order to ensure completion in the final cyclization leading to tetracycle 41, 
methanesulfonic acid (0.100 mL, 1.50 mmol, 15 equiv) was added to the reaction mixture 
at –25 °C after the initial 5 min IDSI-cyclization period, and the resultant solution was 
stirred for 60 min at –25 °C prior to the standard reaction quench described above.  41: 
white amorphous solid, 0.025 g, 60% yield; Rf = 0.47 (silica gel, hexanes: CH2Cl2, 9:1); 
IR (film) νmax 3059, 2941, 2868, 1451, 1386, 1145, 758 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 7.22 (m, 1 H), 7.16–7.00 (m, 3 H), 4.26 (dd, J = 13.2, 4.4 Hz, 1 H), 2.98–2.78 
(m, 2 H), 2.49 (dq, J = 4.0, 13.6 Hz, 1 H), 2.38 (dt, J = 12.4, 3.2 Hz, 1 H), 2.31 (dq, J = 
13.6, 3.6 Hz, 1 H), 1.88–1.63 (m, 5 H), 1.58–1.49 (m, 2 H), 1.28 (dd, J = 12.0, 2.4 Hz, 1 
H), 1.20 (s, 3 H), 1.10 (dd, J = 11.6, 2.0 Hz, 1 H), 1.06 (s, 3 H), 1.02 (s, 3 H), 0.99 (s, 3 




55.0, 43.2, 40.8, 39.6, 38.2, 37.9, 34.0, 33.2, 30.8, 26.1, 21.8, 21.0, 18.2, 16.3; HRMS 
(EI) calcd for C22H31I [M]+ 422.1471, found 422.1471. 
 
 Alkene 27. DBU (0.25 mL, 1.70 mmol, 20 equiv) was added to a solution of 28 
(0.030 g, 0.085 mmol, 1.0 equiv) in pyridine (1 mL) at 25 °C.  The resultant solution was 
then heated with stirring at 120 °C for 12 h.  Upon completion, the reaction contents were 
cooled to 25 °C, quenched with saturated aqueous NH4Cl (10 mL), and extracted with 
Et2O (3 × 10 mL).  The combined organic layers were then washed with water (10 mL), 
dried (MgSO4), filtered, and concentrated.  The resulting brown oil was purified by flash 
column chromatography (silica gel, hexanes:CH2Cl2, 9:1) to afford alkene 27 (0.160 g, 
83% yield) as a white amorphous solid. 27: Rf = 0.68 (silica gel, hexanes: CH2Cl2, 9:1); 
IR (film) νmax 3011, 2959, 2936, 2838, 1489, 1447, 1373, 1044, 758, 729 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 7.29 (m, 1 H), 7.18–7.02 (m, 3 H), 5.62 (ddd, J = 10.0, 6.0, 2.0 Hz, 
1 H), 5.50 (dd, J = 10.0, 2.8 Hz, 1 H), 2.96–2.80 (m, 2 H), 2.55 (dd, J = 16.8, 6.0 Hz, 1 
H), 2.13 (d, J = 16.4 Hz, 1 H), 1.87 (m, 1 H), 1.76–1.65 (m, 2 H), 1.27 (s, 3 H), 1.06 (s, 3 
H), 1.00 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 148.1,138.3, 135.6, 129.0, 126.2, 126.1, 
125.4, 122.0, 48.3, 39.9, 37.2, 35.2, 32.0, 31.3, 25.4, 22.5, 20.1; HRMS (EI) calcd for 
C17H22 [M]+ 226.1722, found 226.1716. 
 
Formal Synthesis of K-76 
16. Procedure adapted from: Brown, R. C. D.; Bataille, C. J.; Hughes, R. M.; 
Kenney, A.; Luker, T. J. J. Org. Chem. 2002, 67, 8079–8085.  To a solution of CuI (0.24 




2.6 mmol, 3.0 equiv) dropwise.  After 5 min at 0 °C, the reaction mixture was cooled to –
78 °C and a solution of 74 (0.345 g, 0.859 mmol, 1.0 equiv) in Et2O (2 mL) was added.  
The reaction mixture was allowed to slowly warm to –30 °C over the course of 2 h, then 
quenched with saturated aqueous NH4Cl (10 mL).  The reaction mixture was poured into 
water (5 mL), and extracted with hexanes:EtOAc (2:1, 3 x 10 mL). The combined 
organic layers were washed with brine (10 mL), dried (MgSO4), filtered, and 
concentrated.  The crude yellow viscous oil was purified by careful column flash column 
chromatography (silica gel, hexanes:CH2Cl2, 9:1→5:2) to afford 16 (0.175 g, 77% yield) 
as a light yellow viscous oil, spectroscopically identical to previously synthesized 
material. 
 63.  Following the above procedure for the poylene cyclizations with IDSI at –25 
°C for 5 min using substrate 16, cyclization product 63 (0.013 g, 77% yield) was obtained 
as a colorless viscous oil.  63: Rf = 0.43 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 
2971, 2947, 2852, 1735, 1440, 1164, 1132 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.51 (br 
s, 1 H), 4.25 (dd, J = 12.8, 4.4 Hz, 1 H), 3.67 (s, 3 H), 2.90 (br s, 1 H), 2.42–2.25 (m, 2 
H), 2.20–2.02 (m, 2 H), 1.60 (br s, 3 H), 1.51 (q, J = 4.0 Hz, 1 H), 1.46 (m, 1 H), 1.43 
(dd, J = 11.4, 5.6 Hz, 1 H), 1.09 (s, 3 H), 1.04 (s, 3 H), 0.99 (s, 3 H); 13C NMR (75 MHz, 
CDCl3) δ 172.8, 129.1, 124.0, 61.9, 53.0, 51.3, 48.7, 43.3, 39.2, 36.5, 33.8, 33.3, 26.2, 
21.3, 21.1, 15.0; HRMS (FAB) calcd for C16H26IO2 [M+H]+ 377.0978, found 377.0977. 
 Alkene 65. DBU (0.160 mL, 1.00 mmol, 20 equiv) was added to a solution of 63 
(0.020 g, 0.048 mmol, 1.0 equiv) in pyridine (1 mL) at 25 °C. The resulting solution was 
heated with stirring at 80 °C for 12 h.  Upon completion, the reaction contents were 




mL).  The combined organic layers were washed with water (10 mL), dried (MgSO4), 
filtered, and concentrated.  The resulting light yellow oil was purified by flash column 
chromatography (silica gel, hexanes:CH2Cl2, 4:1) to afford alkene 65 (0.010 g, 86% 
yield) as a colorless viscous oil. 65: Rf = 0.43 (silica gel, hexanes:EtOAc, 9:1); IR (film) 
νmax 3011, 2955, 1722, 1431, 1281, 1211, 1021, 731 cm–1; 1H NMR (400 MHz, CDCl3) δ 
5.46 (ddd, J = 10.0, 5.6, 1.6 Hz, 1 H), 5.41 (dd, J = 10.4, 2.8 Hz, 1 H), 3.74 (s, 3 H), 
2.13–1.97 (m, 2 H), 2.04 (d, J = 16.8 Hz, 1 H), 1.78 (dd, J = 16.4, 5.6 Hz, 1 H), 1.68 (m, 
1 H), 1.64 (s, 3 H), 1.60–1.42 (m, 2 H), 1.18 (s, 3 H), 0.98 (s, 3 H), 0.92 (s, 3 H); 13C 
NMR (75 MHz, CDCl3) δ 170.9, 138.1, 136.6, 133.5, 121.3, 51.2, 47.6, 37.2, 36.0, 34.9, 
32.4, 31.8, 22.5, 21.3, 20.2, 19.5; HRMS (EI) calcd for C16H24O2 [M]+ 248.1776, found 
248.1761. 
 
Formal Synthesis of Loliolide 
 71.  Following the above procedure for the polyene cyclizations with IDSI at –25 
°C or 0 °C for 5 min using 70 or 68 respectively, cyclization product 71 (0.024 g, 79% 
yield, 19:1 inseparable diastereomers from 70 or 0.027 g, 88% yield from 68) was 
obtained as a white crystalline solid.  71: Rf = 0.53 (silica gel, hexanes: EtOAc, 4:1); IR 
(film) νmax 2957, 2871, 1774, 1457, 1188, 1126, 920 cm–1; Major diastereomer: 1H NMR 
(400 MHz, CDCl3) δ 4.08 (dd, J = 13.2, 4.8 Hz, 1 H), 2.59–2.48 (m, 2 H), 2.40 (dd, J = 
16.4, 6.8 Hz, 1 H), 2.29 (m, 1 H), 2.11 (dd, J = 14.4, 6.8 Hz, 1 H), 1.89–1.74 (m, 2 H) 
1.37 (s, 3 H), 1.03 (s, 3 H), 1.02 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 175.2, 84.9, 52.9, 
44.9, 40.0, 38.3, 35.0, 32.1, 30.9, 20.5, 19.8; HRMS (EI) calcd for C11H17IO2 [M]+ 




 Alkene 72. Dry LiCl (0.125 g, 2.95 mmol, 50 equiv) was added to a solution of 
iodide 71 (0.018 g, 0.060 mmol, 1.0 equiv) in DMF (2 mL) at 25 °C.  The resulting 
solution was heated with stirring at 80 °C for 12 h.  Upon completion, the reaction 
contents were quenched with saturated aqueous NH4Cl (10 mL).  Water (3 mL) was then 
added and the reaction mixture was extracted with Et2O (3 × 5 mL).  The combined 
organic layers were dried (MgSO4), filtered, and concentrated.  The resulting yellow oil 
was purified by flash column chromatography (silica gel, hexanes:EtOAc, 4:1) to afford 
alkene 72 (0.010 g, 97% yield) as a colorless amorphous solid.  72: Rf = 0.56 (silica gel, 
hexanes: EtOAc, 4:1); IR (film) νmax 2958, 2871, 1786, 1771, 1227, 1053, 952 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 5.55 (ddd, J = 10.0, 5.2, 2.0 Hz, 1 H), 5.50 (dd, J = 10.0, 2.8 
Hz, 1 H), 2.53–2.27 (m, 5 H), 1.33 (s, 3 H), 1.07 (s, 3 H), 1.04 (s, 3 H); 13C NMR (100 
MHz, CDCl3) δ 176.2, 138.2, 121.9, 85.0, 52.3, 38.6, 35.4, 31.8, 28.8, 20.7, 20.6; HRMS 
(EI) calcd for C11H16O2 [M]+ 180.1150, found 180.1146. 
 
Formal Synthesis of Stemodin 
74.  Procedure adapted from: Brown, R. C. D.; Bataille, C. J.; Hughes, R. M.; 
Kenney, A.; Luker, T. J. J. Org. Chem. 2002, 67, 8079.  Methyl acetoacetate (0.30 mL, 
2.8 mmol, 1.2 equiv) was added dropwise under constant flow of argon to a suspension of 
NaH (60% dispersion in mineral oil, 0.12 g, 3.0 mmol, 1.3 equiv) in THF (4 mL) at 0 °C.  
The reaction mixture was stirred for 30 min at 0 °C, then a solution of n-BuLi (1.6 M in 
hexanes, 1.7 mL, 2.8 mmol, 1.2 equiv) was added slowly and the resultant light orange 
solution was stirred an additional 10 min at 0 °C.  This dianion solution was cannulated 




0 °C.  After 15 min at 0 °C, diethyl chlorophosphate (0.67 mL, 4.6 mmol, 2.0 equiv) was 
then added dropwise at 0 °C.  The reaction mixture was allowed to warm slowly to 25 °C 
over the course of 90 min, then the reaction mixture was quenched with 0.25 M HCl (10 
mL) and extracted with EtOAc (3 x 10 mL).  The combined organic layers were washed 
with saturated aqueous NaHCO3 (10 mL), dried (MgSO4), filtered, and concentrated.  
The crude yellow oil was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1→5:2) to afford 74 (0.67 g, 72% yield) as a light yellow viscous oil, 
spectroscopically identical to previously synthesized material.  To synthesize derivatives 
of 74 found in Table 3, in place of the chlorophosphate, the same equivalents of either 
TIPSCl, TBSOTf, TBDPSCl, MOMCl, or Me3OBF4 were used. 
 75.  A solution of IDSI (0.097 g, 0.120 mmol, 1.2 equiv) in nitromethane (0.5 
mL) was added quickly via syringe to a solution of enol phosphate 74 (0.039 g, 0.100 
mmol, 1.0 equiv) in nitromethane (3.5 mL) at 25 °C.  After stirring for 5 min at 25 °C, 
the resulting mixture was poured into a solution of saturated aqueous NaHCO3:5% 
aqueous Na2SO3 (1:1, 10 mL) and stirred for an additional 15 min at 25 °C.  The reaction 
contents were then extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers 
were concentrated and the crude partially cyclized material was then dissolved in toluene 
(2 mL) and cooled to 0 °C. Concentrated H2SO4 (0.080 mL, 1.5 mmol, 15 equiv) was 
added dropwise to the solution and the resultant mixture was stirred for 30 min at 0 °C.  
Upon completion, the reaction contents were slowly quenched with saturated aqueous 
NaHCO3 (10 mL), and extracted with Et2O (3 × 10 mL).  The combined organic layers 
were dried (MgSO4), filtered, and concentrated.  The resulting brown oil was purified by 




adduct 75 (0.015 g, 40% yield) as a white crystalline solid. 75: Rf = 0.34 (silica gel, 
hexanes: EtOAc, 4:1); IR (film) νmax 2949, 1748, 1715, 1434, 1263, 1170, 1135 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 4.25 (dd, J = 12.8, 4.4 Hz, 1 H), 3.67 (s, 3 H), 3.21 (s, 1 H), 
2.53–2.28 (m, 4 H), 2.14 (m, 1 H), 1.90 (dq, J = 5.2, 12.8 Hz, 1 H), 1.65 (dd, J = 12.4, 3.2 
Hz, 1 H), 1.60 (dt, J = 13.2, 3.6 Hz, 1 H), 1.43 (dt, J = 4.4, 13.2 Hz, 1 H), 1.21 (s, 3 H), 
1.14 (s, 3 H), 1.07 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 204.4, 168.3, 69.4, 52.1, 51.7, 
51.0, 42.1, 41.9, 41.2, 39.6, 33.6, 33.5, 25.5, 21.2, 14.9; HRMS (FAB) calcd for 
C15H24IO3 [M+H]+ 379.0770, found 379.0772. 
 
Model System Towards the Formal Synthesis of Shonanol 
 83.  Procedure adapted from: Shing, T. K. M.; Yeung, Y.-Y.; Su, P. L. Org. Lett. 
2006, 8, 3149.  To a solution of alkene 27 (5 mg, 0.022 mmol, 1.0 equiv) in EtOAc (0.18 
mL) was added TBHP (5.5 M in decane, 20.5 µL, 0.11 mmol, 5.0 equiv) and 3Å 
molecular sieves (8 mg), and the reaction mixture was allowed to stir for 30 min at 25 °C.  
Next Mn(OAc)3•2H2O (0.6 mg, 0.0022 mmol, 0.1 equiv) was added and the solution was 
allowed to stir at 25 °C for 48 h.  Upon completion, the reaction contents were filtered 
through a pad of Celite with EtOAc (2 mL) and concentrated.  The crude benzylic 
oxidation adduct 83 was a resulting brown oil which was only tentatively characterized 
by 1H NMR. 
 85. Prepared adapted from: Brown, H. C.; Dhokte, U. P. J. Org. Chem. 1994, 59, 
2025.  To a stirred suspension of SeO2 (small spatula tip) and AcOH (0.05 µL, 0.0014 
mmol, 0.2 equiv) in 1,2-dichloroethane (50 µL) was added TBHP (5.5 M in decane, 3.8 




solution of alkene 83 (2 mg, 0.007 mmol, 1.0 equiv) in 1,2-dichloroethane (50 µL) was 
added and the reaction mixture was heated to 70 °C and stirred at this temperature for 12 
h.  Upon completion, the reaction contents were slowly quenched with saturated aqueous 
NaHCO3 (1 mL), and extracted with EtOAc (3 × 5 mL).  The combined organic layers 
were dried (MgSO4), filtered, and concentrated.  The crude oxidation adduct 85 was only 
tentatively characterized by 1H NMR. 
 
Model System Towards the Formal Synthesis of Celahypodiol 
 93.  To a solution of 28 (0.030 g, 0.085 mmol, 1.0 equiv) in AcOH (15 mL) was 
added AgOAc (0.017 g, 0.10 mmol, 1.2 equiv) at 25 °C and the reaction was allowed to 
stir for 12 h at 25 °C.  Upon completion, the reaction contents were slowly quenched with 
water (20 mL), and extracted with EtOAc (3 × 10 mL).  The combined organic layers 
were dried (MgSO4), filtered, and concentrated.  The resulting oil was purified by flash 
column chromatography (silica gel, hexanes:CH2Cl2, 9:1) to afford rearranged product 93 
(8 mg, 41% yield), only tentatively characterized by 1H NMR.  
 
Investigations Using CDSC 
 Chlorodiethylsulfonium hexachloroantimonate (94, CDSC).  A flask 
containing a stir bar and 1,2-dichloroethane (10 mL) was cooled to –30 °C.  Chlorine gas 
was then bubbled through the solvent for 1 min, yielding a transparent yellow solution.  
At this point the amount of Cl2 was measured in solution (~0.25 g, 3.5 mmol, 1.0 equiv).  
Et2S (0.41 mL, 3.9 mmol, 1.1 equiv) was then added dropwise to this solution at –30 °C 




mL, 4.2 mmol, 1.2 equiv) was then slowly added via syringe.  The resultant mixture was 
allowed to warm to 0 °C over the course of 30 min (precipitate dissolved).  To collect 
CDSC, hexanes (4 mL) was carefully pipetted onto the top of the solution and the layered 
solution was cooled to –20 °C for 12 h.  The resulting off-white powder was isolated by 
decanting off the liquid, rinsing with hexanes (2 x 1 mL), then drying under vacuum prior 
to use in cation-p cyclizations (1.45 g, 91% yield).   
 
Standard Procedure for Small-Scale Polyene Cyclizations with CDSC 
 A solution of CDSC (94, 0.050 g, 0.110 mmol, 1.1 equiv) in nitromethane (0.5 
mL) was added to a solution of the substrate (0.100 mmol, 1.0 equiv) in nitromethane 
(1.5 mL) at the temperature indicated.  After stirring for the indicated, the resulting 
mixture was poured into a solution of saturated aqueous NaHCO3:5% aqueous Na2SO3 
(1:1, 10 mL) and vigorously stirred for an additional 15 min at 25 °C.  The reaction 
contents were then extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers 
were dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography or preparative TLC to yield the desired cation-p cyclization products in 
the amount and yields shown below.  
 97.  Colorless viscous oil, 0.012 g of a mixture of 1.0:1.0 inseparable 
diastereomers, 46% combined yield; Rf = 0.56 (silica gel, hexanes: CH2Cl2, 9:1); IR 
(film) νmax 2945, 1452, 1262, 1027, 766, 726 cm–1; HRMS (EI) calcd for C17H23Cl [M]+ 
262.1488, found 262.1490; Equatorial chlorine diastereomer (97a): 1H NMR (400 MHz, 
CDCl3) δ 7.23 (m, 1 H), 7.15–7.04 (m, 3 H), 3.81 (dd, J = 12.0, 4.8 Hz, 1 H), 3.02–2.88 




4.2, 11.7 Hz, 1 H), 1.42 (dd, J = 12.0, 2.4 Hz, 1 H), 1.24 (s, 3 H), 1.15 (s, 3 H), 1.03 (s, 3 
H); 13C NMR (75 MHz, CDCl3) δ 148.9, 134.9, 129.1, 126.0, 125.7, 124.5, 72.8, 51.4, 
40.1, 38.9, 37.8, 30.8, 30.3, 29.3, 25.0, 20.0, 16.8. Axial chlorine diastereomer (97b): 1H 
NMR (400 MHz, CDCl3) δ 7.28 (m, 1 H), 7.17–7.03 (m, 3 H), 4.13 (t, J = 2.8 Hz, 1 H), 
3.01–2.83 (m, 2 H), 2.38 (m, 1 H), 2.20–2.06 (m, 2 H), 2.01 (m, 1 H), 1.87–1.79 (m, 2 
H), 1.28 (dd, J = 10.0, 2.4 Hz, 1 H), 1.22 (s, 3 H), 1.11 (s, 3 H), 1.09 (s, 3 H); 13C NMR 
(75 MHz, CDCl3) δ 149.5, 135.1, 129.1, 125.9, 125.5, 124.3, 71.9, 43.1, 38.6, 37.6, 32.0, 
31.0, 30.1, 27.8, 25.4, 23.0, 18.5. [Note: Though the above diastereomers are inseparable, 
characterization was accomplished by comparing our experimental spectra to that of 
previously synthesized equatorial diastereomers.  For instance, the equatorial 
diastereomer of 97 can be generated using our previously reported Hg(II)-based 
polyene cyclization of homogeranylbenzene:  Snyder, S. A.; Treitler, D. S.; Schall, A. 
Tetrahedron, 2010, 66, 4796]. 
 101. 5.3 mg of a 2.2:1.0 mixture of separable diastereomers, 18% combined yield; 
Major diastereomer: White crystalline solid; Rf = 0.14 (silica gel, hexanes: EtOAc, 7:3); 
IR (film) νmax 3419 (br), 2974, 1736, 1369, 1245, 1030 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 4.42 (dd, J = 12.0, 5.2 Hz, 1 H), 4.33 (dd, J = 12.0, 5.2 Hz, 1 H), 3.78 (dd, J = 
12.0, 4.0 Hz, 1 H), 2.48 (br s, 1 H), 2.07 (s, 3 H), 2.03 (m, 1 H), 1.91–1.80 (m, 2 H), 1.69 
(t, J = 5.2 Hz, 1 H), 1.59 (dt, J = 4.0, 13.6 Hz, 1 H), 1.24 (s, 3 H), 1.17 (s, 3 H), 0.96 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 171.1, 71.9, 70.7, 63.2, 55.8, 41.8, 40.0, 30.9, 29.1, 
24.0, 21.3, 16.4; HRMS (FAB) calcd for C12H22ClO3 [M+H]+ 249.1257, found 249.1261. 
Minor diastereomer: White crystalline solid; Rf = 0.21 (silica gel, hexanes: EtOAc, 7:3); 




CDCl3) δ 4.38 (dd, J = 12.0, 5.2 Hz, 1 H), 4.27 (dd, J = 11.6, 5.2 Hz, 1 H), 4.00 (m, 1 H), 
2.14 (br s, 1 H), 2.07 (s, 3 H), 2.07–1.92 (m, 3 H), 1.67 (m, 1 H), 1.26 (br s, 1 H), 1.24 (s, 
3 H), 1.18 (s, 3 H), 1.07 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 171.1, 72.2, 70.4, 62.8, 
39.5, 36.3, 29.8, 29.5, 28.6, 25.4, 23.8, 21.3; HRMS (FAB) calcd for C12H22ClO3 [M+H]+ 
249.1257, found 249.1263.  
 102.  White solid, 8.2 mg of a 4.0:1.0 mixture of separable diastereomers, 38% 
combined yield from 70, 4.4 mg of a 4.0:1.0 mixture of separable diastereomers, 20% 
combined yield from 68; Major diastereomer: Rf = 0.43 (silica gel, hexanes: EtOAc, 
4:1); IR (film) νmax 2947, 1776, 922, 670 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.77 (dd, J 
= 12.0, 4.8 Hz, 1 H), 2.52 (dd, J = 16.4, 14.4 Hz, 1 H), 2.37 (dd, J = 16.4, 6.8 Hz, 1 H), 
2.25 (m, 1 H), 2.05 (dt, J = 12.0, 3.6 Hz, 1 H), 2.01–1.87 (m, 2 H), 1.80 (dt, J = 4.0, 12.8 
Hz, 1 H), 1.37 (s, 3 H), 1.09 (s, 3 H), 0.99 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 175.6, 
84.7, 68.8, 54.9, 38.5, 37.6, 31.4, 29.9, 29.1, 20.6, 15.8; HRMS (FAB) calcd for 
C11H18ClO2 [M+H]+ 217.0995, found 217.1007. 
 
Chiral Polyene Cyclization  
 (2S,5S)-Hexanediol (103) was in turn produced by a yeast reduction of 2,5-
hexanedione according to the procedure in: Braun, W.;  Calmuschi, B.; Haberland, J.; 
Hummel, W.; Liese, A.; Nickel, T.; Stelzer, O.; Salzer, A. Eur. J. Inorg. Chem. 2004, 11, 
2235. 
(2R,5R)-Dimethylthiolane (104).  To a solution of (2S,5S)-hexanediol (103, 3.00 
g, 25.3 mmol, 1.0 equiv) and Et3N (21.2 mL, 152 mmol, 6.0 equiv) in CH2Cl2 (50 mL) at 




solution was then allowed to warm to 0 °C over 1 h before being quenched with 1 M HCl 
(100 mL) and extracted with CH2Cl2 (3 × 100 mL).  The combined organic layers were 
washed with brine (100 mL), dried (MgSO4), filtered, and concentrated to provide the 
desired bis-mesylated intermediate as a viscous oil that was used immediately without 
further purification.  Next, powdered Na2S•9H2O (12.2 g, 50.6 mmol, 2.0 equiv) was 
dissolved in EtOH (200 proof, 80 mL) and the resultant solution was cooled to 0 °C.  The 
crude bis-mesylate (25.3 mmol assumed, 1.0 equiv) was then added and the reaction 
contents were stirred at 0 °C for 4 h before being warmed slowly to 25 °C over the course 
of 4 h.  Next, the reaction mixture was stirred at 25 °C for an additional 36 h.  Upon 
completion, the reaction mixture was quenched with water (150 mL) and extracted with 
pentane (4 × 150 mL).  The combined organic layers were then washed with H2O (3 × 
100 mL) and brine (2 × 100 mL), dried (MgSO4), filtered, concentrated, and purified by 
vacuum distillation (→120 °C at 100 torr) to afford (2R,5R)-dimethylthiolane as a 
colorless liquid (104, 2.70 mL, contaminated with pentane, 65% yield) whose spectral 
properties matched: Julienne, K.; Metzner, P. J. Org. Chem. 1998, 63, 4532. 104: [α]D23 
= 109.1 (c = 1.74, Et2O); 65% e.e.  
 
105 (“Chiral IDSI”).   To a solution of thiolane 104 (3.30 g, 28.4 mmol, 1.0 
equiv) in 1,2-dichloroethane (370 mL) at –25 °C was added ICl (1.42 mL, 28.4 mmol, 1.0 
equiv) and SbCl5 (1.0 M in CH2Cl2, 29.5 mL, 29.5 mmol, 1.1 equiv).  After the reaction 
contents were stirred at –25 °C for 30 min, it was then allowed to warm to 25 °C.  The 
reaction contents were then layered with hexanes (600 mL) and cooled to –20 °C for 1 




(2 × 10 mL) and dried under vacuum to afford 105 (12.4 g, 76% yield) as an orange 
crystalline solid.  
 
Asymmetric Cyclization Attempts of Homogeranylbenzene: 
 A solution of 105 (0.053 g, 0.110 mmol, 1.1 equiv) in nitromethane (0.5 mL) was 
quickly added via syringe to a solution of homogeranylbenzene (44, 0.023 g, 0.100 
mmol, 1.0 equiv) in nitromethane (1.5 mL) at –25 °C.  After stirring for 5 min at –25 °C, 
the resulting mixture was poured into a solution of saturated aqueous NaHCO3:5% 
aqueous Na2SO3 (1:1, 10 mL) and the resultant biphasic mixture was stirred vigorously 
for 15 min at 25 °C.  The reaction contents were then extracted with CH2Cl2 (3 × 10 mL), 
and the combined organic layers were dried (MgSO4), filtered, and concentrated.  The 
resultant residue was purified by flash column chromatography (silica gel, hexanes: 
CH2Cl2, 9:1) to afford bicycle 28 (0.028 g; 78% yield) as a white crystalline solid.  HPLC 









































































 Over 100 years ago, the halogenation of alkenes was first discovered, and this 
reaction has remained a well-studied topic in the entering century.1  While consisting of a 
motif commonly found in nature, the chemical synthesis of enantiopure dihalides has 
proven quite challenging.2 Examining just a few naturally occurring 1,2-dihalides, a 
variety of combinations exist including the 1,2-dichloride found in the chlorosulfolipid 
family (such as 1)3 as well as the 1,2-bromochlorides present in Laurencia natural 
isolates (2)4 and halomon (3)5.  While multiple syntheses of each of these natural 
products exist, none are generated directly via enantiospecific halogenation of the 
corresponding alkene.  Indeed, no real solution for any asymmetric halogenation has been 
provided prior to a few selected examples from just the past few years.  
 
To approach the challenge of enantioselective halogenation, there are two major 
concerns that must be addressed.  The first, and easier problem, is that the opening of the 
generated halonium intermediate must be fully regioselective (Scheme 1).  Opening of 
the chiral halonium 5a at the starred carbon yields 6a, though a regioisomeric opening of 
5a would yield 6b, the enantiomer of 6a.  In order for an enantiopure product to be 
produced, opening at a single side of the cyclic halonium has to occur, or both 6a and 6b 




























The second, and more challenging problem, rests in the generation of the chiral 
halonium intermediate.  Not only does a 3-membered halonium have to form on a single 
face of an alkene (i.e. 5a or 5b), it is well known that halonium transfer to unreacted 
alkenes can erode enantioselectivity.6  As shown in Scheme 2, transfer of a chiral 
halonium 5a to alkene 4 would lead to both enantiomers of the halonium, 5a and 5b, 
dependent on the approach of the nucleophilic alkene, overall eroding any 
enantioselectivity of the initial halonium.  It is also important to note that the rates at 
which these different haloniums transfer follows the stability of each halonium, with the 
most stable ion, iodonium, transferring at the fastest rate6c,d and chloronium transfer 
































































Scheme 2: Mechanism of Halonium Transfer to an Unreacted Alkene
131
 
 There have been a few examples in the literature that are able to overcome these 
obstacles and generate enantiopure dihalides, two of which have shown some substrate 
generality.  The seminal example which produced synthetically useful enantiomeric 
excess was completed in our group as a key step in the total synthesis of napyradiomycin 
A1.7  Intermediate 8 was dichlorinated in 93% yield using Cl2 and ligand A to block a 
single face of the alkene.  While initially 87% ee was obtained, recrystallization allowed 
for an increase in this asymmetry. 
 
Next, Nicolaou and co-workers were able to expand dichlorination to a group of 
similar substrates in modest to good enantioselectivity (Scheme 3).8  Allylic alcohols, a 
common precursor in syntheses of the chlorosulfolipids, were chlorinated through the use 
of a PhICl2 derivative in combination with the chiral catalyst (DHQ)2PHAL, a dimeric 
p-Ph(C6H4)ICl2 (1.6 eq)
(DHQ)2PHAL (20 mol %)
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cinchona alkaloid derivative.  This catalyst/substrate combination was key as the 
hydrogen-bonding between the alcohol of the substrate and phthalazine moiety of the 
catalyst likely is the reason for the high enantioselectivity.  In support of this observation, 
both triethylsilane protection of 10 or the use of naphthalene core derivative of 
(DHQ)2PHAL led to low asymmetric induction.   
Beyond dichlorination, dibromides have also been synthesized in high 
enantioselectivites by two groups.9  First, the Henry group expanded upon their chiral 
chlorohydrin synthesis9a-d to include generation of 1,2-dibromides under modified 
Wacker conditions.9e  A more recent example comes from Burns and co-workers in an 
effort to synthesize enantiopure dibromides (Scheme 4).9f  Here, enantioselective 
dibromination of cinnamyl alcohol (10) and its derivatives was achieved with the use of 
diethyldibromomalonate as the bromonium source, BrTi(OiPr)3 as the Lewis base, and a 
TADDOL derivative to induce asymmetry.  The authors propose that the titanium-
derived Lewis base allowed for chelation to each component of the reaction mixture, 
enabling overall delivery of the bromonium electrophile and bromide nucleophile via an 
inner-sphere-type mechanism.  Under these conditions, a larger array of substitutions 
(both of electron rich and poor) as well as differently substituted arenes are tolerated 




 Given that there are just these few methods available for asymmetric 
dihalogenation, clearly there is room for additional approaches; due to the overall 
difficulty of both asymmetric halonium generation and regioselective opening, any new 
results would help chemists understand how to better solve these difficult problems since 
the field as a whole is underdeveloped.  At the onset of the discovery of the halonium 
reagents, BDSB, IDSI, and CDSC, it was quickly surmised that the diethyl sulfide 
backbone could be replaced with alternative Lewis bases, including chiral sulfide 
derivatives.  Thus, we hoped to develop an additional method to generate this valuable 
1,2-dihalogen motif enantioselectively with the use of chiral XDSX variants.   
 
3.2  Initial Results with Chiral Halonium Reagents 
Having achieved little success in enantioselective polyene cyclization in Chapter 
2, we turned to an alternative substrate class with a smaller array of challenges.  In 
particular using a substrate with only a single alkene, such as 1,2-dihydronaphthalene 
(14), would reduce halonium transfer to unreacted olefins relative to the two alkenes 
found in homogeranyl benzene.  Additionally, the chosen substrate should not have 
regioisomeric issues, as halide ring opening should be favored at the benzylic position.  






















Scheme 4: Burns and Coworkers' Enantioselective Dibromination
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At the onset of exploring this variant of asymmetric halogenation, we desired that the 
XDSX halonium reagents could access a variety of 1,2-dihalide combinations.  Initial 
results using chiral BDSB and CDSC were obtained by my colleague Dr. Daniel Treitler 
(Scheme 5).10  He discovered that treatment of 14 with chiral BDSB (15a) produced 
bromochloride 13, though only in trace enantioselectivity and yield; the SbCl6- counterion 
is the source of the chloride used here to quench the formed bromonium intermediate.  
Using chiral CDSC (15b), dichloride 16 was observed with 41% ee, though a poor yield 
was obtained as multiple other by-products were produced.  Optimization of both of these 
reactions was attempted, though further improvement in yields and enantioselectivities 
proved unattainable.  We predicted that the chloronium variant (15b) should produce 
higher enantioselectivities, as chloronium transfer to unreacted alkenes is a slower 
process than its bromonium counterpart.6g 
 
 With these initial results using the chiral bromonium and chloronium reagents 
producing poor yields and enantioselectivities, we next turned to our attention to chiral 
iodonium derivatives.  Following conditions similar to those used in successful polyene 
cyclizations, 1,2-dihydronaphthalene (14) was treated with chiral IDSI (18) in MeNO2 at 
-30ºC for 10 min, yielding the chloroiodide 17 (Scheme 6).  Attempted purification of this 











Reagents and Conditions: a. 15a (1 equiv), MeNO2/CH2Cl2, -30
oC, 10 min, 15% yield, <5% ee; b. 
15b (1 equiv), EtNO2, -78 to 0












iodonium reformation, a reactive intermediate that we believe readily decomposes.  
Synthesis and isolation of chloroidide 17 was completed previously with the use of solid 
supported ICl reagents, therefore no chromatography was needed to for purification.11  
Interestingly, when the reaction mixture was stirred for a longer period of time with water 
present, iodohydrin 19 was obtained instead in an isolated 62% yield.  Mechanistically, 
the initially installed chloride must be replaced with retention in the aqueous quench to 
give the trans-iodohydrin, presumably via iodonium reformation.  To our delight, 
iodohydrin 19 was generated in this reaction in 19% ee.  The absolute configuration of 
the iodohydrin was derived based on Mosher’s ester analysis as discussed in the 
Experimental Section (Section 3.7).12  Given the marked yield generated, we were 
hopeful this initial enantioselectivity could be improved by varying a number of 




3.3  Synthesis of Chiral Variants of IDSI 
Outside of the standard variations in solvent, temperature, and time, another major 
factor in obtaining optimal results was altering the chiral source.  Prior to discussing the 











Reagents and Conditions: a. 18 (1 equiv), MeNO2/CH2Cl2, -30
oC, 10 min; b. 18 (1 equiv), 
MeNO2/CH2Cl2, -30
oC, 10 min; H2O, 25












of chiral thiolanes for our optimization studies.  Of note is the design of these 
compounds, as the general XDSX reagent class is incompatible with electron-rich 
aromatic rings, carbonyls, alkenes, and alcohols.   
The first variations we attempted were substituents at the C2 and C5 of the 
potential core thiolane ring with different alkyl groups.  Preparation of the ethyl or iso-
propyl derivatives was completed using the appropriate chiral alcohol as shown in 
Scheme 7.  From the diol precursors, dimesylation and Na2S displacement yielded chiral 
thiolanes 21 and 24.13  Due to the larger groups at the C2 and C5 positions, we 
hypothesized that the thiolane may have racemized upon cyclization.  Indeed, Connon 
and co-workers synthesized the iso-propyl derivative (24) following the same reaction 
conditions and measured only 18% ee of the product 24.  Nevertheless, pushing forward, 
the isolable, solid chiral iodonium reagents were prepared by treatment with ICl and 
SbCl5. 
 
 To increase the overall steric bulk and allow π-stacking between the substrate and 
the halonium source, a diaryl thiolane was also synthesized as shown in Scheme 8.  The 
aryl ring chosen was 3,5-bis(trifluoromethyl)benzene, as its withdrawing groups were 








Reagents and Conditions: a. MsCl (4 equiv), Et3N (6 equiv), CH2Cl2, -20 to 0
oC, 1 h; 
c. Na2S•9H2O (2 equiv), EtOH, 25
oC; c. ICl (1 equiv), SbCl5 (1.1 equiv), DCE.




















not iodinate itself.  This synthesis began with double Weinreb amide formation14 and 
arylation15 of succinyl chloride to produce diketone 26.  A Corey-Bakshi-Shibata (CBS) 
reduction then allowed for the synthesis of enantiopure 27 in 78% yield.16  Typically, 
CBS reductions are performed between -10 and 25 ºC; here the reaction had to be heated 
to 40ºC (due to the insolubility of starting diketone 26 in THF) for productive reaction to 
occur.17  Subsequent dimesylation and cyclization with Na2S•9H2O yielded the diaryl 
thiolane 28 in good yield.  Comparison of this asymmetric material (28) to its racemic 
variant through chiral HPLC revealed the desired thiolane was prepared in 94% ee.  
Pleasingly, final transformation to the solid chiral iodonium reagent proceeded smoothly, 




 Lastly, a reagent with additional substitution on the thiolane backbone was also 
synthesized, by substrate 35 (Scheme 9).  Derived from D-mannitol, all chirality in this 
reagent was purchased, meaning that only manipulation of each functional group had to 
be completed to transform commercially-available 31 into the desired dimethoxy 
dimethyl thiolane (35).18  As shown, initial dimethylation of 31, ketal cleavage, and 
bistosylation produced intermediate 33 in 61% yield.  Next, treatment with LiAlH4 
displaced each of the primary leaving groups.  Mechanistically, this process occurs via 
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Reagents and Conditions: a. MeNHOMe•HCl (3 equiv), Et3N (4 equiv), CH2Cl2,
25oC, 3 h; b. 1-bromo-3,5-bis(trifluoromethyl)benzene (3 equiv), nBuLi (3 equiv),
Et2O, -78 to 25
oC, 4 h, 53%; c. 30 (0.15 equiv), B(OMe)3 (0.2 equiv), BH3•SMe2 (2.2 
equiv), THF, 40oC, 30 min, 78%; d. MsCl (4 equiv), Et3N (6 equiv), CH2Cl2, -20 to
0oC, 1 h; e. Na2S•9H2O (2 equiv), EtOH, 25
oC, 30 min, 53%; f. ICl (1 equiv), SbCl5










position of the generated epoxide.  With chiral diol 34 in hand, bismesylation and 
substitution then produced 35 in 13% overall yield.  Throughput here likely reflects the 
additional steric bulk provided by the methyl ethers since their positing in a ring requires 
that at least two groups sit pseudo-axially.  Attempts to generate an isolable solid 
iodonium reagent from 35 were unsuccessful and in situ generation of the reagent was 
deployed instead for all subsequent reactions with this chiral sulfide. 
 
 
3.4 Enantioselective Iodohydrin Formation 
With the synthesis of these chiral iodonium reagents completed, we next studied 
their effectiveness at transferring an iodonium electrophile asymmetrically.    Initial 
optimization was performed by my colleague, Dr. Daniel Treitler, and was focused on 
solvent, temperature, and time, overall leading to the major improvements displayed in 
Scheme 10.  Interestingly, 2.2 equivalents of the chiral reagent proved to be optimal, 
possibly suggesting the aggregation of at least two monomers in solution.  The change of 






































Reagents and Conditions: a. NaH (4 equiv), MeI (3 equiv), THF, 25oC, 1 h b. 70% aq AcOH, 40oC, 2
h; TsCl (2.2 equiv), pyridine, 0oC, 4 h, 61%; c. LiAlH4 (2.5 equiv), THF, 25
oC, 12 h, 27%; e. MsCl (4
equiv), Et3N (6 equiv), CH2Cl2, -20 to 0
oC, 1 h; f. Na2S•9H2O (2 equiv), EtOH, 25
oC, 30 min, 13%; g. 
ICl (1 equiv), SbCl5 (1.1 equiv), DCE, -25
oC, 30 min.
Scheme 9: Synthesis of Chiral Thiolane 35
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reduced, while achieving greater enantioselectivities, though longer reaction times were 
needed to drive the process to completion.  The solvent choice may have had additional 
effects on the reaction success that are less obvious.   
 
For instance, it has been shown that MeCN is a more coordinating solvent than 
nitromethane [DN (MeNO2) = 2.7 kcal/mol vs DN (MeCN) = 14.1 kcal/mol; DN = 
donicity value calculated as –ΔH of the electron pair donor to SbCl5].19  Thus overall, the 
presence of MeCN may have increased coordination to the 3-membered iodonium 
intermediate (by its own solvation) thereby decreasing the likelihood of iodonium 
transfer to unreacted alkenes.6  Collectively, putting these reaction alterations in practice 
allowed for the generation of iodohydrin 19 in 74% yield and 53% ee.  By quenching the 
reaction with MeOH instead of water, methyl ether 36 could be isolated instead in 67% 





















Reagents and Conditions: a. 18 (2.2 equiv),
MeCN/CH2Cl2, -78 to -20
oC, 1 h; H2O, 25
oC, 30 min, 
74% yield, 53% ee; b. 18 (2.2 equiv), MeCN/CH2Cl2,
-78 to -20oC, 1 h; MeOH, 25oC, 30 min, 67% yield,
33% ee;
Scheme 10: Optimizaition Results to Generate Iodohydrin 19






 Next, we explored the alternative chiral halonium sources in the newly found 
iodohydrin formation reaction.  Use of the synthesized iodonium reagent 22 produced the 
desired iodohydrin 19 in 67% yield with increased enantioselectivity at 63% ee (Scheme 
11).  Interestingly, however, use of the iso-propyl derivative produced methyl ether 36 
with only 18% ee.  Yet examining the aryl thiolane iodonium reagent 29, the iodohydrin 
was obtained with only 13% ee (Scheme 12); this was the first case in which the reduced 
thiolane 28 was re-isolated after the reaction completion.  Further analysis of 28 revealed 
the thiolane had retained 93% ee, implying that no erosion of the thiolane occurred under 
the reaction conditions.  Increasing the steric bulk of the thiolane initiator (from Me < Et 
< iPr < Aryl), decreases the ee, possibly making it difficult for the substrate to properly 





















Reagents and Conditions: a. 22 (2.2 equiv),
MeCN/CH2Cl2, -78 to -20
oC, 1 h; H2O, 25
oC, 30 min, 
67% yield, 63% ee; b. 25 (2.2 equiv), MeCN/CH2Cl2,
-78 to -20oC, 1 h; MeOH, 25oC, 30 min, 59% yield,
18% ee.






The final examination of the chiral thiolane with substitution along the C3 and C4 
positions was a bit more challenging.  As previously stated, isolation of a solid iodonium 
reagent was difficult, so the reagent was generated in situ.  Treatment of thiolane 35 with 
ICl and SbCl5 in CH2Cl2 yielded the desired iodonium intermediate 37 (Scheme 13).  
Addition of the alkene 14 under the standard reaction conditions produced the desired 
iodohydrin in 53% yield with 24% ee.   
 
Globally, analysis of all the synthesized thiolane derivatives revealed the ethyl 
thiolane 22 to be superior, generating 19 in 67% yield with 63% ee.  With an increased 
yield and enantioselectivity in hand, we next examined 1,2-dihydronaphthalene 
derivatives in hopes of revealing a substrate scope for the developed protocol, as well as a 
potentially better substrate/halonium initiator match (Scheme 14).  The initial idea was to 
increase the stability of the benzylic position to either a) increase electrophilicity, which 






















Reagents and Conditions: a. 29 (2.2 equiv), MeCN, -78 to -20oC, 1 h; H2O, 25
oC, 30 min.















14; H2Oa. ICl, SbCl5
Reagents and Conditions: a. ICl (2.2 equiv), SbCl5 (2.2 equiv), CH2Cl2, -25 to 0
oC, 1 h 
then 14 (1 equiv), MeCN, -78 to -20oC, 1 h; H2O, 25
oC, 30 min.
Scheme 13: Use of Initiating Reagent 37 for Asymmetric Iodohydrin Formation
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intermediate to decrease potential transfer to unreacted alkenes.  This task could easily be 
performed by installing an electron donating group onto the aryl ring at the ortho- or 
para-positions.  Substrate 38 was presumed to have this effect, though the final results 
were less than desirable, with iodohydrin 39 obtained in an increased yield (80%) but 
with only 21% ee.  Addition of steric bulk on the arene in the form of a bromine 
(substrate 40) produced 41 in a 50% yield with little enantioselectivity (5% ee) upon 
treatment with chiral iodonium reagent 18.  Larger modifications to the substrate, 
including acyclic trans-β-methylstyrene (42) or indene (44), both led to very low yields 






























Reagents and Conditions: a. 18 (2.2 equiv),














The development of a method to achieve the asymmetric iodohydrin of 1,2-
dihydronaphthalene was accomplished using a chiral IDSI derivative.  With the synthesis 
of numerous chiral thiolane analogs and reaction optimization, the desired iodohydrin 
was produced in 67% yield with 63% ee.  Remarkably this example is one of only a 
handful which has afforded a chiral iodonium in >50% ee.  This result is proof of concept 
that these chiral reagents are capable of transferring an iodonium atom asymmetrically.  
Incomplete transfer of the enantioselectivity could be due to a) poor catalyst/substrate 
match leading to incomplete transfer of asymmetry or b) iodonium transfer to unreacted 
alkenes in solution.  While both of these processes are possible, it is unclear at this time 
which one (or both) might be the underlying factor in preventing production of 
enantiopure products.  As mentioned, this developed method seems to be highly substrate 
specific, as substrates with only slight modifications underwent iodohydrin formation 
largely in racemic fashion.  Additionally, the overall approach has room for further 
improvement, as use of 2.2 equivalents of the chiral reagent is not ideal, especially if a 
multiple step synthesis of the needed reagent is necessary.  Nevertheless, the synthesized 
chiral XDSX reagents are the first class of isolable asymmetric halonium reagents 
capable of producing products with promising enantioselectivity and path the way for 
future explorations along these lines.  These results were also highlighted in a review 
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3.7 Experimental Section 
 General Procedures.  All reactions were carried out under an argon atmosphere 
with dry solvents under anhydrous conditions, unless otherwise noted.  Dry methylene 
chloride (CH2Cl2), benzene, toluene, diethyl ether (Et2O) and tetrahydrofuran (THF) were 
obtained by passing commercially available pre-dried, oxygen-free formulations through 
activated alumina columns; acetonitrile (MeCN) was dried over 3 Å molecular sieves, 
distilled, and stored over 3 Å molecular sieves; pyridine was distilled from CaH2 and 
stored over 3 Å molecular sieves; triethylamine (Et3N) was distilled from KOH; N,N-
dimethylformamide (DMF) was stored over 3 Å molecular sieves; 1,2-dichloroethane, 
acetone, ethanol (EtOH) and methanol (MeOH) were purchased in anhydrous form from 
Sigma-Aldrich and used as received.  Yields refer to chromatographically and 
spectroscopically (1H and 13C NMR) homogeneous materials, unless otherwise stated.  
Reagents were purchased at the highest commercial quality and used without further 
purification, unless otherwise stated.  Reactions were magnetically stirred and monitored 
by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck silica gel plates 
(60F-254) using UV light as visualizing agent and an aqueous solution of 
phosphomolybdic acid and cerium sulfate, and heat as developing agents.  Preparative 
thin-layer chromatography was carried out on 0.50 mm E. Merck silica gel plates (60F-
254).  SiliCycle silica gel (60, academic grade, particle size 0.040–0.063 mm) was used 
for flash column chromatography.  NMR spectra were recorded on Bruker DRX-300 and 
DRX-400 instruments and calibrated using residual undeuterated solvent as an internal 
reference.  The following abbreviations were used to explain the multiplicities: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, AB = AB quartet, br = broad, 
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app = apparent.  IR spectra were recorded on a Nicolet Avatar 370 DTGS series FT-IR 
spectrometer. High-resolution mass spectra (HRMS) were recorded in the Columbia 
University Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB 
(Fast Atom Bombardment) and EI (Electron Ionization) techniques.  All enantiomeric 
excess (e.e.) values were obtained by HPLC using a Daicel CHIRALCEL OD column. 
 Abbreviations.  AcOH = acetic acid, BH3•Me2S = borane dimethyl sulfide 
complex, n-BuLi = n-butyl lithium, t-BuLi = tert-butyl lithium, 4-DMAP = 4-
(dimethylamino)pyridine, EtOAc = ethyl acetate, EtOH = ethanol, IPA = iso-propanol, 
MeI = iodomethane, MsCl = methanesulfonyl chloride, p-TsCl = para-toluenesulfonyl 
chloride. 
 
(2R,5R)-Dimethylthiolane (Precursor to 18).  To a solution of (2S, 5S)-
hexandiol (3.00 g, 25.3 mmol, 1.0 equiv) and Et3N (21.2 mL, 152 mmol, 6.0 equiv) in 
CH2Cl2 (50 mL) at –20 °C was added MsCl (7.83 mL, 101 mmol, 4.0 equiv) dropwise.  
The reaction solution was then allowed to warm to 0 °C over 1 h before being quenched 
with 1 M HCl (100 mL) and extracted with CH2Cl2 (3 × 100 mL).  The combined organic 
layers were washed with brine (100 mL), dried (MgSO4), filtered, and concentrated to 
provide the desired bis-mesylated intermediate as a viscous oil that was used immediately 
without further purification.  Next, powdered Na2S•9H2O (12.2 g, 50.6 mmol, 2.0 equiv) 
was dissolved in EtOH (200 proof, 80 mL) and the resultant solution was cooled to 0 °C.  
The crude bis-mesylate (25.3 mmol assumed, 1.0 equiv) was then added and the reaction 
contents were stirred at 0 °C for 4 h before being warmed slowly to 25 °C over the course 
of 4 h.  Next, the reaction mixture was stirred at 25 °C for an additional 36 h.  Upon 
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completion, the reaction mixture was quenched with water (150 mL) and extracted with 
pentane (4 × 150 mL).  The combined organic layers were then washed with H2O (3 × 
100 mL) and brine (2 × 100 mL), dried (MgSO4), filtered, concentrated, and purified by 
vacuum distillation (→120 °C at 100 torr) to afford (2R,5R)-dimethylthiolane as a 
colorless liquid (2.70 mL, contaminated with pentane, 65% yield) whose spectral 
properties matched: Julienne, K.; Metzner, P. J. Org. Chem. 1998, 63, 4532. [α]D23 = 
109.1 (c = 1.74, Et2O); 65% e.e.  
18 (“Chiral IDSI”).   To a solution of (2R,5R)-dimethylthiolane (3.30 g, 28.4 
mmol, 1.0 equiv) in 1,2-dichloroethane (370 mL) at –25 °C was added ICl (1.42 mL, 28.4 
mmol, 1.0 equiv) and SbCl5 (1.0 M in CH2Cl2, 29.5 mL, 29.5 mmol, 1.1 equiv).  After the 
reaction contents were stirred at –25 °C for 30 min, it was then allowed to warm to 25 °C.  
The reaction contents were then layered with hexanes (600 mL) and cooled to –20 °C for 
1 week.  The filtrate was decanted and the resultant crystals were washed with cold 
CH2Cl2 (2 × 10 mL) and dried under vacuum to afford 18 (12.4 g, 76% yield) as an 
orange crystalline solid.  
trans-1-Hydroxy-2-iodotetralin (19). A solution of 1,2-dihydronaphthalene (14, 
5.0 mg, 0.038 mmol, 1.0 equiv) in MeCN (0.2 mL) and CH2Cl2 (0.5 mL) was cooled to –
78 °C.  A separate solution of chiral reagent 18 (48 mg, 0.084 mmol, 2.2 equiv) in MeCN 
(0.3 mL) was added to the substrate slowly down the side of the flask.  The resultant 
reaction solution was then allowed to warm slowly from –78 °C to –20 °C over the 
course of 1 h before being quenched by the sequential and rapid addition of MeCN (1.0 
mL) and H2O (1.0 mL).  The cold bath was removed, and the resultant solution was 
stirred at 25 °C for 1 h.  Upon completion, 5% aqueous Na2SO3 (1 mL) and saturated 
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aqueous NaHCO3 (1 mL) were added, and this heterogeneous mixture was then stirred 
vigorously at 25 °C for 20 min before being poured into H2O (2 mL) and extracted with 
CH2Cl2 (3 × 5 mL).  The combined organic layers were then dried (MgSO4), filtered, 
concentrated, and purified by column chromatography (silica gel, hexanes:EtOAc, 
9:1→7:3) to afford 19 (8 mg, 74% yield) as a white crystalline solid.  19: Rf = 0.46 (silica 
gel, hexanes:EtOAc, 7:3); IR (film) νmax 3243 (br), 2903, 1419, 1203, 979, 774, 741 cm–
1; 1H NMR (400 MHz, CDCl3) δ 7.52 (m, 1 H), 7.30–7.24 (m, 2 H), 7.14 (m, 1 H), 5.03 
(t, J = 5.6 Hz, 1 H), 4.52 (td, J = 6.8, 3.2 Hz, 1 H), 2.94 (t, J = 6.4 Hz, 2 H), 2.54–2.45 
(m, 2 H), 2.36 (m, 1 H); 13C NMR (100 MHz, CDCl3) δ 135.2, 135.1, 128.7, 128.5, 
128.1, 126.7, 75.1, 36.0, 30.8, 29.3; HRMS (EI) calcd for C10H11IO [M]+ 273.9855, 
found 273.9858; HPLC (OD column, 1.0 mL/min, 50:1 hex:IPA, 30 °C, 265 nm, tR 
(major) = 9.94 min, tR (minor) = 12.31 min): 53% e.e.  The absolute configuration of 19 
was determined based on Mosher’s ester analysis: Hoye, T. R.; Jeffrey, C. S.; Shao, F. 
Nature Protocols 2007, 2, 2451.  This reaction was performed with both (R)- and (S)-
Mosher’s acid separately, and the major diastereomer produced in each case was then 
characterized by 1H NMR.  Specifically, to a solution of methoxy-α-
trifluoromethylphenylacetic acid (39.8 mg, 0.17 mmol, 2.0 equiv) in hexane (2.3 mL) at 
25 °C was sequentially added DMF (4.5 mL, 0.058 mmol, 1.0 equiv) and oxalyl chloride 
(25 mL, 0.29 mmol, 5.0 equiv).  The reaction solution was then stirred at 25 °C for 1 h, 
filtered through Celite, rinsed with hexanes (2 × 1 mL), and concentrated.  Next, a 
solution of the resultant crude acid chloride (0.17 mmol assumed) and iodohydrin 19 (16 
mg, 0.058 mmol, 1.0 equiv) in CH2Cl2 (0.12 mL) was cooled to 0 °C and 4-DMAP (0.07 
mg, 0.0006 mmol, 0.01 equiv) and Et3N (40 mL, 0.29 mmol, 5.0 equiv) were added 
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sequentially.  The reaction contents were then allowed to warm slowly to 25 °C over the 
course 2 h, quenched with 1 M HCl (1 mL), and extracted with CH2Cl2 (3 × 5 mL).  The 
combined organic layers were dried (MgSO4), filtered, concentrated, and purified by 
column chromatography (silica gel, hexanes:EtOAc, 9:1) to afford the major 
diastereomer ester as a white crystalline solid.  (R)-Mosher’s ester: (5.0 mg, 17% yield); 
1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 7.5 Hz, 2 H), 7.41–7.28 (m, 5 H), 7.22 (t, J = 
7.0 Hz, 1 H), 7.17 (d, J = 7.5 Hz, 1 H), 6.41 (d, J = 3.0 Hz, 1 H), 4.60 (q, J = 3.5 Hz, 1 
H), 3.49 (s, 3 H), 3.01 (dt, J = 17.0, 6.0 Hz, 1 H), 2.83 (dq, J = 17.5, 3.0 Hz, 1 H), 2.08–
1.93 (m, 2 H).  (S)-Mosher’s ester: (5.6 mg, 20% yield); 1H NMR (500 MHz, CDCl3) δ 
7.49 (d, J = 7.0 Hz, 2 H), 7.41–7.34 (m, 3 H), 7.26 (m, 1 H), 7.19–7.12 (m, 3 H), 6.40 (d, 
J = 3.5 Hz, 1 H), 4.68 (q, J = 4.0 Hz, 1 H), 3.49 (s, 3 H), 3.01 (dt, J = 17.0, 8.0 Hz, 1 H), 
2.85 (dt, J = 17.5, 4.5 Hz, 1 H), 2.15 (quintet, J = 4.5 Hz, 1 H). 
(2S,5S)-Diethylthiolane (21). Prepared according to the procedure used to 
synthesize (2R,5R)-dimethylthiolane.  The cyclization with Na2S•9H2O was performed at 
25 °C for 22 h. (2S,5S)-Diethylthiolane (0.28 g, contaminated with pentane, 75% yield) 
was obtained as a colorless liquid.  Rf = 0.62 (silica gel, hexanes:CH2Cl2, 9:1); IR (film) 
νmax 2939, 1275, 1266, 767, 750 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.36–3.28 (m, 2 H), 
2.23–2.14 (m, 2 H), 1.71–1.60 (m, 2 H), 1.60–1.48 (m, 4 H), 0.95 (t, J = 7.2 Hz, 6 H); 13C 
NMR (100 MHz, CDCl3) δ 51.4 (2 C), 36.9 (2 C), 30.6 (2 C), 13.4 (2 C); HRMS: no 
molecular ion peak was observed; [a]D23 = -38.4 (c = 0.65, CHCl3). 
22. Prepared according to the procedure used to synthesize 18.  Compound 22 




(2R,5R)-Di-iso-propylthiolane (24). Prepared according to the procedure used to 
synthesize (2R,5R)-dimethylthiolane.  The cyclization with Na2S•9H2O was performed at 
25 °C for 7 d.  (2R,5R)-Di-iso-propylthiolane (0.60 g, contaminated with pentane, 50% 
yield) was obtained as a colorless liquid whose spectral properties that matched literature 
data: Piccinini, A.; Kavanaugh, S. A.; Connon, P. B.; Connon, S. J. Org. Lett. 2010, 12, 
608. 
25. Prepared according to the procedure used to synthesize 18.  Compound 25 
(0.15 g, 48%) was obtained as an orange crystalline solid. 
26. Prepared according to a procedure adapted from: (a) Déziel, R.; Goulet, S.; 
Grenier, L.; Bordeleau, J.; Bernier, J. J. Org. Chem. 1993, 58, 3619; (b) Prasad, K. R. K.; 
Joshi, N. N. J. Org. Chem. 1996, 61, 3888; (c) Kumar, G. D. K.; Chavarria, G. E.; 
Charlton-Sevcik, A. K.; Arispe, W. M.; MacDonough, M. T.; Strecker, T. E.; Chen, S.-
E.; Siim, B. G.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G. Bioorg. Med. Chem. Lett. 
2010, 20, 1415.  N,O-Dimethylhydroxylamine hydrochloride (4.10 g, 42.0 mmol, 3.0 
equiv) was azeotroped with toluene, sealed under argon, and cooled to 0 °C.  CH2Cl2 
(32.6 mL) and Et3N (7.8 mL, 56 mmol, 4.0 equiv) were then added sequentially at 0 °C.  
The resultant suspension was then stirred for 10 min at 0 °C before a solution of succinyl 
chloride (1.54 mL, 14.0 mmol, 1.0 equiv) in CH2Cl2 (10.7 mL) was added at 0 °C.  The 
reaction solution was then allowed to warm to 25 °C over the course of 3 h.  Upon 
completion, the reaction contents were quenched with H2O (10 mL) and extracted with 
EtOAc (3 × 10 mL).  The combined organic layers were then dried (MgSO4), filtered, and 
concentrated to afford the crude bis-Weinreb amide (only a portion of which was carried 
forward in the next operation).  Next, a solution of 3,5-bis(trifluoromethyl)bromobenzene 
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(0.75 mL, 4.5 mmol, 3.0 equiv) was dissolved in Et2O (5.0 mL), cooled to –78 °C and n-
BuLi (1.6 M in Et2O, 2.8 mL, 4.5 mmol, 3.0 equiv) was added dropwise to produce the 
desired aryl lithium species following an additional 1 h of stirring at –78 °C.  In a 
separate flask, a suspension of crude bis-Weinreb amide (0.31 g, 1.5 mmol, 1.0 equiv) in 
Et2O (5.0 mL) was cooled to –78 °C.  The so-prepared aryllithium solution was then 
added to this suspension of diamide at –78 °C, and the resultant reaction mixture was 
allowed to warm to 25 °C over the course of 3 h and stirred for an additional 1 h at 25 °C.  
Upon completion, the reaction contents were quenched with 1 M HCl (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic layers were then dried 
(MgSO4), filtered, concentrated, and purified by recrystallization by dissolving the crude 
solid in hot EtOAc (4 mL), cooling the resultant solution to 25 °C, and then layering it 
with hexanes (1 mL) and cooling it to –20 °C for 12 h; the filtrate was decanted and the 
resultant crystals were washed with cold hexanes (2 × 1 mL) and dried under vacuum to 
afford the diaryl ketone intermediate 26 (0.40 g, 53% yield over 2 steps) as a shiny 
orange/yellow crystalline solid.   
27. (S)-α,α-Diphenyl-2-pyrrolidinemethanol (7.7 mg, 0.030 mmol, 0.15 equiv) 
was azeotroped with toluene (1.0 mL), sealed under argon, and then dissolved in THF 
(0.3 mL).  Trimethylborate (4.5 mL, 0.040 mmol, 0.20 equiv) was added at 25 °C and the 
reaction contents were stirred at 25 °C for 1 h, at which time BH3•Me2S (42 mL, 0.44 
mmol, 2.2 equiv) was added.  After stirring at 25 °C for 10 min, THF (0.5 mL) was added 
followed by solid diaryl ketone (0.10 g, 0.20 mmol, 1.0 equiv).  The reaction solution 
was then heated at 40 °C for 30 min before being re-cooled to 25 °C, quenched with 1 M 
HCl (4 mL), and extracted with EtOAc (3 × 10 mL).  The combined organic layers were 
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then dried (MgSO4), filtered, concentrated, and purified by column chromatography 
(silica gel, hexanes:EtOAc 9:1→1:1) to afford the diaryl diol 27 (0.080 g, 78% yield) as a 
white crystalline solid. 27: Rf = 0.53 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3384 
(br), 3283 (br), 2927, 1275, 1167, 1122, 898, 682 cm–1; 1H NMR (400 MHz, (CD3)2CO) 
δ 8.03 (s, 4 H), 7.90 (s, 2 H), 5.08–4.97 (m, 2 H), 4.90 (br d, J = 18.4 Hz, 2 H), 2.05–1.94 
(m, 3 H), 1.85 (m, 1 H); 13C NMR (100 MHz, (CD3)2CO) δ 150.6, 150.6, 131.9 (q, J = 
32.6 Hz, 4 C), 127.3 (4 C), 124.6 (q, J = 270.3 Hz, 4 C), 121.4 (t, J = 3.6 Hz, 2 C), 72.8, 
72.6, 36.4, 36.3; HRMS: no molecular ion peak was observed.  
28. The diaryl thiolane 28 was prepared according to the procedure used to 
synthesize (2R,5R)-dimethylthiolane.  The cyclization with Na2S•9H2O was performed at 
25 °C for 30 min.  The diaryl thiolane 28 (0.068 g, 53% yield) was obtained as a white 
crystalline solid.  Rf = 0.27 (silica gel, hexanes:CH2Cl2, 9:1); IR (film) νmax 2934, 2859, 
1376, 1275, 1123, 681 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.93 (s, 4 H), 7.80 (s, 2 H), 
5.02–4.96 (m, 2 H), 2.77–2.67 (m, 2 H), 2.21–2.09 (m, 2 H); 13C NMR (100 MHz, 
CDCl3) δ 144.5 (2 C), 132.0 (q, J = 33.2 Hz, 4 C), 128.0 (4 C), 123.2 (q, J = 271.1 Hz, 4 
C), 121.6 (quintet, J = 3.8 Hz, 2 C), 53.6 (2 C), 41.2 (2 C); HRMS (FAB) calcd for 
C20H11F12S [M–H]+ 511.0390, found 511.0373; HPLC (OD column, 1.0 mL/min, 50:1 
hex:IPA, 30 °C, 200 nm, tR (major) = 4.11 min, tR (minor) = 4.63 min): 94% e.e. 
29. Prepared according to the procedure used to synthesize 18.  Compound 29 
(0.17 g, 92%) was obtained as a yellow crystalline solid. 
 33. Prepared according to a procedure adapted from: Hanaya, T.; Nakamura, Y.; 
Yamamoto, H. Heterocycles 2007, 74, 983.  To a stirred suspension of NaH (60% 
dispersion in mineral oil, 1.28 g, 38.1 mmol, 4.0 equiv) in THF (6.5 mL) at 0 °C was 
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added slowly a solution of 1,2:5,6-di-O-isopropylidene-D-mannitol (31, 2.50 g, 9.53 
mmol, 1.0 equiv) in THF (2.0 mL).  The resultant suspension was then stirred at 0 °C for 
30 min.  MeI (1.78 mL, 28.6 mmol, 3.0 equiv) was then added dropwise, and the reaction 
contents were stirred for 1 h at 25 °C.  Upon completion, the solution was cooled to 0 °C, 
quenched by the slow addition of H2O (10 mL), and extracted with EtOAc (3 × 10 mL).  
The combined organic layers were then dried (MgSO4), filtered, and concentrated to 
afford the desired crude bis-methylated mannitol derivative.  Moving forward without 
any additional purification, this crude intermediate was dissolved in 70% aqueous AcOH 
(25 mL) and heated to 40 °C for 2 h.  The reaction contents were then cooled to 25 °C, 
and concentrated directly with toluene coevaporations (6 × 25 mL) to remove all of the 
AcOH and H2O.  The resultant crude tetraol was then dissolved in dry pyridine (28 mL), 
cooled to 0 °C, and p-TsCl (4.09 g, 21.4 mmol, 2.25 equiv) was added.  The resultant 
solution was then stirred at 0 °C for 4 h.  Upon completion, the reaction contents were 
quenched by the addition of H2O (3 mL) and directly concentrated using toluene 
coevaporations (3 × 10 mL) to remove any residual pyridine.  The resultant crude mixture 
was then redissolved in CH2Cl2 (10 mL) and washed with H2O (2 × 10 mL).  The organic 
layer was then dried (MgSO4), filtered, concentrated, and purified by column 
chromatography (silica gel, hexanes:EtOAc 7:3→1:4) to afford the desired bis-tosylated 
intermediate 33 (3.0 g, 61% yield over 3 steps) as a yellow amorphous solid.   
34. The bis-tosylate 33 (3.0 g, 5.78 mmol, 1.0 equiv) was dissolved in THF (27 
mL), cooled to 0 °C, and solid LiAlH4 (0.548 g, 14.5 mmol, 2.5 equiv) was added in five 
separate portions over the course of 30 min.  The resultant slurry was then stirred at 25 
°C for 12 h, cooled to 0 °C, and quenched slowly with H2O (10 drops).  The resultant 
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suspension was then filtered through Celite and rinsed with MeOH (5 mL).  The filtrate 
was then concentrated and purified by column chromatography (silica gel, 
CH2Cl2:MeOH, 9:1) to afford (2R,3R,4R,5R)-3,4-dimethoxyhexane-2,5-diol (34, 0.044 g, 
27% yield over 4 steps) as a white crystalline solid.  34: Rf = 0.58 (silica gel, 
CH2Cl2:MeOH, 9:1); IR (film) νmax 3443 (br), 3378 (br), 2969, 2839, 1111, 1028 cm–1; 
1H NMR (400 MHz, CDCl3) δ 4.07 (t, J = 5.2 Hz, 2 H), 3.50 (s, 6 H), 3.32–3.28 (m, 2 H), 
2.98 (br s, 2 H), 1.26 (d, J = 6.4 Hz, 6 H); 13C NMR (100 MHz, CDCl3) δ 83.2 (2 C), 
66.8 (2 C), 58.7 (2 C), 19.9 (2 C); HRMS (FAB) calcd for C8H19O4 [M+H]+ 179.1283, 
found 179.1293. 
(2S,3S,4S,5S)-3,4-Dimethoxy-2,5-dimethylthiolane (35). Prepared according to 
the procedure used to synthesize (2R,5R)-dimethylthiolane.  The cyclization with 
Na2S•9H2O was performed at 50 °C for 24 h.  Compound 35 (11.5 mg, 13% yield) was 
obtained as a light yellow volatile oil.  35: Rf = 0.81 (silica gel, hexanes:EtOAc, 4:1); IR 
(film) νmax 2934, 1451, 1121, 752, 474 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.74–3.70 
(m, 2 H), 3.64–3.55 (m, 2 H), 3.43 (s, 6 H), 1.27 (d, J = 6.8 Hz, 6 H); 13C NMR (100 
MHz, CDCl3) δ 86.0 (2 C), 58.3 (2 C), 40.6 (2 C), 16.6 (2 C); HRMS: no molecular ion 
peak was observed; [a]D23 = -48.3 (c = 0.44, CHCl3). 
trans-2-Iodo-1-methoxytetralin (36). Prepared according to the procedure used 
to synthesize 19, quenching with MeOH.  Compound 36 (7.3 mg, 67% yield) was 
obtained as a white crystalline solid.  36: Rf = 0.52 (silica gel, hexanes:EtOAc, 19:1); IR 
(film) νmax 2924, 2818, 1455, 1203,1070, 768, 746 cm–1; 1H NMR (400 MHz, CDCl3) δ 
7.41–7.18 (m, 3 H), 7.14 (d, J = 6.8 Hz, 1 H), 4.75 (m, 1 H), 4.57 (d, J = 3.6 Hz, 1 H), 
3.50 (s, 3 H), 2.97 (dq, J = 16.8, 5.6 Hz, 1 H), 2.85 (dq, J = 17.2, 3.6 Hz, 1 H), 2.29 (m, 1 
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H), 2.10 (m, 1 H); 13C NMR (100 MHz, (CDCl3) δ 135.7, 133.0, 130.4, 129.1, 128.5, 
126.3, 83.0, 57.3, 29.4, 27.9, 27.8; HRMS (EI) calcd for C11H13IO [M]+ 288.0011, found 
288.0000; HPLC (AD-H column, 1.0 mL/min, 99:1 hex:IPA, 30 °C, 263 nm, tR (major) = 
5.94 min, tR (minor) = 6.46 min): 33% e.e. 
trans-3-Iodochroman-4-ol (39). Prepared according to the procedure used to 
synthesize 19.  Compound 39 (9 mg, 80% yield) was obtained as a white crystalline solid.  
39: Rf = 0.47 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3344 (br), 2859, 1486, 1223, 
1981, 757 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.37 (dd, J = 8.0, 1.6 Hz, 1 H), 7.26 (td, J 
= 7.8, 1.6 Hz, 1 H), 6.99 (td, J = 7.2, 0.8 Hz, 1 H), 6.89 (dd, J = 8.4, 1.2 Hz, 1 H), 5.00 (t, 
J = 5.2 Hz, 1 H), 4.45–4.39 (m, 2 H), 4.32 (m, 1 H), 2.43 (d, J = 5.2 Hz, 1 H); 13C NMR 
(100 MHz, (CD3)2CO) δ 153.3, 130.4, 129.2, 122.4, 120.7, 116.3, 70.2, 66.9, 28.0; 
HRMS (EI) calcd for C9H9IO2 [M]+ 275.9647, found 275.9640; HPLC (AD-H column, 
1.0 mL/min, 9:1 hex:IPA, 30 °C, 280 nm, tR (major) = 8.14 min, tR (minor) = 7.68 min): 
21% e.e. 
5-bromo-1,2-dihydronaphthalene (40). Prepared according to a procedure 
adapted from: Izmer, V. V.; Lebedev, A. Y.; Nikulin, M. V.; Ryabov, A. N.; Asachenko, 
A. F.; Lygin, A. V.; Sorokin, D. A.; Voskoboynikov, A. Z. Organometallics 2006, 25, 
1217.  To a solution of 1,2,3,4-tetrahydro-1-naphthol (0.74 g, 5.0 mmol, 1.0 equiv) in 
hexanes (10 mL) at 0 °C was added t-BuLi (1.7 M in pentane, 8.8 mL, 15 mmol, 3.0 
equiv) dropwise.  The reaction contents were then heated at 40 °C for 1 h.  Once 
complete, the solution was cooled to –78 °C and BrCl2CCCl2Br (3.42 g, 10.5 mmol, 2.1 
equiv) was added quickly in a single portion.  The reaction contents were then allowed to 
warm to 25 °C over the course of 4 h.  Upon completion, the solution was quenched with 
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saturated aqueous NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic layers were dried (MgSO4), filtered, concentrated, and purified by column 
chromatography (silica gel, hexanes:EtOAc 9:1→4:1) to afford 8-bromo-1,2,3,4-
tetrahydro-1-naphthol (0.42 g, 37% yield) as a light brown, crystalline solid.  Next, a 
portion of the newly synthesized alcohol (0.10 g, 0.44 mmol, 1.0 equiv) was dissolved in 
CH2Cl2 (2.2 mL) and cooled to 0 °C.  MsCl (68 mL, 0.88 mml, 2.0 equiv) and Et3N 
(0.245 mL, 1.76 mmol, 4.0 equiv) were then added sequentially and the resultant solution 
was allowed to warm to 25 °C over the course of 3 h.  Upon completion, the reaction 
contents were quenched with 1 M HCl (3 mL) and extracted with CH2Cl2 (3 × 5 mL). 
The combined organic layers were then dried (MgSO4), filtered, concentrated, and 
purified by column chromatography (silica gel, hexanes:CH2Cl2, 9:1) to afford 40 (21 
mg, 23% yield) as a colorless viscous oil.  40: Rf = 0.90 (silica gel, hexanes:CH2Cl2, 9:1); 
IR (film) nmax 3054, 2935, 2829, 1552, 1442, 1012, 763 cm–1; 1H NMR (400 MHz, 
CDCl3) d 7.38 (d, J = 7.6 Hz, 1 H), 7.04 (d, J = 7.2 Hz, 1 H), 6.96 (t, J = 8.0 Hz, 1 H), 
6.85 (dq, J = 10.0, 1.6 Hz, 1 H), 6.18 (dt, J = 9.2, 4.4 Hz, 1 H), 2.79 (t, J = 8.0 Hz, 2 H), 
2.34–2.27 (m, 2 H); 13C NMR (100 MHz, CDCl3) d 138.0, 133.0, 130.9, 130.7, 127.8, 
126.7, 126.4, 121.9, 28.2, 22.8; HRMS (EI) calcd for C10H9Br [M]+ 207.9888, found 
207.9877. 
trans-8-Bromo-1-hydroxy-2-iodotetralin (41). Prepared according to the 
procedure used to synthesize 19.  Compound 41 (4 mg, 50%) was obtained as a white 
crystalline solid.  41: Rf = 0.42 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3289 (br), 
2929, 2854, 1566, 1446, 1261, 768 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.47 (m, 1 H), 
7.17–7.10 (m, 2 H), 5.31 (t, J = 3.2 Hz, 1 H), 4.72 (q, J = 2.8 Hz, 1 H), 3.09 (ddd, J = 
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17.6, 11.6, 5.6 Hz, 1 H), 2.86 (m, 1 H), 2.56 (d, J = 4.4 Hz, 1 H), 2.21 (m, 1 H), 2.06 (m, 
1 H); 13C NMR (100 MHz, CDCl3) δ 138.3, 133.7, 131.0, 129.6, 128.6, 126.2, 72.7, 31.2, 
27.8, 25.8; HRMS (EI) calcd for C10H10BrIO [M]+ 351.8960, found 351.8972; HPLC 
(AD-H column, 1.0 mL/min, 9:1 hex:IPA, 30 °C, 220 nm, tR (major) = 11.58 min, tR 
(minor) = 10.80 min): 5% e.e. 
trans-2-Iodo-1-phenylpropan-1-ol (43). Prepared according to the procedure 
used to synthesize 19.  Compound 43 (7 mg, 8%) was obtained as a white crystalline 
solid.  43: Rf = 0.67 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3431 (br), 2969, 
2922, 1451, 1165, 1014, 751, 700 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.40–7.29 (m, 5 
H), 4.96 (t, J = 3.2 Hz, 1 H), 4.53 (ddd, J = 14.0, 6.8, 3.6 Hz, 1 H), 2.35 (d, J = 3.2 Hz, 1 
H), 1.74 (d, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 139.7, 128.4 (2 C), 128.0, 
126.4 (2 C), 78.5, 35.9, 21.2; HRMS (EI) calcd for C9H11IO [M]+ 261.9855, found 
261.9845. 
trans-1-Hydroxy-2-iodoindane (45). Prepared according to the procedure used to 
synthesize 19.  Compound 43 (2 mg, 5%) was obtained as a white crystalline solid whose 
spectral properties matched literature data: (a) Stavber, G.; Iskra, J.; Zupan, M.; Stavber, 
S. Adv. Synth. Catal. 2008, 350, 2921. (b) Pandit, P.; Gayen, K. S.; Khamarui, S.; 
















































Discovery and Development of a Bromonium-Induced Ring Expansion to Rapidly 




The first natural products from the Laurencia red algae were isolated in 1965, 
specifically, when Irie and co-workers discovered and characterized laurencin (1).1  Since 
then, over 150 members have been isolated in total, all containing a 15 carbon framework 
that includes an enyne or bromoallene unit at one end.2  A majority of the isolates also 
contain a cyclic ether ranging in size between 3 and 12 atoms, with the largest subset of 
the family containing 8-membered bromoethers.  That subset comprises over 50 natural 
products, a small number of which are drawn in Figure 1.3  These 8-membered rings 
encompass both 8-endo and 8-exo bromoether systems, i.e. ones where the bromine is 
attached directly to a carbon in the ring (1, 2, or 3) or a carbon outside of it (4, 5, or 6).  
Additionally, this family has also been classified in the literature as the lauroxocane (8-
membered ether ring) class, and more specifically as lauthisan-like (8-endo) or laurenan-
like (8-exo) materials based on the positioning of their bromine atoms.3 Globally, over 
the past 50 years, the lauroxocanes have attracted a deal of attention, particularly 
recently, whether it is synthetic efforts as discussed in this chapter5 or the elucidation of 




Based on the array of previous total syntheses of these 8-membered bromoethers, 
reviewed in a detailed fashion by Fujiwara in 2006,5 there are numerous approaches 
toward a single target core, but only a small number of solutions capable of achieving a 
potentially global solution for the diversity of cores found in the family.  Using one 
strategy, Crimmins and co-workers have synthesized six natural products in the class 
with the key sequence being an aldol reaction/ring closing metathesis to generate the 
medium-sized ether ring (Scheme 1);7 targets prepared include 7-, 8-, and 9-membered 
ring cores, including the natural products laurencin and laurallene (1 and 6, Figure 1).  As 
a second example, the Kim group developed an alkylation-based strategy to synthesize 
multiple natural products with medium-sized bromoether cores, including 
pinnatifidenyne (4) and laurencin (1), as shown in Scheme 1b.8  While both described 
approaches are impressive in terms of generating a single diastereomer of the desired 
medium-sized ring in good yields, on average, the complete step count of these (and 























































Equally interesting, to note as indicated for the work in Scheme 1 as well as the 
over 30 additional syntheses of 8-membered bromoethers, every route has installed the 
bromide atom late stage, typically though displacement of an alcohol;5 none generate the 
8-membered bromoether core directly via a bromoetherification, a strategy which is the 
original biosynthetic proposal for the formation of these medium-sized rings in Nature.  
Indeed, Murai and co-workers have studied this idea extensively through use of 
enzymatic conditions in a laboratory setting.9  As shown in Scheme 2, (R,R)-laurediol 
(11a) was transformed into deacyllaurencin (12) using lactoperoxidase (LPO) via what is 
presumed to be a direct 8-endo bromoetherification.  LPO, the enzyme isolated from the 
same producing species as these natural products were discovered, in combination with 
hydrogen peroxide and bromide ion, is known to produce Br2 or BrOH, species which 
can serve as the active bromonium source in these proposed transformations.10  
Interestingly, use of the enantiomer, (S,S)-laurediol (11b), led to prelaureatin (13)11, an 8-
exo bromoether, in 0.05% yield along with 5-membered bromoether 14 in 0.2% yield as 
the major cyclized product.  Whether the enzyme plays a role in stereoselection is 
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unclear.  A larger question, given the poor yields, is whether this direct 
bromoetherification of a linear precursor to a medium-sized ring is plausible for the 
biosynthesis of these natural products, even in the confines of an enzymatic pocket, 
which contains additional factors that could assist to overcome the enthalpic and entropic 
penalties associated with such a closure. 
 
Since the direct bromoetherification to generate the 8-membered core of these 
Laurencia isolates had never been attempted in a purely chemical setting (with the 
exception of enzymatically promoted processes), we hoped to develop a method capable 
of effecting this direct transformation.  Similar to our approach in polyene cyclizations, 
we wanted to use the proposed biosynthesis to ideally decrease step count, thereby 
streamlining the synthesis of these medium-sized cyclic bromoethers through a more 
expediant process.  As discussed below, we targeted the lauroxocanes, the largest class as 



































4.2 Discovery of Ring-Expansion Methodology 
Rousseau and co-workers previously generated cyclic medium-sized bromoethers 
via bromonium-induced etherifications of linear precursors.13  As shown in Scheme 3 
with some selected examples, treatment of linear precursor 15 with a bis(collidine) 
bromonium salt yielded 8-exo bromoether 16 in 45% yield.  Using the same conditions, 
8-exo bromoether 18 was produced in only 11% yield from 17 with no diastereocontrol 
about the newly generated stereocenter.  Both examples shown produce 8-exo 
bromoethers, with no examples of the 8-endo alternative described in this study; 
additionally, the use of a conformational constraint (i.e. aromatic ring or cyclic ketal) was 
necessary to generate the desired medium-sized rings.  The Rousseau group propose that 
this requirement is due to a decrease in the activation entropy of the reaction, thereby 
allowing for greater yields of the bromoethers to be produced in lieu of alternative 
reaction pathways. 
 
While this report is the only example of using a bromonium source to directly 
cyclize a linear alcohol precursor to an 8-membered ring, the requirement for such 
conformational constraint and the observed low levels of diastereoselectivity were 
discouraging for its potential use in the synthesis of the Laurencia bromoethers.  Thus, 
we next turned to our own bromonium reagent, BDSB, hoping its unique reactivity would 
Scheme 3: Rousseau and Co-workers Bromoetherification to 




















be capable of effecting the desired transformation without some of the same substrate 
requirements and issues of diastereocontrol.  As shown in Scheme 4, initial tests through 
cyclization of linear alcohol 19 with BDSB yielded the 7-exo bromoether 20 in 60% yield 
without any trace of the alternative 8-endo bromoether 21 observed.  Next, in an attempt 
to favor 8-membered ring formation via added stabilization through an allylic carbocation 
intermediate (i.e. 24), substrate 22 was synthesized and again treated with BDSB.  In this 
case, only 7-membered allylic bromide 23 was obtained in 80% yield.  Mechanistically, 
this reaction most likely generated a 5-membered bromonium intermediate (25)14 that 
underwent simple displacement to the final 7-membered ether (23).  Since 7-membered 
rings are easier to produce than any medium-sized ring,12 we then elongated the chain to 
potentially disallow this process.  Thus, compound 26 was synthesized and then treated 
with BDSB; here, however, only bromochloride 27 was produced with no ring formation 
observed.  In this case, because the direct generation of the 8-membered ring is 
energetically disfavored, we surmise that intermolecular attack by a chloride (likely from 




In an attempt to avoid the observed intermolecular chloride addition, we then 
wondered if better sequestration of the chloride nucleophile could favor intramolecular 
cyclization.  Such a switching of the SbCl6- ion for an alternate counterion was performed 
either by the addition of a silver (I) salt or a Lewis base to the initially generated 
bromodiethylsulfonium bromide (28, Scheme 5).  Out of the numerous variations 
attempted, only 29h and 29i proved to be isolable solids; all the other derivatives were 
generated in situ prior to evaluation.  However, even with these alternative stabilizing 
anions, no intramolecular cyclization to a medium-sized ring was detected for any linear 
precursor probed; typically, addition of a halide from the counterion or decomposition 
was observed instead. 



































Since all of these efforts to achieve a direct bromoetherification to form medium-
sized rings from a linear precursor were unsuccessful, we re-examined the precedent 
from Murai and co-workers using enzymes, the only successful attempt at this 
transformation (albeit in only trace yield, Scheme 2).9  Upon further analysis, we noted 
that the major cyclized product in each case was a 5-membered bromoether.  This 
discovery led us to wonder whether this type of compound could actually be an 
intermediate en route to the larger 8-membered ethers of the family.  In particular, we 
believed that this idea could have biogenetic merit since it is both thermodynamically and 
kinetically more favorable in general to generate 5-membered rings over the 8-membered 
alternative. 
Scheme 5: Attempts at Alternate Counterion Cyclization
29h, X = PBrCl5
29i,  X = PBr6
29a, X = SbF6
29b, X = BF4
29c, X = PF6
29d, X = NO3
29e, X = OTf
29f,  X = ClO4





















Reagents and Conditions: a. Et2S (1.0 equiv), Br2 (1.1 equiv), CH2Cl2, -30
oC, 10 min; 
b. AgX (1.2 equiv), -30 to 25oC, 30 min; c. PCl5 (1.2 equiv) or PBr5 (1.2 equiv), -30 to 





 Scheme 6 presents our new proposal  on the biogenesis of these natural isolates 
based on 5-membered ring formation.  As shown, instead of the unfavorable, direct 8-
membered bromoetherification, what if an initial 5-endo bromoetherification occurred to 
generate 30?  Then, treatment with a second equivalent of a bromonium electrophile and 
nucleophilic attack from the tetrahydrofuran oxygen could produce bicycle 31,15 an 
intermediate that upon opening at C10 (via loss of a bromonium from C9) could yield 
deacyllaurencin (12).  While the direct loss of a bromine atom is not a common idea in a 
laboratory setting, in nature perhaps a residual cysteine or the metal center of the enzyme 
itself could accept this electrophile.  Globally though, we quickly realized that this 
overall idea of ring expansion via a series of smaller ring forming events could lead to a 
variety of different 7-, 8-, and 9-membered isolates from the Laurencia family.  This 
biosynthetic hypothesis will be further discussed in Chapter 5, including synthetic results 
to confirm these proposed intermediates. 
With initial explorations to achieve this goal completed in work that will not be 
shown here (see Dr. Daniel Treitler’s Ph.D. thesis),16 we learned that in order to open the 
proposed oxonium (31) at C10, a trapping group needed to be installed at C9 to facilitate 
the production of the desired 8-membered ring.17,18  Without this intramolecular trapping 
group, opening at the C7 or C13 of 31 was observed instead to form new tetrahydrofuran 
derivatives.  Thus, as the key initial successful experiment, tetrahydrofuran 32 containing 




















a tert-butyl carbonate instead of a free C9 alcohol was synthesized (to be described in 
Section 4.3, Scheme 7).  Upon treatment of 32 with 1.5 equivalents of BDSB in MeNO2 
for 20 min, the desired 8-endo bromoether 34 was observed in 68% yield.  We propose 
that the desired product was generated via oxonium intermediate 33a, derived from a 5-
endo bromocyclization of starting tetrahydrofuran 32. 
 
 Upon further consideration, however, it was remarkable that only a single 
diastereomer of the 8-membered ring was generated in this reaction.  This observed 
selectivity could be derived from either a) an initial diastereoselective bromonium 
generation or b) a reversible process that favors an intermediate on the path to the 
observed diastereomer.  We believe the stereochemistry of the tetrahydrofuran is far 
enough removed from the alkene to not favor bromonium formation on only a single face 
of the olefin, so that both bromonium intermediates are being produced (i.e. 35a and 35b, 
Scheme 8).  Yet these two generated bromonium intermediates should be in equilibrium 
through bromonium transfer to unreacted alkenes, a feature we believe could make the 
overall process reversible.19  From 35a and 35b, nucleophilic attack with the 
tetrahydrofuran oxygen would yield oxoniums 33a and 33b, followed by opening with 
the pendent carbonate to give 8-endo products 34 and/or 36.20 
Reagents and Conditions: a. BDSB (1.5 equiv), MeNO2, -25 to 25
oC, 
20 min.






















If both bromonium diastereomers (35a and 35b) are indeed formed, then one of 
the intermediates must be favored on a single product-determining pathway in this 
reversible process.  We propose that oxoniums 33a and 33b have a large energy 
difference, which upon analysis of the side view becomes more apparent (Figure 2).  
Opening of 33a produced the observed product, an intermediate we believe is favored 
over alternative 33b.  Here, steric repulsion between the ethyl and methyl groups on the 
concave face of 33b is disfavored, funneling material overall to the less sterically 
encumbered oxonium 33a, where the ethyl substituent is located on the less hindered 
convex face. 
Reagents and Conditions: a. BDSB (1.5 equiv), MeNO2, -25 to 25
oC, 20 min.































With the ring expansion of the tetrahydrofuran into an 8-membered bromoether 
achieved diastereoselectively, we hoped this approach would translate to other 
derivatives.  If so, it could allow for the synthesis of a variety of Laurencia natural 
product cores, including the 8-exo alternatives.  Quite interestingly, the synthesized 8-
endo 34 correlates stereochemically to at least five natural isolates from the Laurencia 
family, including bromofucin (2, Figure 1 is shown again on the next page with a 
different emphasis).  Upon comparison of 8-endo bromoethers 1, 2, and 3, we realized 
that multiple diastereomers of each bromoether core would need to be synthesized as the 
relationship between the three stereocenters containing the bromide (C12) and both sides 
of the cyclic ether (C7 and C13) differ in these examples.  A similar pattern of variability 
is observed in the 8-exo examples (i.e. 4, 5, and 6) with C6, C12, and C13 differing 
stereochemically.  Our goal was to install these three stereocenters in the correct 
orientation in the cyclization itself, as attempts to vary them late stage in the synthesis 
would most likely be a lengthy process; thus, since the bromonium-induced ring 
expansion developed is diastereoselective, the starting tetrahydrofuran stereochemistry 
would need to be altered to provide the correct diastereomer of each 8-membered ring.  
The following section will discuss the selective synthesis of each diastereomeric 
tetrahydrofuran starting material needed for a general appraoch.  After which, Section 4.4 




























will then analyze their use in generating laurosocane cores which specifically correlate to 
the Laurencia natural isolates. 
 
 
4.3  Synthesis of Tetrahydrofuran Precursors 
As discussed earlier, a variety of diastereomeric tetrahydrofurans needed to be 
synthesized selectively (work done in collaboration with undergraduate Ioana Moga).  In 
terms of the previously utilized tetrahydrofuran starting material 32, cyclization and tert-
butyl carbonate formation of 37 led to the desired compound (Scheme 9).  Diol 37 could 
be accessed from a three step route of α-chlorination, an aldol (with the enolate of 
acetone), and reduction to the trans-diol starting from aldehyde 38.  This overall 
synthetic sequence was first developed by Britton and co-workers for the synthesis of a 
varied tetrahydrofuran.21  For additional analogs, adjustment of the starting aldehyde 
chain length and/or stereochemistry of alkene would be needed (i.e. 38, 41, 44, and 47).  
In this fashion we hoped that the same sequence, could lead to multiple tetrahydrofuran 
















































step could afford either the cis- or trans-diol (only trans-diol shown), thereby producing 
two diastereomers at the terminal methyl position of each derivative. 
 
In the forward direction, aldehydes 38, 44, and 47 required syntheses, with 41 
being commercially available (Scheme 10).  Synthesis of the trans-alkene derivative 38 
commenced with a Johnson-Claisen reaction catalyzed by propionic acid followed by 
LiAlH4 reduction.  These steps generated alcohol 48 in 84% yield.  Next, simple 
oxidation of 48 using standard Swern conditions produced aldehyde 38 in 84% yield.  
Pleasingly, if 48 was transformed instead into bromide 49 followed by NaCN 
displacement, reduction, and hydrolysis, then the homologated aldehyde 44 was obtained 
in good yield.  Finally, the synthesis of aldehyde 47 began with 1,5-hexanediol, which 










































after mono-TBS protection, oxidation, Wittig olefination, and deprotection, yielded 
alcohol 50.  Oxidation of this alcohol, again using Swern conditions, produced the 
desired aldehyde (47) in 91% yield.     
 
Pushing forward, α-chlorination using NCS and proline as a catalyst provided the 
desired α-chlorinated aldehyde derivatives (Scheme 11).  This reaction was sensitive to 
both time and temperature as reflected in part by the low yields initially obtained, as 
dichlorination was a common by-product; its formation could be avoided or minimized 
by slow addition of NCS to the reaction mixture as well as keeping the reaction 
temperature at 0ºC throughout this addition.  An aldol reaction with the enolate of 
acetone then resulted in the production of only trans-chlorohydrin derivatives due to 
Felkin-Ahn control in the addition of the enolate to the aldehyde precursor. 
Reagents and Conditions: a. propionic acid (0.05 equiv), 120oC, 12 h; b. LiAlH4 (1
equiv), Et2O, 0
oC, 1 h; c. oxalyl chloride (1.2 equiv), DMSO (2 equiv), Et3N (4 equiv),
CH2Cl2, -78 to -20
oC, 2 h; d. Br2 (1.05 equiv), PPh3 (1.2 equiv), CH2Cl2, -20 to 25
oC, 2
h; e. NaCN (1.5 equiv), DMSO, 25oC, 3 h; f. DIBAL-H (1.2 equiv), CH2Cl2, -78 to -50
oC,
1.5 h; g. NaH (1 equiv), THF, 25oC, 45 min; TBSCl (1 equiv), 25oC, 2 h, 79%; h. Propyl-
PPh3Br (1.2 equiv), KOtBu (1.1 equiv), THF, 0


















  84% yield
HO
g. NaH; TBSCl

























With the desired ketones in hand, reduction with NaBH4 led to a mixture of 
separable cis- and trans-diol derivatives (Scheme 12).  These diols were then heated in a 
polar protic solvent to undergo cyclization to the tetrahydrofuran.  Finally, the addition of 
a tert-butyl carbonate generated the desired tetrahydrofuran precursors for the key 
BDSB-promoted cyclization.  As shown in Scheme 12, eight derivatives of the 
tetrahydrofuran starting material were produced selectively in good yield dependent on 
the starting ketone derivative (i.e. 51 – 54) and selected reduction adduct (cis- or trans-
























    proline
b. acetone
    LDA
a. NCS
    proline
b. acetone
    LDA
a. NCS
    proline
b. acetone
    LDA
a. NCS
    proline
b. acetone







Reagents and Conditions: a. NCS (1.3 equiv), L-proline (0.1 equiv),
CH2Cl2, 0 to 25





































































Scheme 12: Synthesis of Various Tetrahydrofuran Precursors
Reagents and Conditions: a. NaBH4 (1.2 equiv), MeOH, -20
oC, 15 min; b. MeOH/H2O, 130
oC, 4 h; c. nBuLi (1 







































4.4 8-Membered Bromoether Cores 
With several analogs of the origional tetrahydrofuran system synthesized, the next 
goal was to test each in the bromonium-induced ring expansion, with the hope that a 
single diastereomer would be produced in good yields in each case.  Scheme 13 displays 
attempts to generate all four diastereomers of the 8-endo bromoether cores.  Starting 
tetrahydrofurans containing the trans-alkene (i.e. 32 and 56) underwent the ring 
expansion to generate 34 and 63 in good yields.  When using the cis-disposed olefins (i.e. 
39 and 58), however, the desired 8-membered rings were not observed.  Instead, it 
appears that the tert-butyl carbonate was cleaved first, which then allowed the resultant 
pendant alcohol to undergo a 5-exo bromoetherification to generate 65 or 67.  BDSB is 
most likely assisting in carbonate cleavage with its Lewis acidic properties at both sulfur 
and bromine, and upon reacting with trace water that could form HBr and Et2SOH+ in 
situ.  Yet, this reaction manifold is known to be challenging, as in general 5-endo 
bromoetherificiations are slower with cis-alkenes.22  In spite of that, the two synthesized 
8-endo bromoether cores (i.e. 34 and 63) have the same stereochemical relationship as at 
least 15 natural isolates, whereas the two cores derived from the unsuccessful ring 





Beyond 8-endo products, the 8-exo alternatives were also explored using our 
bromonium-induced ring expansion method (Scheme 14).  Now, the starting materials 
contain an additional methylene between the tetrahydrofuran and alkene to generate 8-
exo products via a 5-exo bromocyclization.  As shown, each diastereomeric 
tetrahydrofuran underwent the reaction smoothly, producing 69 - 72 in good yields.  
When using the trans-alkene containing starting material (i.e. 42 and 60), the trans-Br/H 

















Reagents and Conditions: a. BDSB (1.5 equiv), MeNO2, 20 min, -25 to 25
oC.
































the cis-Br/H relationship.  Additionally, the methyl stereochemistry at C6 appears to have 
no effect on the overall transformation as both the α- and β-methyl underwent the desired 
ring expansion transformation.  The bromonoium source used in these cyclizations 
proved key, as BDSB provided the optimal results in synthesis of these lauroxocane 
cores.  The use of alternative bromonium sources, such as TBCO or Br(coll)2OTf, 
generated the 8-exo bromoether (71) in decreased yields (62% and 52% yield 

























Reagents and Conditions: a. BDSB (1.2 equiv), MeNO2, 10 min, -25 to 25
oC.





























 Comparing these successful model systems to the natural product derivatives 
reveals that the produced six diastereomers of the 8-membered bromoethers have the 
same stereochemical relationship at approximately 60% of the natural product isolates 
(over 28 of the 50 total 8-membered isolates).  In addition, using the developed method, 
we have been able to produce a non-natural core (71), potentially one that has yet to be 
isolated.  Structurally, all of the synthesized 8-membered rings were confirmed using 
crystallographic analysis of the diol derivatives, performed by Dr. Wesley Sattler of the 
Parkin group.  Additionaly, the installed carbonate functionality is not unwanted, as it can 
be used for further diversification since the natural products that correspond to each core 
differ at the positions where the oxygen atoms are attached to the cores.  Specifically, 
while the carbonate backbone of the 8-endo cores are correctly positioned to match the 
functionality of the natural product backbone, the 8-exo alternatives have the carbonate 
incorrectly substituted.  As shown in Scheme 15, model compound 70 has the same 
stereochemical array at C6, C12, and C13 as epoxy-isodihydrorhodophytin (5), yet the 
carbonate at C8/C9 of 70 should to be located in the same position as the epoxide at 
C9/C10 of 5.  Since movement of this functionality would require multiple steps, 
installation of the carbonate at C9/C10 could provide a more direct approach to 5.  With 
that notion in place, the synthesis of a model system similar to 73 was approached, where 
the precursor of the ring expansion step would now be tetrahydrofuran 74 containing the 




 The synthesis of tetrahydrofuran 74 was completed following the route outlined in 
Scheme 16.  As shown, initial Hg(II)-promoted Claisen rearrangement23 and subsequent 
reduction generated alcohol 75 in 62% yield.  Epoxidation and cross metathesis initiated 
by the Hoveyda-Grubbs second generation catalyst24 yielded compound 76, which upon 
treatment with acid produced two separable diastereomers of the tetrahydrofuran core 
(77a and 77b).   Carrying only 77a forward (since it can be separated from 77b by silica 
gel column chromatography), tert-butyl carbonate formation produced the required 
precursor for the ring expansion step (i.e. 78).  Next, in the key step, treatment of 78 with 
1.2 equiv of BDSB yielded the desired 8-exo bromoether 79 in 76% yield as a single 
diastereomer.  Compound 79 now contains the correct positioning at the cyclic carbonate 











































4.5 9-Membered Bromoether Cores 
 
 Having developed a model system to generate various 8-endo and 8-exo 
bromoethers diastereoselectively in good yields, we hoped this method would extend to 
syntheses of other medium-sized ring systems, specifically 9-membered bromoethers.  
There are at least 10 natural products containing a 9-membered bromoether core, termed 
lauroxonane in the context of the Laurencia isolates (Figure 3).25,26  Having just 
discussed our success with generation of 8-membered rings, in this section, we will first 
discuss results in formation of 9-membered bromoethers followed by syntheses of the 



































Reagents and Conditions: a. Hg(OAc)2 (0.02 equiv), 120
oC, 24 h; b. NaBH4 (2 equiv), MeOH, 0
oC, 30
min; c. mCPBA (1 equiv), CH2Cl2, 25
oC, 2 h; d. trans-3-hexene (5 equiv), Hoveyda-Grubbs second
generation (0.1 equiv), CH2Cl2, 25
oC, 2 h, 41% yield; e. PPTS (1.4 equiv), CH2Cl2, 25
oC, 1 h; f. nBuLi
(1.05 equiv), Boc2O (1 equiv), THF, 0 to 25
oC, 2 h, 76%; g. BDSB (1.2 equiv), MeNO2, -25 to 25
oC, 10 
min, 76%.
Scheme 16: Synthesis of 8-exo Bromoether 79 with Carbonate at Alternate Position















methylenes between the tetrahydrofuran and alkene.  Treatment of 83 with 1.2 equiv of 
BDSB in MeNO2 for 10 min generated the 9-exo bromoether 85, via a 6-exo 
bromocyclization to the proposed intermediate 84.  In addition to the desired product, the 
tetrahydropyran 86 was also producted; the connectivity of 86 was confirmed by COSY 
2D NMR, though full characterization of each stereocenter of the product was derived 
only based on the proposed intermediate.  Intercepting a similar oxonium intermediate, 
the 9-endo bromoether 89 was generated from instead the tetrahydropyran 87.  In this 
case, a 5-endo bromocyclization transformed 87 into oxonium intermediate 88, which 
opened to the desired 9-membered bromoether.  While the 9-endo product 89 
corresponds specifically to only one natural product of the ten isolated 9-membered rings, 
it is worth noting that all the natural products in the class contain 9-endo bromoether 





 The synthesis of tetrahydrofuran precursor 83 followed the same sequence as 
described for previous furan derivatives.21  As shown in Scheme 18, 1,6-hexanediol was 
first transformed to aldehyde 90 in five steps, using simple modifications of the 
previously delineated route.  From aldehyde 90, α-chlorination, an aldol reaction with the 
enolate of acetone, and reduction generated the separable cis- and trans-diol products 
(cis-diol 91 with trans-diol not drawn).  Cyclization and tert-butyl carbonate formation 
from 91 produced the desired tetrahydrofuran (83). 
















































 While the tetrahydrofuran synthesis followed closely to previous routes, 
tetrahydropyran derivative 87 was synthesized using transformations based strongly on 
sugar chemistry (Scheme 19).  In this case, starting from hexanal, nucleophilic allylation 
and subsequent treatment with NaH and allyl bromide yielded bisalkene 92.  Ring-
closing metathesis initiated by the Grubbs first generation initiator, double bond 
migration,27 oxidation, and bis-acylation generated tetrahydropyran 93.  Compound 94 
was then synthesized by introduction of its allyl group using a Lewis acid and allyl 
trimethylsilane28 followed by a cross metathesis to generate the internal alkene.  Lastly, 
acyl cleavage and tert-butyl carbonate formation produced the desired tetrahydropyran 87 
in 55% overall yield. 
OH
e. NCS
    proline







    95% yield
i. Boc2O










    59% yield
b. Swern
    93% yield
90
Reagents and Conditions: a. imidazole (1 equiv), TBSCl (1 equiv), THF,
25oC, 12 h, 49%; b. oxalyl chloride (1.2 equiv), DMSO (2 equiv), Et3N (4
equiv), CH2Cl2, -78 to -20
oC, 2 h; c. Propyl-PPh3Br (1.2 equiv), KOtBu
(1.1 equiv), THF, 0oC, 1 h; d. TBAF (1.2 equiv), THF, 0 to 25oC, 2 h;
59% over 3 steps; e. NCS (1.3 equiv), L-proline (0.1 equiv), CH2Cl2, 0 to 
25oC, 82% yield; f. LDA (1 equiv), acetone (1 equiv), THF, -78oC, 1 h,
53% yield; g. NaBH4 (1.2 equiv), MeOH, -20
oC, 15 min, 60% yield (+
20% yield trans-diol); h. MeOH/H2O, 130
oC, 4 h, 95% yield; i. nBuLi (1
equiv), Boc2O (1 equiv), THF, 0 to 25
oC, 1 h, 75% yield.
f. acetone
    LDA
   53% yield
g. NaBH4
     60% yield






Using the developed ring expansion methodology promoted by BDSB, we have 
been able to synthesize two 8-endo and five 8-exo bromoethers diastereoselectively using 
easily prepared tetrahydrofuran precursors.  These generated lauroxacanes correspond to 
over 28 of the 50 naturally occurring 8-membered bromoethers of the Laurencia C15 
acetogenins.  In addition, the developed transformation was expanded to include the 
synthesis of 9-membered bromoethers as well.  Currently, this method is the only one 
capable of preparing a single diastereomer of a medium-sized bromoether initiated by a 
bromonium-induced cyclization event, and does so in a general and predictable way.  The 




    57% yield
b. NaH; AllylBr
    79% yield
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   87% yield
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    72% yield
h. nBuLi; Boc2O










Scheme 19: Synthesis of Tetrahydropyran Starting Material 87
Reagents and Conditions: a. allylMgBr (1.2 equiv), Et2O, 0
oC, 30 min, 57% yield; b. NaH (2
equiv), allyl bromide (2 equiv), THF, reflux, 45 min, 79% yield; c. Grubbs first generation
(0.05 equiv), PhMe, 25oC, 30 min; NaOH (0.25 equiv), 2-propanol, reflux, 12 h, 87% yield; d. 
PhI(OAc)2 (1.2 equiv), BF3•OEt2 (0.2 equiv), CH2Cl2, -40
oC, 4 h; Ac2O (16 equiv), pyridine, -
40 to 25oC, 12 h, 49% yield; e. AllylTMS (3 equiv), BF3•OEt2 (5 equiv), CH2Cl2, -78 to 25
oC,
12 h, 74% yield; f. Hoveyda Grubbs second generation catalyst (0.03 equiv), trans-3-
hexene, 25oC, 12 h; g. K2CO3 (10 equiv), MeOH, 0
oC, 1 h, 72% yield; h. nBuLi (1 equiv),
Boc2O (1 equiv), THF, 0 to 25
oC, 1 h, 77% yield.
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stereocenters in a direct and efficient manner from a single easily prepared 
tetrahydrofuran.  In addition, this idea was highlighted in two reviews on 
tetrahydrofuran29 and medium-sized ether30 formation as well as in an article featuring 
Laurencia natural isolates.5j  While this chapter delineated results on a model system, 
synthesis of a natural product using this robust method was also completed, to be 
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4.8 Experimental Section 
 General Procedures.  All reactions were carried out under an argon atmosphere 
with dry solvents under anhydrous conditions, unless otherwise noted.  Dry methylene 
chloride (CH2Cl2), benzene, toluene, diethyl ether (Et2O) and tetrahydrofuran (THF) were 
obtained by passing commercially available pre-dried, oxygen-free formulations through 
activated alumina columns; pyridine was distilled from CaH2 and stored over 3 Å 
molecular sieves; triethylamine (Et3N) was distilled from KOH; N,N-dimethylformamide 
(DMF), acetonitrile (MeCN), and nitromethane (MeNO2) were stored over 3 Å molecular 
sieves; 1,2-dichloroethane, acetone, ethyl acetate (EtOAc), and methanol (MeOH) were 
purchased in anhydrous form from Sigma-Aldrich and used as received.  Yields refer to 
chromatographically and spectroscopically (1H and 13C NMR) homogeneous materials, 
unless otherwise stated.  Reagents were purchased at the highest commercial quality and 
used without further purification, unless otherwise stated.  Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. 
Merck silica gel plates (60F-254) using UV light as visualizing agent and an aqueous 
solution of phosphomolybdic acid and cerium sulfate, and heat as developing agents.  
Preparative thin-layer chromatography was carried out on 0.50 mm E. Merck silica gel 
plates (60F-254).  SiliCycle silica gel (60, academic grade, particle size 0.040–0.063 mm) 
was used for flash column chromatography.  NMR spectra were recorded on Bruker 
DRX-300 and DRX-400 instruments and calibrated using residual undeuterated solvent 
as an internal reference.  The following abbreviations were used to explain the 
multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, AB = AB 
quartet, br = broad, app = apparent.  IR spectra were recorded on a Nicolet Avatar 370 
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DTGS series FT-IR spectrometer. High-resolution mass spectra (HRMS) were recorded 
in the Columbia University Mass Spectral Core facility on a JOEL HX110 mass 
spectrometer using FAB (Fast Atom Bombardment) and EI (Electron Ionization) 
techniques.  All enantiomeric excess (e.e.) values were obtained by HPLC using a Daicel 
CHIRALCEL OD column. 
 Abbreviations.  Ac2O = acetic anhydride, BF3•OEt2 = boron trifuloride diethyl 
etherate, Boc2O = di-tert-butyl dicarbonate, n-BuLi = n-butyllithium, DIBAL-H = di-iso-
butylaluminum hydride, 4-DMAP = 4-dimethylaminopyridine, DMSO = 
dimethylsulfoxide, Hg(OAc)2 = mercury (II) acetate, iPr2NH = diisopropyl amine, KOt-
Bu = potassium tert-butoxide, LDA = lithium diisopropylamide, mCPBA = meta-
chloroperoxybenzoic acid, n-BuLi = n-butyl lithium, NCS = N-chlorosuccinimide, 
PhI(OAc)2 = (diacetoxyiodo)benzene, PPTS = pyridinium p-toluenesulfonate, TBAF = 
tetra-n-butyl ammonium fluoride, TBSCl = tert-butylchlorodimethylsilane. 
 
Attempts at Cyclizing Linear Precursors with BDSB 
 19.  Prepared according to a procedue adapted from the work of Warren and co-
workers: Buss, A. D.; Greeves, N.; Mason, R.; Warren, S. J. Chem. Soc. Perkin Trans. 1 
1987, 2569.  To a solution of ethyl diphenylphosphine oxide (1.0 g, 4.3 mmol, 1.0 equiv) 
in THF (12.9 mL) was added n-BuLi (1.5 M in hexanes, 2.87 mL, 4.3 mmol, 1.0 equiv) 
dropwise at 0 °C and the reaction was allowed to strir for 15 min at 0 °C.  The mixture 
was then cooled to –78 °C and ε-caprolactone (0.48 mL, 4.3 mmol, 1.0 equiv) was added.  
The reaction was stirred at –78 °C for 10 min.  Upon completion, the reaction contents 
were quenched by the careful addition of saturated aqueous NH4C1 (5 mL) and extracted 
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with CH2Cl2 (3 ×  5 mL).  The combined organic layers were then dried (MgSO4), 
filtered, and concentrated.  The resultant oil was purified by flash column 
chromatography (silica gel, CH2Cl2:MeOH, 9:1) to afford the ketophosphate (0.84 g, 
72% yield) as a colorless viscous oil.  Next, the freshly prepared ketophosphate (0.84 g, 
3.1 mmol, 1.0 equiv) was dissolved in EtOH (17 mL) and NaBH4 (0.117 g, 3.1 mmol, 1.0 
equiv) was added.  The reaction was then refluxed for 3 h.  Upon completion, the reaction 
contents were quenched by the careful addition of saturated aqueous NH4C1 (5 mL) and 
the EtOH was removed by concentration.  To the remaining contents, 1 M HCl (3 drops) 
and brine (5 mL) were added and extracted with CH2Cl2 (3 ×  5 mL).  The combined 
organic layers were then dried (MgSO4), filtered, and concentrated.  The resultant oil was 
purified by flash column chromatography (silica gel, hexanes:acetone, 1:1) to afford the 
alcohol (0.28 g, 32% yield isolated pure, along with more fractions containing both cis- 
and trans-isomers) as a white foam.  Lastly, this alcohol (0.28 g, 1.0 mmol, 1.0 equiv) 
was dissolved in DMF (24 mL) at 25 °C.  To this solution, NaH (60% dispersion in 
mineral oil, 0.080 g, 2.0 mmol, 2.0 equiv) was added and the reaction mixture was heated 
to 50 °C for 30 min.  Upon completion, the reaction contents were quenched by the 
careful addition of water (20 mL) and brine (5 mL) and extracted with Et2O (3 × 10 mL).  
The combined organic layers were then washed with water (5 mL), dried (MgSO4), 
filtered, and concentrated.  The resultant oil was purified by flash column 
chromatography (silica gel, pentane:Et2O, 1:0 to 1:1) to afford the alkenol 19 (0.064 g, 
60% yield) as a colorless viscous oil whose spectral properties matched: Waizumi, N.; 
Itoh, T.; Fukuyama, T. J. Am. Chem. Soc. 2000, 122, 7825. 
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20.  A solution of BDSB (0.056 g, 0.11 mmol, 1.1 equiv) in MeNO2 (0.5 mL) was 
added rapidly via syringe to a solution of alcohol 19 (0.013 g, 0.100 mmol, 1.0 equiv) in 
MeNO2 (1.5 mL) at –25 °C.  The resultant yellow solution was stirred for 15 min at –25 
°C.  Upon completion, the reaction mixture was quenched by the addition of a 
combination of saturated aqueous NaHCO3 and 5% aqueous Na2SO3 (1:1, 5 mL), and the 
resultant biphasic mixture was stirred vigorously for 20 min at 25 °C.  The reaction 
contents were added to brine (10 mL) and extracted with EtOAc (3 × 15 mL).  The 
combined organic layers were washed with brine (20 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant residue was purified by flash column chromatography (silica 
gel, hexanes:EtOAc 19:1 to 3:2) to afford the 7-exo bromoether 20 (0.012 g, 60% yield).  
Only 1H NMR was completed for characterization of compound 20. 
 22.  To a solution of 1,6-hexandiol (5.0 g, 42 mmol, 1.0 equiv) in THF 
(100 mL) was added NaH (60% dispersion in mineral oil, 1.41 g, 42 mmol, 1.0 equiv) 
slowly at 0 °C.  The suspension was stirred at 25 °C for 30 min, followed by the addition 
of TBSCl (6.96 g, 46.2 mmol, 1.1 equiv).  The reaction was allowed to stir at 25 °C for 
12 h.  Upon completion, the reaction contents were quenched by the careful addition of 
saturated aqueous NH4Cl (30 mL) and extracted with EtOAc (3 × 20 mL).  The combined 
organic layers were then washed with water (5 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant oil was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 4:1) to afford the monoTBS alcohol (5.0 g, 50% yield) as a colorless 
viscous oil.  Next, the monoTBS alcohol (5.0 g, 21.5 mmol, 1.0 equiv) was dissolved in 
DMSO (50 mL) and Et3N (30.0 mL, 215 mmol, 10. equiv) was added followed by a 
solution of pyridine sulfur trioxide (11.4 g, 70.0 mmol, 3.3 equiv) in DMSO (50 mL).  
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The reation mixture was stirred at 25 °C for 10 mn.  Upon completion, the reaction 
contents were quenched by the careful addition of water (100 mL) and extracted with 
Et2O (3 × 50 mL).  The combined organic layers were then washed with CuSO4 (3 × 10 
mL), water (5 mL), dried (MgSO4), filtered, and concentrated.  The resultant oil was 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 19:1 to 17:3) to 
afford the aldehyde (3.5 g, 71% yield) as a colorless viscous oil.  To a stirred solution of 
this freshly prepared aldehyde (3.5 g, 15.2 mmol, 1.0 equiv) in CH2Cl2 (35 mL) was 
added a solution of (carbethoxymethylene)-triphenylphosphorane (7.41 g, 21.3 mmol, 1.4 
equiv) in CH2Cl2 (35 mL) at 25 °C.  The reaction was stirred for 24 h at 25 °C.  Upon 
completion, the reaction contents concentrated to a resultant oil which was purified by 
flash column chromatography (silica gel, hexanes:EtOAc, 19:1 to 9:1) to afford the α,β-
unsaturated ester product (4.33 g, 94% yield) as a light yellow viscous oil.  Subsequently, 
the freshly prepared α,β-unsaturated ester (4.33 g, 14.3 mmol, 1.0 equiv) was dissolved 
in toluene (75 mL) and cooled to –78 °C.  DIBAL-H (1.0 M in toluene, 43 mL, 43 mmol, 
3.0 equiv) was added to the reaction mixture dropwise. And the reaction was stirred at –
78 °C for 30 min.  Upon completion, the reaction contents were quenched by the careful 
dropwise addition of water (17 mL) over 30 min and the reaction was stirred for an 
additional 10 min at 25 °C.  The biphasic solution was then diluted with EtOAc (25 mL) 
and solid NaHCO3 (2 g) was added.  The solid was filtered off, washed with EtOAc (2 × 
10 mL), and the filtrate was concentrated.  The resultant oil was purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1 to 4:1) to afford the allylic alcohol (2.87 
g, 78% yield) as a colorless viscous oil.  Next, to a slurry of MnO2 (7.7 g, 89 mmol, 8 
equiv) in CH2Cl2 (30 mL) was added a solution of the freshly prepared allylic alcohol 
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(2.87 g, 11.1 mmol, 1.0 equiv) in CH2Cl2 (30 mL).  The reaction was stirred at 25 °C for 
24 h.  Upon completion, the slurry was filtered through a pad of Celite and washed with 
CH2Cl2 (2 × 10 mL).  The filtrate was concentrated and the resultant oil was purified by 
flash column chromatography (silica gel, hexanes:EtOAc, 19:1 to 4:1) to afford the 
aldehyde (2.25 g, 79% yield) as a colorless viscous oil.  Subsequently, the Wittig reagent 
was prepared by first dissolving methyltriphenylphosphonium bromide (4.71 g, 13.2 
mmol, 1.5 equiv) in THF (30 mL) at 0 °C.  To this solution, n-BuLi (1.6 M in hexanes, 
7.70 mL, 12.3 mmol, 1.4 equiv) was added dropwise and the reaction mixture was 
allowed to stir at 25 °C for 30 min.  The reaction was cooled to –78 °C and a solution of 
the freshly prepared aldehyde (2.25 g, 8.80 mmol, 1.0 equiv) in THF (10 mL) was added.  
The reaction mixture was allowed to warm to 25 °C over the course of 4 h.  Upon 
completion, the reaction contents were quenched by the careful addition of saturated 
aqueous NH4Cl (30 mL) and extracted with hexanes (3 × 20 mL).  The combined organic 
layers were then washed with water (5 mL), dried (MgSO4), filtered, and concentrated.  
The resultant oil was purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 9:1 to 3:1) to afford the diene (0.270 g, 12% yield) as a colorless 
viscous oil.  Lastly, the TBS group was removed by dissolving a portion of the freshly 
prepared diene (50 mg, 0.20 mmol, 1.0 equiv) in THF (2 mL).  To this solution, TBAF 
(1.0 M in THF, 0.22 mmol, 1.1 equiv) was added at 0 °C and the reaction was stirred at 0 
°C for 2 h.  Upon completion, the reaction contents were quenched by the careful 
addition of water (5 mL) and extracted with EtOAc (3 × 5 mL).  The combined organic 
layers were then dried (MgSO4), filtered, and concentrated.  The resultant oil was purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 9:1 to 3:1) to afford the 
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alcohol 22 (0.020 g, 72% yield) as a colorless viscous oil.  Only 1H NMR was completed 
for characterization of compound 22. 
23.  A solution of BDSB (0.040 g, 0.079 mmol, 1.1 equiv) in MeNO2 (0.5 mL) 
was added rapidly via syringe to a solution of alcohol 22 (0.010 g, 0.072 mmol, 1.0 
equiv) in MeNO2 (1.5 mL) at –25 °C.  The resultant yellow solution was stirred for 15 
min at –25 °C.  Upon completion, the reaction mixture was quenched by the addition of a 
combination of saturated aqueous NaHCO3 and 5% aqueous Na2SO3 (1:1, 5 mL), and the 
resultant biphasic mixture was stirred vigorously for 20 min at 25 °C.  The reaction 
contents were added to brine (10 mL) and extracted with EtOAc (3 × 15 mL).  The 
combined organic layers were washed with brine (20 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant residue was purified by flash column chromatography (silica 
gel, hexanes:EtOAc 99:1 to 9:1) to afford the 7-exo ether 23 (0.013 g, 80% yield).  Only 
1H NMR was completed for characterization of compound 23. 
26.  Prepared according to the seven step route described in the synthesis of 
compound 22, now transforming 1,7-heptanediol into diene 26 in a 20% overall yield.  
Only 1H NMR was completed for characterization of compound 26. 
 27.  Prepared according to the procedure outlined in the synthesis of 23.  The 
bromochloride product 27 was isolated as a colorless viscous oil and was only 
characterized by 1H NMR. 
  
Alternation of Counterion in the BDSB Reagent 
 29a-g.  Et2S (0.037 mL, 0.35 mmol, 1.8 equiv) was added slowly to a solution of 
Br2 (0.016 mL, 0.32 mmol, 1.6 equiv) in CH2Cl2 (0.9 mL) at –30 °C.  The solution was 
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allowed to stir for 10 min at –30 °C, at which point, solid AgX (0.38 mmol, 1.9 equiv) 
was added.  The reaction miture was allowed to warm to 25 °C and stirred at this 
temperature for 1 h.  This newly formed bromonium reagent was then syringed into a 
solution of dienol 26 (0.028 g, 0.2 mmol, 1.0 equiv) in MeNO2 (3 mL) at –30 °C.  The 
resultant yellow solution was stirred for 15 min at –25 °C.  Upon completion, the reaction 
mixture was quenched by the addition of a combination of saturated aqueous NaHCO3 
and 5% aqueous Na2SO3 (1:1, 5 mL), and the resultant biphasic mixture was stirred 
vigorously for 20 min at 25 °C.  The reaction contents were added to brine (10 mL) and 
extracted with EtOAc (3 × 15 mL).  The combined organic layers were washed with brine 
(20 mL), dried (MgSO4), filtered, and concentrated.  The resultant residue was purified 
by flash column chromatography (silica gel, hexanes:EtOAc 99:1 to 9:1) to afford 27 in 
various yields. 
 29h or 29i.  Et2S (0.297 mL, 2.75 mmol, 1.1 equiv) was added slowly to a 
solution of Br2 (0.128 mL, 2.50 mmol, 1.0 equiv) in 1,2-dichloroethane (6 mL) at –30 
°C.  Next, PCl5 (0.688 g, 3.0 mmol, 1.2 equiv) [or PBr5 for synthesis of 29i] was added 
and the solution was warmed to 25 °C.  The reaction mixture was stirred for 30 min at 25 
°C.  At this time, the reaction flask was cooled to 0 °C and stored at that temperature for 
4 h before then being cooled to –20 °C and stored for an additional 12 h, during which 
time large orange needles crystallized from the reaction solution.  The solvent was 
decanted, and the crystals were rinsed with cold CH2Cl2 (2 × 5 mL) and dried under 





Preparation of Unsaturated Aldehydes 
(4E)-Heptenal (38).  
 48.  Prepared according to a procedure adapted from the work of Shayakhmetova 
and co-workers: Shakhmaev, R. N.; Ishbaeva, A. U.; Shayakhmetova, I. S. Russ. J. Gen. 
Chem. 2009, 79, 1171–1174.  1-Penten-3-ol (10.0 g, 116 mmol, 1.0 equiv), propionic 
acid (0.435 mL, 5.80 mmol, 0.05 equiv), and trimethyl orthoacetate (43.6 mL, 348 mmol, 
3.0 equiv) were added to a high-pressure sealed tube.  The reaction vessel was then 
sealed and heated at 120 °C for 12 h.  Upon completion, the reaction contents were 
cooled to 25 °C, the cap was removed, and the reaction contents were reheated to 120 °C 
for 2 h, open to the atmosphere, to distill off the MeOH byproduct.  The resultant yellow 
oil was then dissolved in Et2O (20 mL) and cannulated dropwise into a suspension of 
LiAlH4 (4.41 g, 116 mmol, 1.0 equiv) in Et2O (440 mL) at 0 °C.  The resultant slurry was 
stirred at 0 °C for 60 min and then quenched by the careful dropwise addition of saturated 
aqueous NH4Cl (20 mL), followed by 1 M sodium potassium tartrate solution (300 mL).  
The resultant biphasic mixture was stirred vigorously for 16 h at 25 °C.  The layers were 
then allowed to separate and the aqueous layer was extracted with additional Et2O (2 × 
200 mL).  The combined organic layers were washed with brine (200 mL), dried 
(MgSO4), filtered, and concentrated (→100 mm Hg at 20 °C).  The resultant crude oil 
was purified by flash column chromatography (silica gel, hexanes:Et2O, 1:0→4:1) to 
afford (4E)-hepten-1-ol (48, 11.1 g, 84% yield) as a moderately volatile colorless oil.  48:  
Rf = 0.28 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 3335 (br), 2962, 2934, 2874, 
1454, 1058, 966 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.49 (m, 1 H), 5.41 (m, 1 H), 3.65 
(t, J = 6.4 Hz, 2 H), 2.12–1.96 (m, 4 H), 1.64 (quintet, J = 6.8 Hz, 2 H), 1.40 (br s, 1 H), 
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0.97 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 132.9, 128.6, 62.8, 32.6, 29.0, 
25.7, 14.0; HRMS (EI) calcd for C7H14O [M]+ 114.1045, found 114.1041.   
 38.  Prepared according to the general Swern procedure described in the synthesis 
of 50.  (4E)-hepten-1-ol (48, 3.34 g, 29.2 mmol) was oxidized to (4E)-heptenal (38, 2.36 
g, 72% yield) as a volatile light yellow oil which was carried forward without any 
additional purification.  [Note: this product proved unstable to silica gel exposure, 
rendering column purification impractical].  38: IR (film) νmax 2963, 2719, 1726, 1441, 
1243, 968 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.76 (t, J = 2.0 Hz, 1 H), 5.51 (m, 1 H), 
5.39 (m, 1 H), 2.49 (m, 2 H), 2.33 (m, 2 H), 1.99 (m, 2 H), 0.96 (t, J = 7.6 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 202.6, 133.7, 126.8, 43.7, 25.6, 25.3, 13.9; HRMS: No 
molecular ion peak could be observed. 
(4Z)-Heptenal (41).  Purchased from TCI America. 
(5E)-Octenal (44).  Prepared according to a procedure adapted from the work of 
Shayakhmetova and co-workers: Shakhmaev, R. N.; Ishbaeva, A. U.; Shayakhmetova, I. 
S. Russ. J. Gen. Chem. 2009, 79, 1171–1174.  Bromine (1.08 mL, 21.0 mmol, 1.05 equiv) 
was added dropwise to a solution of Ph3P (6.30 g, 24.0 mmol, 1.2 equiv) in CH2Cl2 (120 
mL) at 0 °C, and the resultant colorless solution was stirred for 5 min.  The reaction 
mixture was then cooled to –20 °C and trans-4-hepten-1-ol (48 [vide infra], 2.28 g, 20.0 
mmol, 1.0 equiv) was added dropwise.  The resultant reaction solution was allowed to 
warm slowly over 2 h to 25 °C.  Upon completion, the reaction contents were 
concentrated by rotary evaporation to a volume of ~20 mL, and the resultant residue was 
purified directly by flash column chromatography (silica gel, pentane:Et2O, 19:1) to 
afford bromide 49 (2.82 g, 75% yield) as a colorless volatile oil.  49: Rf = 0.81 (silica gel, 
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hexanes); IR (film) νmax 2962, 2930, 2848, 1438, 1239, 967 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 5.47 (m, 1 H), 5.29 (m, 1 H), 3.35 (t, J = 6.8 Hz, 2 H), 2.08 (q, J = 6.8 Hz, 2 H), 
1.95 (m, 2 H), 1.85 (quintet, J = 6.8 Hz, 2 H), 0.91 (t, J = 7.6 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 133.9, 127.1, 33.5, 32.6, 31.0, 25.7, 14.0; HRMS (FAB) calcd for 
C8H13O [M–H]+ 125.0966, found 125.0962.  Next, a portion of bromide 49 (2.15 g, 12.1 
mmol, 1.0 equiv) was added to a suspension of NaCN (0.892 g, 18.2 mmol, 1.5 equiv) in 
DMSO (18 mL) at 25 °C, and the resultant reaction mixture was stirred vigorously for 3 
h.  Upon completion, the reaction contents were quenched with water (150 mL) and 
extracted with hexanes:Et2O (1:1, 3 ×  75 mL).  The combined organic layers were then 
washed with water (3 ×  50 mL), then brine (50 mL), dried (MgSO4), filtered, and 
concentrated to afford the desired nitrile, which was carried forward without additional 
purification.  Lastly, prepared according to a procedure adapted from the work of Ishihara 
and co-workers: Uyanik, M.; Ishihara, K.; Yamamoto, H. Org. Lett. 2006, 8, 5649–5652.  
DIBAL-H (1.0 M in toluene, 14.6 mL, 14.6 mmol, 1.2 equiv) was added dropwise over 
the course of 10 min to a solution of the crude nitrile produced above (12.1 mmol 
assumed, 1.0 equiv) in CH2Cl2 (61 mL) at –78 °C.  The resultant colorless solution was 
allowed to warm slowly to –50 °C over 90 min.  Upon completion, the reaction contents 
were quenched by the sequential addition of acetone (120 mL), saturated aqueous NH4Cl 
(10 mL), and 1 M sodium potassium tartrate (30 mL); the resultant biphasic mixture was 
stirred vigorously for 12 h at 25 °C.  The reaction contents were then poured into brine 
(200 mL) and extracted with Et2O (3 ×  100 mL).  The combined organic layers were 
washed with brine (200 mL), dried (MgSO4), filtered, and concentrated to afford (5E)-
octenal (44, 1.26 g, 83% yield) as a light yellow viscous oil which was carried forward 
237
 
without additional purification.  [Note: this product proved unstable to silica gel 
exposure, rendering column purification impractical].  44: IR (film) νmax 2958, 2918, 
2850, 1724, 1460, 968 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.76 (t, J = 2.0 Hz, 1 H), 5.47 
(m, 1 H), 5.34 (m, 1 H), 2.42 (td, J = 7.2, 1.6 Hz, 2 H), 2.07–1.95 (m, 4 H), 1.70 (quintet, 
J = 7.2 Hz, 2 H), 0.96 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 203.0, 133.6, 
127.9, 43.3, 31.9, 25.7, 22.1, 14.0; HRMS (FAB) calcd for C8H13O [M–H]+ 125.0966, 
found 125.0962.  
(5Z)-Octenal (47). 
 50.  Prepared according to a procedure adapted from the work of Condon and co-
workers: McDougal, P. G.; Rico, J. G.; Oh, Y.-I.; Condon, B. D. J. Org. Chem. 1986, 51, 
3388–3390.  1,5-Pentanediol (6.3 mL, 60. mmol, 1.0 equiv) was added dropwise to a 
suspension of NaH (60% dispersion in mineral oil, 2.4 g, 60. mmol, 1.0 equiv) in THF 
(120 mL) at 25 °C (while venting the H2 produced).  The resultant reaction mixture was 
stirred vigorously for 45 min at 25 °C, after which TBSCl (9.0 g, 60. mmol, 1.0 equiv) 
was added in a single portion.  The reaction mixture was then stirred for an additional 2 h 
at 25 °C.  Upon completion, the reaction contents were quenched by the careful addition 
of saturated aqueous NaHCO3 (100 mL) and extracted with EtOAc (3 ×  50 mL).  The 
combined organic layers were then dried (MgSO4), filtered, and concentrated.  The 
resultant colorless oil was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 4:1) to afford desymmetrized alcohol (10.3 g, 79% yield) as a colorless 
viscous oil.  Rf = 0.42 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 3351 (br), 2933, 
2859, 1470, 1388, 1254, 1101 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.65 (t, J = 6.4 Hz, 2 
H), 3.62 (t, J = 6.4 Hz, 2 H), 1.63–1.51 (m, 4 H), 1.46–1.37 (m, 2 H), 0.89 (s, 9 H), 0.05 
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(s, 6 H); 13C NMR (75 MHz, CDCl3) δ 63.5, 63.3, 32.9 (2 C), 26.3 (3 C), 22.4, 18.7, –4.9 
(2 C); HRMS (FAB) calcd for C11H27O2Si [M+H]+ 219.1780, found 219.1779.   
 General Swern Procedure: DMSO (3.75 mL, 52.8 mmol, 2.0 equiv) was added 
dropwise over the course of 5 min to a solution of oxalyl chloride (2.76 mL, 31.7 mmol, 
1.2 equiv) in CH2Cl2 (264 mL) at –78 °C, and the resultant colorless solution was stirred 
at –78 °C for 5 min.  A solution of the freshly prepared monoTBS alcohol (5.77 g, 26.4 
mmol, 1.0 equiv) in CH2Cl2 (50 mL) was then added slowly over the course of 10 min, 
and the resultant colorless solution was stirred for an additional 5 min at –78 °C.  Finally, 
Et3N (14.6 mL, 106 mmol, 4.0 equiv) was added slowly via syringe, and the reaction 
contents were allowed to warm slowly to  –40 °C over the course of 2 h.  Upon 
completion, the reaction contents were quenched by the addition of water (200 mL) and 
extracted with CH2Cl2 (2 ×  100 mL).  The combined organic layers were then washed 
with 1 M HCl (100 mL), dried (MgSO4), filtered, and concentrated to afford the desired 
aldehyde as a light yellow oil, which was carried forward without any additional 
purification.   
 Next, KOt-Bu (1.0 M in THF, 29.0 mL, 29.0 mmol, 1.1 equiv) was added slowly 
to a suspension of propyltriphenylphosphonium bromide (12.2 g, 31.7 mmol, 1.2 equiv) 
in THF (86 mL) at 0 °C.  The resultant orange solution was allowed to warm to 25 °C 
and stirred for an additional 30 min, then re-cooled to 0 °C.  A solution of the aldehyde 
produced above (26.4 mmol assumed, 1.0 equiv) in THF (20 mL) was added slowly into 
the ylid solution via cannula.  After stirring for 1 h at 0 °C, the reaction contents were 
quenched by the sequential addition of saturated aqueous NH4Cl (50 mL) and water (50 
mL), and extracted with Et2O (3 ×  100 mL).  The combined organic layers were then 
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washed with brine (200 mL), dried (MgSO4), filtered, and concentrated.  The bulk of the 
triphenylphosphine oxide byproduct was removed by slowly concentrating the resultant 
crude product from a solution of CH2Cl2:hexanes (1:1, 200 mL) until approximately 50 
mL solvent remained.  The resultant slurry was filtered, and the precipitate was rinsed 
with hexanes (2 ×  30 mL); the combined filtrate and rinses were concentrated to afford 
the internal alkene product as a light yellow oil, which was carried forward without any 
additional purification. [Note: The Wittig reaction was not entirely stereospecific; the 
desired Z-alkene was contaminated with, and inseparable from, about 8% of the 
undesired E-alkene. This undesired isomer was carried through all steps, at no stage 
being separable by chromatography, as such resulting in a slight impurity in 
bromoetherification substrates].  Lastly, a solution of TBAF (1.0 M in THF, 31.7 mL, 
31.7 mmol, 1.2 equiv) was added to a solution of crude prepared internal alkene (26.4 
mmol assumed, 1.0 equiv) in THF (94 mL) at 0 °C, and the resultant reaction mixture 
was stirred at 0 °C for 1 h before being warmed to 25 °C.  After an additional 3 h at 25 
°C, the reaction contents were quenched by the sequential addition of saturated aqueous 
NH4Cl (50 mL) and water (50 mL) and extracted with Et2O (3 × 100 mL).  The combined 
organic layers were washed with brine (200 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant light brown oil was purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 19:1→4:1) to afford 50 (2.44 g, 72% yield 
over 3 steps) as a colorless viscous oil.  50: Rf = 0.44 (silica gel, hexanes:EtOAc, 4:1); IR 
(film) νmax 3332 (br), 3005, 2934, 1458, 1276, 1261, 1062, 750 cm–1; 1H NMR (400 
MHz, CDCl3) δ 5.42–5.28 (m, 2 H), 3.65 (t, J = 6.8 Hz, 2 H), 2.10–2.00 (m, 4 H), 1.58 
(m, 2 H), 1.44 (m, 2 H), 1.35 (br s, 1 H), 0.96 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, 
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CDCl3) δ 132.2, 128.9, 63.1, 32.5, 26.9, 26.0, 20.7, 14.5; HRMS (EI) calcd for C8H16O 
[M]+ 128.1201, found 128.1199. 
 47.  Prepared according to the general Swern procedure described above in the 
synthesis of 50.  50 (2.44 g, 19.0 mmol) was subjected to oxidation followed by 
purification by flash column chromatography (silica gel, hexanes:EtOAc, 1:0→19:1) to 
afford (5Z)-octenal (47, 2.18 g, 91% yield) as a light yellow oil.  47: Rf = 0.36 (silica gel, 
hexanes:EtOAc, 19:1); IR (film) νmax 3005, 2962, 2934, 1748, 1242 cm–1; 1H NMR (400 
MHz, CDCl3) δ 9.77 (t, J = 2.0 Hz, 1 H), 5.42 (m, 1 H), 5.27 (m, 1 H), 2.43 (td, J = 7.2, 
2.0 Hz, 2 H), 2.12–1.97 (m, 4 H), 1.70 (quintet, J = 7.2 Hz, 2 H), 0.96 (t, J = 7.6 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 202.8, 133.1, 127.8, 43.4, 26.5, 22.2, 20.7, 14.4; 
HRMS (FAB) calcd for C8H13O [M–H]+ 125.0966, found 125.0965. 
 
Alpha-Chlorination/Aldol Addition: 
51.  Prepared according to the procedure described below for the synthesis of 54.  
(4E)-Heptenal (38, 1.82 g, 16.2 mmol) was α -chlorinated to yield (4E)-2-chloro-4-
heptenal (1.88 g, 79% yield – no vacuum distillation necessary) as a fragrant colorless 
oil.  The aldol addition with acetone was performed immediately to yield 51 (1.35 g, 62% 
yield) as a colorless viscous oil after purification by careful flash column chromatography 
(silica gel, hexanes:EtOAc, 1:0→7:3). 
52.  Prepared according to the procedure described below for the synthesis of 54.  
(4Z)-Heptenal (41, 2.24 g, 20.0 mmol) was α -chlorinated to yield (4Z)-2-chloro-4-
heptenal (2.23 g, 76% yield after vacuum distillation: 2 mm Hg at 50 °C) as a fragrant 
colorless oil.  The aldol addition with acetone was performed immediately to yield 52 
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(1.56 g, 60% yield) as a colorless viscous oil after purification by careful flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0→7:3). 
53.  Prepared according to the procedure described below for the synthesis of 54.  
(5E)-Octenal (44, 1.26 g, 10.0 mmol) was α-chlorinated to yield the highly unstable (5E)-
2-chloro-5-octenal (0.600 g, 37% yield after vacuum distillation: 2 mm Hg at 60 °C) as a 
fragrant colorless oil.  The aldol addition with acetone was performed immediately to 
yield 53 (0.383 g, 56% yield) as a colorless viscous oil after purification by careful flash 
column chromatography (silica gel, hexanes:EtOAc, 1:0→7:3). 
 54.  Prepared according to a procedure adapted from the work of Britton and co-
workers: Kang, B.; Mowat, J.; Pinter, T.; Britton, R. Org. Lett. 2009, 11, 1717–1720.  A 
suspension of NCS (3.47 g, 26.0 mmol, 1.3 equiv) and L-proline (0.230 g, 2.00 mmol, 
0.10 equiv) in CH2Cl2 (60 mL) was cooled to 0 °C, and (5Z)-octenal (47, 2.52 g, 20.0 
mmol, 1.0 equiv) was added.  The resultant reaction mixture was allowed to warm very 
slowly, approaching 25 °C.  Once the reaction had reached ~50% conversion as judged 
by NMR analysis of reaction aliquots (~3 h, 9 °C), a second portion of L-proline (0.230 g, 
2.00 mmol, 0.10 equiv) was added and the reaction was stirred for an additional 3 h with 
continued slow warming.  Upon completion (final reaction temperature: 18 °C), the 
reaction contents were diluted with hexanes (120 mL) and cooled to –78 °C.  The 
resultant slurry was filtered (precipitate was rinsed with 2 × 15 mL of cold hexanes) and 
the combined filtrate and rinses were concentrated (→150 mm Hg at 20 °C) to a total 
volume of ~20 mL.  The reaction contents were then cooled to –20 °C for 16 h, during 
which time more precipitate formed.  The filtrate was decanted and concentrated (→100 
mm Hg at 20 °C).  The resultant yellow oil was purified by distillation under reduced 
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pressure (2 mm Hg at 60 °C) to afford (5Z)-2-chloro-5-octenal (2.01 g, 63% yield) as a 
fragrant colorless viscous oil.  [Note: this unsaturated a-chloro aldehyde, as with all 
others produced by this procedure, was rather unstable and was used immediately].  
Pressing forward, n-BuLi (1.5 M in hexane, 7.28 mL, 10.9 mmol, 1.05 equiv) was added 
dropwise to a solution of iPr2NH (1.76 mL, 12.5 mmol, 1.2 equiv) in THF (52 mL) at –78 
°C.  The resultant colorless solution was removed from the cold bath and allowed to 
warm (to ~0 °C) over 15 min, then re-cooled to –78 °C.  Acetone (0.766 mL, 10.4 mmol, 
1.0 equiv) was added dropwise to the resultant LDA solution and the reaction contents 
were stirred for 30 min at –78 °C.  The aldehyde produced above, (5Z)-2-chloro-5-
octenal (2.01 g, 12.5 mmol, 1.2 equiv), was then added dropwise and the resultant 
colorless solution was stirred for an additional 60 min at –78 °C.  Upon completion, the 
reaction contents were quenched by the addition of saturated aqueous NH4Cl (30 mL) 
and water (30 mL) and extracted with hexanes:EtOAc (1:1, 3 × 80 mL).  The combined 
organic layers were then washed with brine (150 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant crude yellow oil was purified by careful flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0→7:3) to afford 54 (1.38 g, 61% yield) as 
a colorless viscous oil. [Note: although stable to silica gel, the aldol products tended to 
decompose over time and as such were used immediately].  
 
Production of Both cis- and trans-Diols: 
37/55.  Prepared according to the procedure described for the synthesis of 46/61.  
Reduction of 51 (1.30 g, 6.35 mmol) afforded mostly pure cis-diol 55 (0.635 g) as a white 
solid along with the separable trans-diol 37 (0.397 g, 30% yield).  Analytically pure 55 
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was obtained by recrystallization (10 mL boiling hexanes) to afford 0.460 g (35% yield) 
white needles.  37: Rf = 0.39 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3363 (br), 
2965, 2932, 2874, 1459, 1376, 1067, 967 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.60 (m, 1 
H), 5.45 (m, 1 H), 4.18 (m, 1 H), 4.02 (m, 1 H), 3.95 (m, 1 H), 2.97 (d, J = 6.0 Hz, 1 H), 
2.56 (m, 1 H), 2.42 (m, 1 H), 2.14 (br s, 1 H), 2.04 (quintet, J = 7.2 Hz, 2 H), 1.81 (ddd, J 
= 14.4, 8.8, 2.8 Hz, 1 H), 1.67 (ddd, J = 14.4, 8.4, 2.8 Hz, 1 H), 1.26 (d, J = 6.0 Hz, 3 H), 
0.98 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 136.1, 124.3, 71.5, 67.0, 65.5, 
40.0, 37.0, 25.7, 23.9, 13.8; HRMS (FAB) calcd for C10H20ClO2 [M+H]+ 207.1152, 
found 207.1160.  55: Rf = 0.43 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3363 (br), 
2966, 2933, 1458, 1429, 1133, 1080, 968 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.60 (m, 1 
H), 5.45 (m, 1 H), 4.07 (m, 1 H), 3.98 (m, 1 H), 3.87 (m, 1 H), 3.12 (br s, 2 H), 2.58–2.39 
(m, 2 H), 2.04 (quintet, J = 7.2 Hz, 2 H), 1.80 (dt, J = 14.4, 2.4 Hz, 1 H), 1.62 (m, 1 H), 
1.24 (d, J = 6.4 Hz, 3 H), 0.98 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 136.1, 
124.2, 75.2, 68.8, 67.0, 40.4, 36.6, 25.7, 24.3, 13.8; HRMS (FAB) calcd for C10H20ClO2 
[M+H]+ 207.1152, found 207.1154. 
40/57.  Prepared according to the procedure described for the synthesis of 46/61.  
Reduction of 52 (0.435 g) afforded cis-diol 57 (0.232 g, 53% yield) as a colorless 
amorphous solid, along with the separable trans-diol 40 (0.153 g, 35% yield).  40: Rf = 
0.36 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3372 (br), 2966, 2934, 2876, 1458, 
1376, 1069 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.51 (m, 1 H), 5.39 (m, 1 H), 4.18 (m, 1 
H), 4.05–3.89 (m, 2 H), 2.74 (br s, 2 H), 2.65–2.41 (m, 2 H), 2.06 (quintet, J = 7.6 Hz, 2 
H), 1.81 (ddd, J = 14.4, 8.8, 2.8 Hz, 1 H), 1.66 (ddd, J = 14.4, 8.8, 2.4 Hz, 1 H), 1.26 (d, J 
= 6.4 Hz, 3 H), 0.97 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 134.9, 124.2, 
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71.7, 67.0, 65.4, 40.1, 31.5, 23.9, 20.9, 14.2; HRMS (FAB) calcd for C10H20ClO2 [M+H]+ 
207.1152, found 207.1143.  57: Rf = 0.46 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 
3362 (br), 2967, 2933, 2875, 1457, 1134, 1074 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.55 
(m, 1 H), 5.41 (m, 1 H), 4.09 (m, 1 H), 3.99 (ddd, J = 10.0, 4.8, 2.0 Hz, 1 H), 3.90 (m, 1 
H), 2.82 (br s, 2 H), 2.65–2.45 (m, 2 H), 2.06 (quintet, J = 7.6 Hz, 2 H), 1.81 (dt, J = 
14.4, 2.4 Hz, 1 H), 1.63 (m, 1 H), 1.25 (d, J = 6.0 Hz, 3 H), 0.98 (t, J = 7.6 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 135.0, 124.1, 75.4, 68.9, 67.0, 40.5, 31.1, 24.4, 21.0, 14.2; 
HRMS (FAB) calcd for C10H20ClO2 [M+H]+ 207.1152, found 207.1157. 
43/59.  Prepared according to the procedure described for the synthesis of 46/61.  
Reduction of 53 (0.233 g, 1.07 mmol) afforded cis-diol 59 (0.128 g, 54% yield) as a 
colorless amorphous solid, along with the separable trans-diol 43 (0.062 g, 26% yield).  
43: Rf = 0.35 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3368 (br), 2964, 2931, 1451, 
1376, 1065, 968 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.54 (m, 1 H), 5.35 (m, 1 H), 4.19 
(m, 1 H), 4.06–3.97 (m, 2 H), 2.72 (br s, 1 H), 2.29 (m, 1 H), 2.11 (sextet, J = 7.6 Hz, 1 
H), 2.00 (quintet, J = 7.2 Hz, 2 H), 1.93–1.72 (m, 3 H), 1.62 (ddd, J = 14.4, 8.4, 2.4 Hz, 1 
H), 1.58 (br s, 1 H), 1.28 (d, J = 6.4 Hz, 3 H), 0.97 (t, J = 7.2 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 133.8, 127.3, 72.0, 67.5, 65.5, 40.2, 33.3, 29.5, 25.7, 24.0, 14.0; HRMS 
(FAB) calcd for C11H22ClO2 [M+H]+ 221.1308, found 221.1306.  59: Rf = 0.42 (silica gel, 
hexanes:EtOAc, 1:1); IR (film) νmax 3367 (br), 2964, 2931, 1449, 1076, 968 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 5.53 (m, 1 H), 5.35 (m, 1 H), 4.07 (m, 1 H), 4.01–3.88 (m, 2 
H), 2.86 (br s, 2 H), 2.29 (m, 1 H), 2.10 (sextet, J = 7.2 Hz, 1 H), 2.00 (quintet, J = 7.2 
Hz, 2 H), 1.90–1.59 (m, 4 H), 1.24 (d, J = 6.0 Hz, 3 H), 0.97 (t, J = 7.6 Hz, 3 H); 13C 
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NMR (100 MHz, CDCl3) δ 133.9, 127.3, 75.8, 68.9, 67.3, 40.5, 32.9, 29.5, 25.7, 24.3, 
14.0; HRMS (FAB) calcd for C11H22ClO2 [M+H]+ 221.1308, found 221.1300. 
46/61. Prepared according to a procedure adapted from the work of Britton and 
co-workers: Kang, B.; Mowat, J.; Pinter, T.; Britton, R. Org. Lett. 2009, 11, 1717–1720.  
NaBH4 (0.195 g, 5.16 mmol, 1.2 equiv) was added in a single portion to a solution of 
ketone 54 (0.940 g, 4.30 mmol, 1.0 equiv) in MeOH (43 mL) at –20 °C.  After 15 min at 
–20 °C, the clear solution was quenched by the careful addition of saturated aqueous 
NH4Cl (40 mL) and water (40 mL) and extracted with EtOAc (3 ×  60 mL).  The 
combined organic layers were washed with brine (100 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant crude oil was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 1:0→1:1) to afford cis-diol 61 (0.604 g, 64% yield, 
contaminated with minor inseparable impurities) as a colorless amorphous solid, along 
with the separable trans-diol 46 (0.247 g, 26% yield).  46: Rf = 0.36 (silica gel, 
hexanes:EtOAc, 1:1); IR (Film) νmax 3362 (br), 2965, 2933, 2874, 1455, 1069 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 5.44 (m, 1 H), 5.28 (m, 1 H), 4.19 (m, 1 H), 4.06–3.95 (m, 2 
H), 2.82 (d, J = 6.4 Hz, 1 H), 2.34–2.18 (m, 2 H), 2.07 (quintet, J = 7.2 Hz, 2 H), 1.95 (d, 
J = 4.4 Hz, 1 H), 1.93–1.70 (m, 3 H), 1.63 (ddd, J = 14.8, 8.8, 2.4 Hz, 1 H), 1.27 (d, J = 
6.4 Hz, 3 H), 0.97 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 133.5, 127.2, 72.0, 
67.5, 65.5, 40.2, 33.4, 24.2, 24.0, 20.7, 14.5; HRMS (FAB) calcd for C11H22ClO2 [M+H]+ 
221.1308, found 221.1307.  61: Rf = 0.46 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 
3363 (br), 2965, 2933, 2874, 1455, 1136, 1073 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.43 
(m, 1 H), 5.28 (m, 1 H), 4.06 (m, 1 H), 3.97 (m, 1 H), 3.90 (ddd, J = 10.4, 4.8, 3.2 Hz, 1 
H), 3.40 (d, J = 4.0 Hz, 1 H), 2.87 (d, J = 2.4 Hz, 1 H), 2.34–2.18 (m, 2 H), 2.07 (quintet 
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of doublets, J = 7.6, 0.8 Hz, 2 H), 1.89–1.58 (m, 4 H), 1.24 (d, J = 6.4 Hz, 3 H), 0.97 (t, J 
= 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 133.6, 127.2, 75.8, 68.8, 67.3, 40.5, 32.9, 
24.3, 24.1, 20.7, 14.5; HRMS (FAB) calcd for C11H22ClO2 [M+H]+ 221.1308, found 
221.1306. 
 
Cyclization/Carbonate Formation to Form Bromoetherification Substrates:  
32.  Prepared according to the procedures described for the synthesis of 45.  
Cyclization of trans-diol 37 (0.260 g, 1.26 mmol) at 130 °C for 2 h afforded the desired 
hydroxytetrahydrofuran intermediate (0.122 g, 57% yield) as a colorless viscous oil.  
Carbonate formation on 0.50 mmol scale afforded 32 (0.104 g, 77% yield) as a colorless 
viscous oil.  32: Rf = 0.44 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2974, 2934, 
2873, 1739, 1369, 1281, 1256, 1167 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.55 (m, 1 H), 
5.39 (m, 1 H), 5.08 (m, 1 H), 3.92 (m, 1 H), 3.68 (td, J = 6.8, 4.0 Hz, 1 H), 2.47 (quintet, 
J = 7.2 Hz, 1 H), 2.41–2.29 (m, 2 H), 2.00 (m, 2 H), 1.58 (ddd, J = 14.0, 7.6, 2.8 Hz, 1 
H), 1.47 (s, 9 H), 1.31 (d, J = 6.4 Hz, 3 H), 0.95 (t, J = 7.2 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 153.5, 134.9, 124.7, 82.1, 82.0, 77.9, 73.7, 40.8, 32.4, 27.9 (3 C), 25.7, 
21.5, 13.8; HRMS (FAB) calcd for C15H27O4 [M+H]+ 271.1909, found 271.1912. 
56.  Prepared according to the procedures described for the synthesis of 45.  
Cyclization of cis-diol 55 (0.460 g, 2.23 mmol) at 130 °C for 2 h afforded the desired 
hydroxytetrahydrofuran intermediate (0.316 g, 83% yield) as a colorless viscous oil.  
Carbonate formation on 0.50 mmol scale afforded 56 (0.100 g, 74% yield) as a colorless 
viscous oil.  56:  Rf = 0.46 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2969, 2931, 
2874, 1740, 1369, 1280, 1254, 1166 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.55 (m, 1 H), 
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5.37 (m, 1 H), 5.15 (t, J = 4.0 Hz, 1 H), 4.32 (m, 1 H), 4.01 (td, J = 7.2, 3.6 Hz, 1 H), 
2.37–2.21 (m, 2 H), 2.17 (ddd, J = 14.0, 6.0, 1.2 Hz, 1 H), 1.99 (m, 2 H), 1.76 (ddd, J = 
14.0, 9.2, 5.2 Hz, 1 H), 1.47 (s, 9 H), 1.23 (d, J = 6.0 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 153.3, 134.9, 124.7, 82.2, 80.8, 78.3, 73.4, 41.1, 32.8, 
27.9 (3 C), 25.7, 21.5, 13.8; HRMS (FAB) calcd for C15H27O4 [M+H]+ 271.1909, found 
271.1901. 
39.  Prepared according to the procedures described for the synthesis of 45.  
Cyclization of trans-diol 40 (0.263 g, 1.27 mmol) at 130 °C for 4 h afforded the desired 
hydroxytetrahydrofuran intermediate (0.155 g, 72% yield) as a colorless viscous oil.  
Carbonate formation on 0.30 mmol scale afforded 39 (0.068 g, 84% yield) as a colorless 
viscous oil.  39: Rf = 0.34 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2975, 2934, 
2873, 1739, 1282, 1256, 1166 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.48 (m, 1 H), 5.36 
(m, 1 H), 5.08 (m, 1 H), 3.93 (m, 1 H), 3.70 (td, J = 7.2, 4.4 Hz, 1 H), 2.48 (quintet, J = 
7.2 Hz, 1 H), 2.41 (t, J = 7.2 Hz, 2 H), 2.11–2.00 (m, 2 H), 1.60 (ddd, J = 14.0, 7.2, 2.8 
Hz, 1 H), 1.47 (s, 9 H), 1.31 (d, J = 6.0 Hz, 3 H), 0.95 (t, J = 7.6 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 153.5, 134.1, 124.4, 82.2, 81.7, 77.9, 73.7, 40.9, 27.9 (3 C), 27.2, 21.4, 
20.8, 14.3; HRMS (FAB) calcd for C15H27O4 [M+H]+ 271.1909, found 271.1899. 
58.  Prepared according to the procedures described for the synthesis of 45.  
Cyclization of cis-diol 57 (0.216 g, 1.04 mmol) at 130 °C for 5 h afforded the desired 
hydroxytetrahydrofuran intermediate (0.153 g, 86% yield) as a colorless viscous oil.  
Carbonate formation on 0.30 mmol scale afforded 58 (0.067 g, 83% yield) as a colorless 
viscous oil.  58: Rf = 0.34 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2973, 2932, 
2874, 1740, 1281, 1254, 1165 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.48 (m, 1 H), 5.31 
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(m, 1 H), 5.14 (t, J = 4.4 Hz, 1 H), 4.32 (m, 1 H), 4.03 (td, J = 7.2, 4.0 Hz, 1 H), 2.42–
2.28 (m, 2 H), 2.19 (dd, J = 13.6, 5.6 Hz, 1 H), 2.11–1.98 (m, 2 H), 1.77 (ddd, J = 14.4, 
9.6, 5.2 Hz, 1 H), 1.48 (s, 9 H), 1.24 (d, J = 6.4 Hz, 3 H), 0.95 (t, J = 7.6 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 153.4, 134.1, 124.3, 82.3, 80.6, 78.3, 73.3, 41.1, 27.9 (3 C), 
27.5, 21.5, 20.8, 14.3; HRMS (FAB) calcd for C15H27O4 [M+H]+ 271.1909, found 
271.1900. 
42.  Prepared according to the procedures described for the synthesis of 45.  
Cyclization of trans-diol 43 (0.198 g, 0.898 mmol) at 130 °C for 8 h afforded the desired 
hydroxytetrahydrofuran intermediate (0.118 g, 72% yield) as a colorless viscous oil.  
Carbonate formation on 0.50 mmol scale afforded 42 (0.105 g, 74% yield) as a colorless 
viscous oil.  42: Rf = 0.39 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2977, 2934, 
2872, 1739, 1369, 1280, 1255, 1167 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.52–5.34 (m, 2 
H), 5.07 (ddd, J = 7.2, 4.0, 2.8 Hz, 1 H), 3.89 (m, 1 H), 3.66 (ddd, J = 10.0, 5.6, 3.6 Hz, 1 
H), 2.47 (quintet, J = 7.2 Hz, 1 H), 2.19–1.93 (m, 4 H), 1.79–1.63 (m, 2 H), 1.58 (ddd, J 
= 14.0, 7.6, 2.8 Hz, 1 H), 1.47 (s, 9 H), 1.30 (d, J = 6.4 Hz, 3 H), 0.94 (t, J = 7.2 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 153.6, 132.7, 128.5, 82.1, 81.4, 78.2, 73.5, 40.9, 29.4, 
28.8, 27.9 (3 C), 25.7, 21.4, 14.0; HRMS (FAB) calcd for C16H29O4 [M+H]+ 285.2066, 
found 285.2063. 
60.  Prepared according to the procedures described for the synthesis of 45.  
Cyclization of cis-diol 59 (0.128 g, 0.580 mmol) at 130 °C for 2 h afforded the desired 
hydroxytetrahydrofuran intermediate (0.101 g, 94% yield) as a colorless viscous oil.  
Carbonate formation on 0.50 mmol scale afforded 60 (0.108 g, 76% yield) as a colorless 
viscous oil.  60:  Rf = 0.39 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2967, 2932, 
249
 
2873, 1739, 1369, 1279, 1255, 1166 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.51–5.33 (m, 2 
H), 5.15 (t, J = 4.0 Hz, 1 H), 4.29 (m, 1 H), 4.00 (ddd, J = 9.6, 6.0, 4.0 Hz, 1 H), 2.21–
1.94 (m, 5 H), 1.77 (ddd, J = 14.0, 9.2, 5.2 Hz, 1 H), 1.71–1.51 (m, 2 H), 1.47 (s, 9 H), 
1.22 (d, J = 6.4 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.4, 
132.7, 128.5, 82.2, 80.2, 78.6, 73.0, 41.1, 29.3, 29.1, 27.9 (3 C), 25.7, 21.5, 14.0; HRMS 
(FAB) calcd for C16H29O4 [M+H]+ 285.2066, found 285.2073. 
45.  Prepared according to a procedure adapted from the work of Britton and co-
workers: Kang, B.; Chang, S.; Decker, S.; Britton, R. Org. Lett. 2010, 12, 1716–1719.  
trans-Diol 46 (0.274 g, 1.24 mmol, 1.0 equiv) was dissolved in MeOH (24 mL) and water 
(12 mL) in a high-pressure sealed tube.  The reaction vessel was then sealed and heated at 
130 °C for 4 h.  Upon completion, the reaction mixture was allowed to cool to 25 °C, 
quenched by the addition of saturated aqueous NaHCO3 (30 mL) and water (30 mL), and 
extracted with EtOAc (3 × 40 mL).  The combined organic layers were washed with brine 
(50 mL), dried (MgSO4), filtered, and concentrated.  The resultant yellow oil was purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 1:0→7:3) to afford the 
hydroxytetrahydrofuran intermediate (0.183 g, 80% yield) as a colorless viscous oil.  Rf = 
0.46 (silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 3419 (br), 3004, 2965, 2933, 2870, 
1453, 1072 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.45–5.31 (m, 2 H), 4.16 (m, 1 H), 3.90 
(sextet, J = 6.4 Hz, 1 H), 3.52 (td, J = 6.8, 3.6 Hz, 1 H), 2.41 (m, 1 H), 2.22–2.10 (m, 2 
H), 2.05 (quintet, J = 7.2 Hz, 2 H), 1.81–1.62 (m, 2 H), 1.53 (d, J = 7.6 Hz, 1 H), 1.48 
(ddd, J = 14.0, 6.8, 2.0 Hz, 1 H), 1.33 (d, J = 6.4 Hz, 3 H), 0.95 (t, J = 7.6 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 132.6, 128.5, 83.0, 73.5, 73.4, 43.7, 28.9, 24.0, 22.3, 20.7, 
14.4; HRMS (FAB) calcd for C11H21O2 [M+H]+ 185.1542, found 185.1549.  Next, a 
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solution of n-BuLi (1.5 M in hexanes, 0.662 mL, 0.993 mmol, 1.0 equiv) was added to a 
solution of the freshly prepared hydroxytetrahydrofuran (0.183 g, 0.993 mmol, 1.0 equiv) 
in THF (8 mL) at 0 °C.  After stirring for 5 min at 0 °C, a solution of Boc2O (0.217 g, 
0.993 mmol, 1.0 equiv) in THF (2 mL) was added slowly, and the resultant colorless 
solution was warmed to 25 °C and stirred for 1 h.  Upon completion, the reaction mixture 
was quenched by the addition of saturated aqueous NH4Cl (10 mL) and water (10 mL).  
The crude product was extracted into Et2O (3 × 15 mL), and the combined organic layers 
were washed with brine (30 mL), dried (MgSO4), filtered, and concentrated.  Purification 
of the resultant yellow oil by flash column chromatography (silica gel, hexanes:EtOAc, 
19:1) afforded 45 (0.232 g, 82% yield) as a colorless viscous oil [Note: as mentioned 
above, the previous Wittig reaction was not entirely stereoselective, as such 45 was 
contaminated with approximately 8% of undesired E-alkene 42].  45: Rf = 0.43 (silica gel, 
hexanes:EtOAc, 9:1); IR (film) νmax 2973, 2935, 2872, 1738, 1280, 1256, 1167 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 5.42–5.28 (m, 2 H), 5.07 (m, 1 H), 3.90 (sextet, J = 6.4 Hz, 1 
H), 3.67 (m, 1 H), 2.48 (app quintet, 1 H), 2.20–2.10 (m, 2 H), 2.04 (quintet, J = 7.2 Hz, 
2 H), 1.79–1.55 (m, 3 H), 1.47 (s, 9 H), 1.31 (d, J = 6.0 Hz, 3 H), 0.94 (t, J = 7.2 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 153.6, 132.5, 128.4, 82.1, 81.4, 78.2, 73.6, 41.0, 29.0, 
27.9 (3 C), 24.1, 21.4, 20.6, 14.5; HRMS (FAB) calcd for C16H29O4 [M+H]+ 285.2066, 
found 285.2065. 
62.  Prepared according to the procedures described for the synthesis of 45.  
Cyclization of cis-diol 61 (0.590 g, 2.67 mmol) at 130 °C for 1 h afforded the desired 
hydroxytetrahydrofuran intermediate (0.430 g, 87% yield) as a colorless viscous oil.  
Carbonate formation on 0.50 mmol scale afforded 62 (0.111 g, 78% yield) as a colorless 
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viscous oil [Note: as mentioned above, the previous Wittig reaction was not entirely 
stereoselective, as such 62 was contaminated with approximately 8% of undesired E-
alkene 60].   62: Rf = 0.44 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2969, 2933, 
2872, 1739, 1369, 1280, 1254, 1165 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.41–5.27 (m, 2 
H), 5.15 (t, J = 4.0 Hz, 1 H), 4.31 (m, 1 H), 4.00 (ddd, J = 9.6, 5.6, 3.6 Hz, 1 H), 2.23–
1.96 (m, 5 H), 1.78 (ddd, J = 14.4, 9.2, 5.2 Hz, 1 H), 1.74–1.50 (m, 2 H), 1.48 (s, 9 H), 
1.23 (d, J = 6.4 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.5, 
132.5, 128.4, 82.3, 80.2, 78.6, 73.0, 41.1, 29.3, 27.9 (3 C), 24.0, 21.5, 20.6, 14.5; HRMS 
(FAB) calcd for C16H29O4 [M+H]+ 285.2066, found 285.2055. 
 
BDSB Cyclizations: 
 General Cyclization Procedure A.  A cold (–25 °C) solution of BDSB (0.0659 
g, 0.120 mmol, 1.2 equiv) in MeNO2 (0.5 mL) was added rapidly via syringe to a solution 
of the cyclization precursor (0.100 mmol, 1.0 equiv) in MeNO2 (4.5 mL) at –25 °C.  
After stirring the resultant yellow solution for 5 min at –25 °C, the flask was removed 
from the cold bath and stirred for an additional 5 min.  Upon completion, the reaction 
mixture was quenched by the addition of a combination of saturated aqueous NaHCO3 
and 5% aqueous Na2SO3 (1:1, 5 mL), and the resultant biphasic mixture was stirred 
vigorously for 20 min at 25 °C.  The reaction contents were added to brine (10 mL) and 
extracted with EtOAc (3 × 15 mL).  The combined organic layers were washed with brine 
(20 mL), dried (MgSO4), filtered, and concentrated.  The resultant residue was purified 
by flash column chromatography (silica gel, hexanes:EtOAc) to afford the desired 
products as detailed below. 
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 General Cyclization Procedure B.  Identical to cyclization Procedure A, except 
that 1.5 equivalents of BDSB was utilized and the reaction was stirred for 15 min at –25 
°C before being removed from the cold bath and stirred for an additional 5 min prior to 
quench.  This procedure proved ideal for the more sluggish reactions forming the 8-endo 
products. 
 General Cyclization Procedure C. Identical to cyclization Procedure A, except 
that the reaction was quenched immediately after 5 min at –25 °C without allowing any 




 34.  Cyclization of 32 utilizing General Cyclization Procedure B afforded 34 
(0.0198 g, 68% yield) as a colorless amorphous solid.  34: Rf = 0.49 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 2971, 2939, 2881, 1805, 1192, 1041 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 4.86–4.77 (m, 2 H), 4.02 (sextet of doublets, J = 6.4, 2.8 Hz, 1 H), 
3.81 (m, 1 H), 3.62 (td, J = 10.8, 4.0 Hz, 1 H), 2.60–2.47 (m, 2 H), 2.19 (m, 1 H), 2.06 
(dt, J = 14.4, 3.2 Hz, 1 H), 1.91 (sextet of doublets, J = 7.2, 4.0 Hz, 1 H), 1.70 (sextet of 
doublets, J = 7.2, 3.6 Hz, 1 H), 1.27 (d, J = 6.8 Hz, 3 H), 0.89 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 153.8, 79.7, 78.8, 74.1, 70.6, 48.1, 39.3, 34.1, 27.6, 18.7, 6.9; 
HRMS (FAB) calcd for C11H18BrO4 [M+H]+ 293.0388, found 293.0395. 
 63.  Cyclization of 56 utilizing General Cyclization Procedure B afforded 63 
(0.0195 g, 67% yield) as a white crystalline solid.  63: Rf = 0.54 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 2973, 2939, 2881, 1807, 1188, 1052, 1034 cm–1; 1H 
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NMR (400 MHz, CDCl3) δ 4.98 (ddd, J = 12.4, 7.2, 3.6 Hz, 1 H), 4.83 (ddd, J = 10.8, 
7.2, 1.2 Hz, 1 H), 3.79 (quintet, J = 6.4 Hz, 1 H), 3.72 (m, 1 H), 3.26 (m, 1 H), 2.59 (m, 1 
H), 2.52–2.42 (m, 2 H), 2.12 (sextet of doublets, J = 7.2, 2.4 Hz, 1 H), 2.02 (dd, J = 14.4, 
3.6 Hz, 1 H), 1.44 (m, 1 H), 1.29 (d, J = 6.4 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 153.9, 84.4, 80.0, 75.6, 73.4, 49.3, 39.1, 32.5, 28.0, 20.1, 9.3; 
HRMS (FAB) calcd for C11H18BrO4 [M+H]+ 293.0388, found 293.0395. 
 65.  Attempted cyclization of 39 utilizing General Cyclization Procedure B 
afforded 65 (0.0116 g, 47% yield) as a colorless amorphous solid (as the predominant 
product of a complex mixture of products).  Connectivity and stereochemistry were 
determined by COSY and NOESY NMR experiments (see attached spectra).  As 
additional evidence for the structure of 65, cyclization of the alcohol precursor to 64 
using BDSB was undertaken using Procedure C, and 65 was produced in >90% yield.  
65: Rf = 0.40 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2970, 2934, 2877, 1384, 
1117, 1083 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.79 (quintet, J = 4.0 Hz, 1 H), 4.46 (t, J 
= 4.8 Hz, 1 H), 4.22 (quintet, J = 5.2 Hz, 1 H), 3.92–3.84 (m, 2 H), 2.35 (m, 1 H), 2.17 
(dd, J = 13.2, 5.2 Hz, 1 H), 1.98–1.73 (m, 3 H), 1.55 (ddd, J = 13.2, 9.6, 4.0 Hz, 1 H), 
1.30 (d, J = 6.0 Hz, 3 H), 1.09 (t, J = 7.2 Hz, 3 H); 13C NMR (75 MHz, CDCl3) δ 85.0, 
83.8, 80.4, 76.0, 60.8, 42.0, 37.5, 28.9, 20.6, 12.6; HRMS (EI) calcd for C10H16BrO2 [M–




 67.  Attempted cyclization of 58 utilizing General Cyclization Procedure B above 
afforded 67 (8.9 mg, 36% yield) as a colorless amorphous solid (as the predominant 
product of a complex mixture of products).  Connectivity and stereochemistry were 
determined by COSY and NOESY NMR experiments (see attached spectra).  As 
additional evidence for the structure of 67, cyclization of the alcohol precursor to 66 
using BDSB was undertaken using Procedure C, and 67 was produced in >90% yield.  
67: Rf = 0.40 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2969, 2933, 2875, 1381, 
1123, 1089, 1047 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.80–4.72 (m, 2 H), 4.26–4.13 (m, 
2 H), 3.86 (quintet, J = 4.4 Hz, 1 H), 2.27–2.15 (m, 2 H), 1.96–1.78 (m, 3 H), 1.54 (ddd, 
J = 14.8, 10.0, 4.4 Hz, 1 H), 1.24 (d, J = 6.0 Hz, 3 H), 1.08 (t, J = 7.2 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 85.4, 83.6, 82.6, 75.9, 61.7, 43.0, 39.3, 28.7, 20.8, 12.6; HRMS (EI) 





















 69.  Cyclization of 42 utilizing General Cyclization Procedure A afforded 69 
(0.0183 g, 60% yield) as a white crystalline solid.  69: Rf = 0.44 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 2969, 2937, 2877, 1797, 1192, 1040 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 4.89–4.80 (m, 2 H), 4.11 (sextet of doublets, J = 6.8, 3.2 Hz, 1 H), 
3.84 (ddd, J = 10.0, 4.4, 3.6 Hz, 1 H), 3.43 (dt, J = 10.4, 2.8 Hz, 1 H), 2.22–1.94 (m, 4 
H), 1.89–1.68 (m, 4 H), 1.27 (d, J = 6.8 Hz, 3 H), 1.08 (t, J = 7.2 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 154.2, 82.0, 78.9, 72.9, 70.5, 64.8, 34.3, 29.4, 28.3, 27.4, 19.0, 13.1; 
HRMS (FAB) calcd for C12H20BrO4 [M+H]+ 307.0545, found 307.0545. 
 70.  Cyclization of 60 utilizing General Cyclization Procedure A afforded 70 
(0.0254 g, 83% yield) as a colorless amorphous solid.  70: Rf = 0.53 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 2973, 2938, 2878, 1804, 1188, 1050, 1034 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 4.98 (ddd, J = 12.4, 7.6, 3.2 Hz, 1 H), 4.79 (ddd, J = 10.8, 
7.2, 1.2 Hz, 1 H), 3.91 (quintet, J = 6.4 Hz, 1 H), 3.72 (ddd, J = 10.4, 6.4, 2.8 Hz, 1 H), 
3.45 (ddd, J = 11.6, 6.4, 2.0 Hz, 1 H), 2.45 (ddd, J = 18.4, 12.4, 5.6 Hz, 1 H), 2.22–1.90 























13C NMR (100 MHz, CDCl3) δ 154.3, 82.5, 82.3, 75.6, 73.0, 61.8, 32.6, 30.9, 27.5, 26.8, 
19.8, 12.8; HRMS (FAB) calcd for C12H20BrO4 [M+H]+ 307.0545, found 307.0556. 
 71.  Cyclization of 45 utilizing General Cyclization Procedure A [Note: 0.0108 
mmol of starting material and 0.130 mmol BDSB were utilized, since 8% was the 
undesired E-alkene isomer], followed by purification by flash column chromatography 
(silica gel, hexanes:EtOAc, 4:1), afforded 71 (0.0283 g) as a colorless amorphous solid 
(contaminated with a small impurity, likely the product derived from the E-alkene 
contaminant in the starting material, ~85% yield).  71: Rf  = 0.52 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 2970, 2933, 1805, 1210, 1076, 1055 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 4.57 (td, J = 10.4, 5.6 Hz, 1 H), 4.36 (m, 1 H), 4.09 (septet, J = 5.6 
Hz, 1 H), 3.86–3.78 (m, 2 H), 2.45 (ddt, J = 14.0, 7.6, 2.0 Hz, 1 H), 2.28 (ddd, J = 15.6, 
10.0, 5.2 Hz, 1 H), 2.12 (m, 1 H), 1.99–1.72 (m, 5 H), 1.37 (d, J = 6.4 Hz, 3 H), 1.06 (t, J 
= 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 154.0, 83.4, 81.6, 79.6, 64.3, 63.0, 39.6, 
30.8, 28.6, 27.2, 22.6, 12.4; HRMS (FAB) calcd for C12H20BrO4 [M+H]+ 307.0545, 
found 307.0530. 
 72.  Cyclization of 62 utilizing General Cyclization Procedure A [Note: 0.0108 
mmol of starting material and 0.130 mmol BDSB were utilized, since 8% was the 
undesired E-alkene isomer] afforded 72 (0.0257 g, 84% yield) as a white crystalline solid.  
72: Rf = 0.46 (silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 2972, 2940, 2879, 1802, 
1188, 1048, 1029 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.00 (ddd, J = 12.4, 7.2, 3.2 Hz, 1 
H), 4.81 (ddd, J = 10.8, 7.2, 1.2 Hz, 1 H), 3.91 (quintet, J = 6.4 Hz, 1 H), 3.83 (m, 1 H), 
3.40 (ddd, J = 11.6, 5.2, 2.0 Hz, 1 H), 2.44 (ddd, J = 18.0, 12.4, 5.6 Hz, 1 H), 2.13–1.84 
(m, 5 H), 1.68–1.54 (m, 2 H), 1.31 (d, J = 6.4 Hz, 3 H), 1.07 (t, J = 7.2 Hz, 3 H); 13C 
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NMR (100 MHz, CDCl3) d 154.3, 82.3, 81.7, 75.7, 72.7, 62.1, 32.6, 29.7, 27.6, 27.4, 
19.9, 12.5; HRMS (FAB) calcd for C12H20BrO4 [M+H]+ 307.0545, found 307.0545 
 
Alterative Bromonium Source Cyclizations: 
 Bis(collidine)bromonium Triflate.  A solution of (coll)2BrOTf (0.0566 g, 0.120 
mmol, 1.2 equiv) in MeNO2 (0.5 mL) was syringed into a solution of 45 (0.0284 g, 0.100 
mmol, 1.0 equiv) in MeNO2 (4.5 mL) at 0 °C.  After 5 min at 0 °C, the reaction mixture 
was removed from the ice bath and stirred at 25 °C for an additional 5 min.  Upon 
completion, the reaction mixture was quenched by the addition of 5% aqueous Na2SO3 (5 
mL).  The reaction contents were added to water (5 mL) and then extracted with CH2Cl2 
(3 × 10 mL).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated.  The resultant residue was purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:0→7:3) to afford 0.0199 g of 71 contaminated by two minor, 
inseparable, impurities (calculated yield of pure 71 is 0.0159 g, 52% yield). 
 TBCO.  TBCO (0.0492 g, 0.120 mmol, 1.2 equiv) was added in one portion to a 
solution of 45 (0.0284 g, 0.100 mmol, 1.0 equiv) in MeCN (5 mL) at 25 °C.  After 10 
min at 25 °C, the reaction mixture was quenched by the addition of a mixture of saturated 
aqueous NaHCO3 and 5% aqueous Na2SO3 (1:1, 5 mL).  The reaction contents were 
added to water (5 mL) and then extracted with CH2Cl2 (3 × 10 mL).  The combined 
organic layers were dried (MgSO4), filtered, and concentrated.  The resultant residue was 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 1:0→7:3) to afford 
0.0190 g (62% yield) of pure 71. 
 NBS.  NBS (0.0214 g, 0.120 mmol, 1.2 equiv) was added in one portion to a 
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solution of 45 (0.0284 g, 0.100 mmol, 1.0 equiv) in CH2Cl2 (0.5 mL) at 25 °C.  After 48 
h, the solvent was removed under vacuum and the residue subjected to flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0→1:1) to afford 3.6 mg of 71 that was 
approximately 75% pure by NMR (2.8 mg pure 71, 9% yield).  The remaining mass 
balance contained approximately 50% starting material in addition to numerous 
unidentified byproducts.  Performing the reaction at lower temperatures or higher dilution 
led to only recovered starting material.  Utilizing excess NBS or 3 equivalents of N,N-
dimethylacetamide as a nucleophilic promoter resulted in faster reactions, but with 
increased side product formation such that even less desired product was formed.  More 
polar solvents such as THF and DMF resulted in an increased rate of consumption of 
starting material, but with no product formation at all.  
 
Post-cyclization Modification of 8-Membered Rings: 
 General Procedure for Acetate/Carbonate Hydrolysis.  K2CO3 (0.069 g, 0.50 
mmol, 10 equiv) was added in a single portion to a solution of the cyclic carbonate or 
acetate (0.050 mmol, 1.0 equiv) in MeOH (1.8 mL) and water (0.2 mL) at 0 °C.  The 
reaction mixture was allowed to warm slowly to 25 °C and was monitored by TLC.  
Upon completion (~0.5 to 2 h), the reaction mixture was quenched by the addition of 
saturated aqueous NH4Cl (5 mL) and water (5 mL), and the crude product was extracted 
into EtOAc (3 × 10 mL).  The combined organic layers were washed with brine (10 mL), 
dried (MgSO4), filtered, and concentrated.  Purification by flash column chromatography 
(silica gel, hexanes:EtOAc) afforded the desired diols as white crystalline solids (in all 
but one case – derivative of 70).  Recrystallization was performed by slow evaporation 
259
 
from a hexanes:CH2Cl2 mixture to afford single crystals suitable for X-ray diffraction.  
 Diol Derivative of 36:  White crystalline solid.  Rf = 0.31 (silica gel, 
hexanes:EtOAc, 1:2); IR (film) νmax 3357 (br), 2963, 2930, 2879, 1460, 1375, 1062, 1044 
cm–1; 1H NMR (400 MHz, CDCl3) δ 4.23 (td, J = 7.2, 3.6 Hz, 1 H), 4.01–3.90 (m, 3 H), 
3.63 (ddd, J = 10.4, 5.6, 3.6 Hz, 1 H), 2.61 (ddd, J = 20.4, 12.4, 8.0 Hz, 1 H), 2.44 (d, J = 
2.8 Hz, 1 H), 2.35 (br s, 1 H), 2.21 (dd, J = 14.8, 4.4 Hz, 1 H), 1.95–1.72 (m, 4 H), 1.18 
(d, J = 6.8 Hz, 3 H), 0.92 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 74.8 (br), 
71.8 (2 C), 69.4, 51.7, 42.2, 38.1, 27.8, 20.9, 8.1; HRMS (FAB) calcd for C10H20BrO3 
[M+H]+ 267.0596, found 267.0592; structure confirmed by single crystal X-Ray 
diffraction.  [Note: Owing to the appearance of the strangely broad carbon peak, an 
HSQC spectrum is also attached, establishing that the peak at 74.8 ppm is real]. 
 
 Diol Derivative of 63:  White crystalline solid.  Rf = 0.37 (silica gel, 
hexanes:EtOAc, 1:2); IR (film) νmax 3372 (br), 2969, 2933, 2877, 1101, 1064, 1031 cm–1; 
1H NMR (400 MHz, CDCl3) δ 4.27 (dd, J = 7.6, 2.8 Hz, 1 H), 4.13 (quintet, J = 4.4 Hz, 1 
H), 3.90 (ddd, J = 14.4, 10.4, 4.0 Hz, 1 H), 3.80 (m, 1 H), 3.34 (td, J = 9.6, 2.4 Hz, 1 H), 
2.78 (ddd, J = 20.4, 12.4, 10.4 Hz, 1 H), 2.28 (br s, 1 H), 2.20–2.08 (m, 2 H), 2.02 (m, 1 
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H), 1.83 (dt, J = 14.8, 4.4 Hz, 1 H), 1.58 (br s, 1 H), 1.39 (m, 1 H), 1.21 (d, J = 6.4 Hz, 3 
H), 0.94 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 83.3, 73.2, 72.2, 70.0, 53.5, 
41.8, 37.8, 28.4, 20.9, 9.8; HRMS (FAB) calcd for C10H20BrO3 [M+H]+ 267.0596, found 
267.0607; structure could not be fully solved by single crystal X-Ray diffraction, 
although the crystallographer (W. S.) is confident it matches the assigned structure. 
 Diol Derivative of 69:  White crystalline solid.  Rf = 0.22 (silica gel, 
hexanes:EtOAc, 1:2); IR (film) νmax 3391 (br), 2965, 2935, 1459, 1376, 1144, 1059 cm–1; 
1H NMR (400 MHz, CDCl3) δ 4.21 (app d, 1 H), 4.07 (sextet of doublets, J = 6.4, 2.4 Hz, 
1 H), 3.93 (m, 1 H), 3.85 (m, 1 H), 3.57 (m, 1 H), 2.31 (br s, 2 H), 2.10–1.68 (m, 7 H), 
1.63 (dt, J = 15.2, 4.0 Hz, 1 H), 1.19 (d, J = 6.4 Hz, 3 H), 1.06 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 73.7, 73.4, 72.3, 69.2, 65.0, 38.3, 29.3 (2 C), 28.3, 21.3, 13.0; 
HRMS (FAB) calcd for C11H22BrO3 [M+H]+ 281.0752, found 281.0767; structure 
confirmed by single crystal X-Ray diffraction. 
 
 Diol Derivative of 70:  Colorless amorphous solid.  Rf = 0.29 (silica gel, 
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hexanes:EtOAc, 1:2); IR (film) νmax 3373 (br), 2969, 2935, 2876, 1460, 1110, 1047, 
1027, 1006 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.22 (app d, 1 H), 4.13 (dt, J = 10.4, 4.0 
Hz, 1 H), 3.85 (m, 1 H), 3.74 (m, 1 H), 3.53 (m, 1 H), 2.24 (br s, 2 H), 2.18–1.98 (m, 4 
H), 1.80–1.54 (m, 4 H), 1.23 (d, J = 6.4 Hz, 3 H), 1.06 (t, J = 7.6 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 81.0, 73.3, 72.7, 69.4, 63.0, 36.9, 31.4, 29.3, 27.1, 20.8, 12.7; 
HRMS (FAB) calcd for C11H20BrO2 [M-OH]+ 263.0647, found 263.0661. 
 pBrBz Derivative of 70.  4-Bromobenzoyl chloride (0.059 g, 0.27 mmol, 4.0 
equiv) was added to a solution of diol derivative of 70 (0.019 g, 0.067 mmol, 1.0 equiv), 
4-DMAP (8.2 mg, 0.067 mmol, 1.0 equiv), and Et3N (0.075 mL, 0.54 mmol, 8.0 equiv) in 
CH2Cl2 (1 mL) at 0 °C.  The resultant colorless solution was then allowed to warm to 25 
°C and was stirred at that temperature for 3 h.  Upon completion, the light orange 
heterogeneous reaction mixture was quenched by the addition of water (8 mL) and 1 M 
HCl (2 mL).  The crude product was then extracted with CH2Cl2 (3 ×  10 mL), and the 
combined organic layers were washed with saturated aqueous NaHCO3 (30 mL) and 
brine (30 mL), dried (MgSO4), filtered, and concentrated.  Purification of the resultant 
residue by flash column chromatography (silica gel, hexanes:EtOAc, 19:1 + 2% Et3N) 
afforded bis-bromobenzoate derivative of 70 (0.037 g, 85% yield) as a white crystalline 
solid.  Recrystallization from boiling MeOH (8 mL) afforded single crystals suitable for 
X-ray diffraction.  Rf = 0.44 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2968, 2930, 
2875, 2851, 1718, 1590, 1265, 1101, 1012, 755 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.91 
(d, J = 8.4 Hz, 2 H), 7.76 (d, J = 8.4 Hz, 2 H), 7.62 (d, J = 8.8 Hz, 2 H), 7.50 (d, J = 8.4 
Hz, 2 H), 5.75–5.66 (m, 2 H), 3.95 (m, 1 H), 3.85 (ddd, J = 9.6, 6.8, 2.4 Hz, 1 H), 3.72 
(m, 1 H), 2.41–2.22 (m, 3 H), 2.11 (sextet of doublets, J = 7.2, 2.8 Hz, 1 H), 2.05–1.85 
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(m, 3 H), 1.78 (m, 1 H), 1.32 (d, J = 6.4 Hz, 3 H), 1.09 (t, J = 7.2 Hz, 3 H); 13C NMR 
(125 MHz, CDCl3) δ 165.2, 165.1, 132.1 (2 C), 131.8 (2 C), 131.2 (4 C), 129.3 (2 C), 
128.5, 128.2, 82.0, 76.2, 72.6 (2 C), 61.8, 37.1, 30.7, 27.3, 27.1, 21.4, 12.5; HRMS: No 
molecular ion peak could be observed; structure confirmed by single crystal X-Ray 
diffraction. 
 
 Diol Derivative of 71:  White crystalline solid.  Rf = 0.28 (silica gel, 
hexanes:EtOAc, 1:2); IR (film) νmax 3380 (br), 2965, 2934, 2875, 1459, 1376, 1052 cm–1; 
1H NMR (400 MHz, CDCl3) δ 4.18 (m, 1 H), 4.07–3.90 (m, 2 H), 3.69–3.62 (app d, 2 H), 
2.53 (d, J = 2.8 Hz, 1 H), 2.21 (d, J = 6.0 Hz, 1 H), 2.10–1.82 (m, 4 H), 1.79–1.57 (m, 4 
H), 1.19 (d, J = 6.8 Hz, 3 H), 1.05 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
74.3, 73.5, 72.1, 69.4, 62.3, 37.9, 29.6, 27.3, 26.5, 21.3, 13.2; HRMS (FAB) calcd for 





 Diol Derivative of 72:  White crystalline solid; Rf = 0.29 (silica gel, 
hexanes:EtOAc, 1:2); IR (film) νmax 3394 (br), 2969, 2936, 2876, 1462, 1113, 1062, 
1039, 1009 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.23 (m, 1 H), 4.14 (m, 1 H), 3.91–3.82 
(m, 2 H), 3.50 (ddd, J = 10.8, 5.2, 2.4 Hz, 1 H), 2.40 (d, J = 2.4 Hz, 1 H), 2.18–1.99 (m, 3 
H), 1.92 (sextet of doublets, J = 7.2, 3.6 Hz, 1 H), 1.85–1.55 (m, 5 H), 1.23 (d, J = 6.8 
Hz, 3 H), 1.06 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 80.3, 73.4, 72.6, 69.4, 
63.4, 37.1, 30.4, 29.3, 27.9, 20.9, 12.5; HRMS (FAB) calcd for C11H20BrO2 [M-OH]+ 





Synthesis of 8-Exo Bromoether 79: 
 75. Prepared according to a procedure adapted from the work of Reddy: Reddy, 
D. S. Org. Lett. 2004, 6, 3345–3347.  1,5-hexadiene-3-ol (1.34 mL, 12.0 mmol, 1.0 
equiv) and 2-methoxypropene (5.77 mL, 60.0 mmol, 5.0 equiv) were added to a thick-
walled reaction tube.  Next, Hg(OAc)2 (0.0769 g, 0.240 mmol, 0.020 equiv) was added, 
the tube was sealed, and the resultant mixture was heated at 120 °C for 24 h.  Upon 
completion (as monitored by 1H NMR of small reaction aliquots), the reaction contents 
were quenched by the addition of water (50 mL) and extracted with Et2O (3 ×  15 mL).  
The combined organic layers were then dried (MgSO4), filtered, and carefully 
concentrated (the desired ketone is volatile).  Pressing forward without any additional 
purification, the crude ketone (12.0 mmol assumed, 1.0 equiv) was dissolved in MeOH (6 
mL) and cooled to 0 °C.  NaBH4 (0.908 g, 24.0 mmol, 2.0 equiv) was then added slowly 
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at 0 °C, and the resultant reaction mixture was stirred for 30 min at 0 °C.  Upon 
completion, the reaction mixture was quenched at 0 °C by the slow addition of water (20 
mL) and extracted with Et2O (3 × 20 mL). The combined organic layers were then dried 
(MgSO4), filtered, and carefully concentrated.  The resultant crude residue was purified 
by flash column chromatography (silica gel, pentane:Et2O, 9:1→7:3) to afford 75 (3.20 g, 
62% yield over 2 steps) as colorless oil.  75:  Rf = 0.43 (silica gel, hexanes:EtOAc, 7:3); 
IR (film) νmax 3337 (br), 2968, 2925, 1429, 1374, 1128, 969, 911 cm–1; 1H NMR (400 
MHz, CDCl3) δ 5.82 (m, 1 H), 5.52–5.42 (m, 2 H), 5.06–4.95 (m, 2 H), 3.81 (sextet, J = 
6.0 Hz, 1 H), 2.74 (m, 2 H), 2.19–2.05 (m, 2 H), 1.60–1.48 (m, 2 H), 1.19 (d, J = 6.4 Hz, 
3 H); 13C NMR (125 MHz, CDCl3) δ 137.2, 131.0, 128.2, 114.9, 67.7, 38.8, 36.7, 28.9, 
23.4; HRMS: No molecular ion peak was observed. 
76.  To a solution of diene 75 (0.240 g, 1.71 mmol, 1.0 equiv) in CH2Cl2 (17 mL) 
at 25 °C was added mCPBA (0.363 g, 1.71 mmol, 1.0 equiv), and the resultant reaction 
mixture was stirred for 2 h at 25 °C.  Upon completion, the reaction contents were 
quenched by the addition of saturated aqueous Na2SO3 (10 mL).  After vigorously stirring 
the resultant biphasic mixture for 15 min at 25 °C, the organic layer was separated and 
washed with saturated aqueous NaHCO3 (10 mL) and water (10 mL).  The combined 
organic layers were then dried (MgSO4), filtered, and concentrated.  Pressing forward 
without any additional purification, the crude epoxide products (1.71 mmol assumed, 1.0 
equiv) were dissolved in CH2Cl2 (17 mL).  Trans-3-hexene (1.06 mL, 8.53 mmol, 5.0 
equiv) and Hoveyda-Grubbs second generation catalyst (0.011 g, 0.017 mmol, 0.10 
equiv) were added sequentially at 25 °C, and the reaction mixture was then stirred for 2 h 
at 25 °C.  Upon completion (as monitored by 1H NMR analysis of small reaction 
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aliquots), the reaction contents were concentrated and purified directly by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1→1:1) to afford 76 (0.132 g, 41% yield 
over 2 steps, contaminated with ~5% of an unknown side product) as a light brown 
viscous oil.  76:  Rf = 0.52 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3417 (br), 
2966, 2927, 1457, 1071, 968, 751 cm–1; 1H NMR (400 MHz, CDCl3; Note: although 
there are two diastereomers, the 1H NMR spectrum appears to be one compound) δ 5.58 
(m, 1 H), 5.39 (m, 1 H), 3.84 (m, 1 H), 2.78–2.71 (m, 2 H), 2.30–2.16 (m, 2 H), 2.02 
(quintet, J = 7.2 Hz, 2 H), 1.88–1.67 (m, 2 H), 1.63–1.48 (m, 3 H), 1.19 (d, J = 6.0 Hz, 3 
H), 0.97 (t, J = 7.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 135.2 (2 C), 123.2 (2 C), 
67.6, 67.3, 58.5, 58.4, 58.2, 58.1, 35.5, 35.3, 35.0 (2 C), 28.4, 28.2, 25.6 (2 C), 23.5, 23.4, 
13.6 (2 C); HRMS (EI) calcd for C11H20O2 [M]+ 184.1463, found 184.1472. 
78. To a solution of epoxide 76 (0.132 g, 0.717 mmol, 1.0 equiv) in CH2Cl2 (25 
mL) at 25 °C was added PPTS (0.255 g, 1.01 mmol, 1.4 equiv), and the resultant solution 
was stirred for 1 h at 25 °C.  Upon completion, the reaction contents were quenched with 
water (10 mL).  The organic layer was then separated and washed with saturated aqueous 
NaHCO3 (10 mL) and 1 M HCl (10 mL), dried (MgSO4), filtered, and concentrated.  The 
resultant crude residue was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1→7:3) to afford the desired tetrahydrofuran products as a 1:1 mixture 
of separable diastereomers (less polar diastereomer, 77a, 0.055 g, 42% yield; more polar 
diastereomer, 77b, 0.057 g, 44% yield), both as light yellow viscous oils.  The reaction 
was repeated and the combined less polar diastereomer (77a, 0.062 g, 0.34 mmol, 1.0 
equiv) was then dissolved in THF (1.3 mL) and n-BuLi (1.6 M in hexanes, 0.223 mL, 
0.357 mmol, 1.05 equiv) was added at 0 °C.  The reaction was removed from the ice bath 
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and stirred for 10 min at 25 °C before being recooled to 0 °C.  At this time, a solution of 
Boc2O (0.074 g, 0.34 mmol, 1.0 equiv) in THF (0.34 mL) was added and then the 
reaction mixture was allowed to warm to 25 °C over 2 h with stirring.  Upon completion, 
the reaction contents were quenched with water (5 mL) and extracted with EtOAc (3 × 5 
mL).  The combined organic layers were then concentrated and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 99:1→9:1) to afford 78 (0.073 g, 76% yield) 
as a light yellow viscous oil.  78:  Rf = 0.48 (silica gel, hexanes:EtOAc, 9:1); IR (film) 
νmax 2969, 1740, 1274, 1254, 1164, 1094, 850 cm–1; 1H NMR (500 MHz, CDCl3) δ 5.56 
(dt, J = 15.0, 6.5 Hz, 1 H), 5.37 (m, 1 H), 4.70 (dt, J = 8.0, 5.0 Hz, 1 H), 4.00 (m, 1 H), 
3.92 (q, J = 6.0 Hz, 1 H), 2.36 (dt, J = 14.0, 6.0 Hz, 1 H), 2.27 (m, 1 H), 2.02–1.80 (m, 6 
H), 1.47 (s, 9 H), 1.20 (d, J = 6.0 Hz, 3 H), 0.95 (t, J = 7.5 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 153.4, 135.4, 123.7, 81.6, 79.6, 77.6, 76.0, 34.5, 32.7, 27.8 (3 C), 27.1, 
25.6, 21.2, 13.7; HRMS (FAB) calcd for C16H29O4 [M+H]+ 285.2058, found 285.2066. 
 
79.  A solution of BDSB (0.066 g, 0.12 mmol, 1.2 equiv) in MeNO2 (0.5 mL) was 
added quickly via syringe to a solution of 78 (0.028 g, 0.10 mmol, 1.0 equiv) in MeNO2 
(4.5 mL) at –25 °C.  After stirring for 5 min at –25 °C, the reaction flask was removed 
from the cooling bath and the reaction contents were stirred at 25 °C for 5 min.  At that 

















and saturated aqueous NaHCO3 (3 mL).  After vigorously stirring the resultant biphasic 
mixture for 5 min at 25 °C, the reaction contents were extracted with CH2Cl2 (3 ×  10 
mL).  The combined organic layers were then dried (MgSO4), filtered, and concentrated.  
The resultant crude residue was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1→1:1) to afford 79 (0.023 g, 76% yield, contaminated with ~5% of 
an unknown side product) as a colorless viscous oil.  79:  Rf = 0.36 (silica gel, 
hexanes:EtOAc, 7:3); IR (film) νmax 2968, 1799, 1382, 1206, 1064, 773 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 5.03 (td, J = 9.6, 6.4 Hz, 1 H), 4.49 (ddd, J = 13.2, 9.6, 3.6 Hz, 1 
H), 4.03 (m, 1 H), 3.85 (dt, J = 10.0, 4.0 Hz, 1 H), 3.63 (m, 1 H), 2.37–2.24 (m, 2 H), 
2.10 (m, 1 H), 1.93–1.68 (m, 4 H), 1.63 (m, 1 H), 1.19 (d, J = 6.4 Hz, 3 H), 1.09 (t, J = 
7.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 154.0, 81.5, 79.3, 73.9, 68.7, 63.8, 34.9, 




Synthesis of 83 and Cyclization to 9-exo Product 85: 
 (6Z)-Nonenal (90).  TBSCl (9.0 g, 60. mmol, 1.0 equiv) and imidazole (4.9 g, 60. 
mmol, 1.0 equiv) were added sequentially to a solution of 1,6-hexanediol (7.1 g, 60. 




























were quenched by the addition of saturated aqueous NH4Cl (100 mL) and water (50 mL).  
The layers were separated, and the aqueous layer was extracted with EtOAc (3 ×  100 
mL); the combined organic layers were dried (MgSO4), filtered, and concentrated.  The 
resultant oil was purified by flash column chromatography (silica gel, hexanes:EtOAc, 
1:0→4:1) to afford the mono-TBS protected alcohol (6.8 g, 49% yield) as a colorless 
viscous oil.  Rf = 0.31 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 3407 (br), 2932, 
2858, 1640, 1254, 1097, 835, 775 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.64 (t, J = 6.8 
Hz, 2 H), 3.61 (t, J = 6.4 Hz, 2 H), 1.62–1.48 (m, 4 H), 1.42–1.32 (m, 4 H), 1.22 (br s, 1 
H), 0.89 (s, 9 H), 0.05 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 63.2, 63.0, 32.8 (2 C), 
26.0 (3 C), 25.6, 25.5, 18.4, –5.3 (2 C); HRMS (FAB) calcd for C12H29O2Si [M+H]+ 
233.1937, found 233.1940.  The next sequence was prepared according to the procedures 
described above for the transformation to 50.  The freshly prepared mono-TBS protected 
alcohol (5.11 g, 22.0 mmol) was subject to Swern oxidation, Wittig olefination, and 
deprotection followed by purification by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0→4:1) to afford alcohol intermediate (1.47 g, 59% yield over 3 steps) 
as a colorless viscous oil.  Rf = 0.25 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 3377 
(br), 3005, 2962, 2932, 2858, 1649, 1460, 1054 cm–1; 1H NMR (400 MHz, CDCl3) δ 
5.41–5.28 (m, 2 H), 3.64 (t, J = 6.4 Hz, 2 H), 2.08–1.97 (m, 4 H), 1.58 (m, 2 H), 1.41–
1.33 (m, 4 H), 1.24 (br s, 1 H), 0.95 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
131.8, 129.0, 63.0, 32.7, 29.5, 27.0, 25.4, 20.5, 14.4; HRMS (EI) calcd for C9H18O [M]+ 
142.1358, found 142.1360.  The next procedure was prepared according to the general 
Swern procedure for the oxidation of 50.  Oxidation of the freshly prepared alcohol (1.47 
g, 12.9 mmol) afforded the desired aldehyde 90 (1.35 g, 93% yield) as a light yellow oil 
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that was used directly without purification.  90: Rf = 0.48 (silica gel, hexanes:EtOAc, 
9:1); IR (film) νmax 3005, 2962, 2934, 2861, 2718, 1727, 1460 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 9.76 (t, J = 2.0 Hz, 1 H), 5.43–5.25 (m, 2 H), 2.43 (td, J = 7.2, 2.0 Hz, 2 H), 
2.09–1.98 (m, 4 H), 1.65 (quintet, J = 7.6 Hz, 2 H), 1.39 (quintet, J = 7.6 Hz, 2 H), 0.95 
(t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 202.7, 132.2, 128.3, 43.8, 29.2, 26.7, 
21.7, 20.5, 14.3; HRMS (FAB) calcd for C9H15O [M–H]+ 139.1123, found 139.1118. 
 91.  Prepared according to the procedure described above for the synthesis of 54.  
(6Z)-Nonenal (90, 1.35 g) was α -chlorinated to yield (6Z)-2-chloro-6-nonenal (1.99 g, 
82% yield) as a colorless viscous oil that was used directly without purification.  The 
aldol addition with acetone was performed immediately, followed by purification by 
careful flash column chromatography (silica gel, hexanes:EtOAc, 1:0→4:1) to afford the 
desired ketone (0.963 g, 53% yield) as a colorless viscous oil.  Rf = 0.28 (silica gel, 
hexanes:EtOAc, 4:1); IR (film) νmax 3435 (br), 3005, 2962, 2934, 2872, 1714, 1362, 
1165, 1080 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.38 (m, 1 H), 5.30 (m, 1 H), 4.10 (m, 1 
H), 3.92 (ddd, J = 9.6, 6.0, 3.2 Hz, 1 H), 3.24 (d, J = 5.2 Hz, 1 H), 2.89–2.74 (m, 2 H), 
2.22 (s, 3 H), 2.12–1.98 (m, 4 H), 1.90 (m, 1 H), 1.73–1.58 (m, 2 H), 1.46 (m, 1 H), 0.96 
(t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 209.3, 132.4, 128.2, 70.8, 65.8, 45.9, 
33.3, 30.9, 26.4 (2 C), 20.5, 14.3; HRMS (FAB) calcd for C12H22ClO2 [M+H]+ 233.1308, 
found 233.1308.   The next procedure was prepared according to the procedure described 
above for the synthesis of 46/61.  NaBH4 reduction of the freshly prepared ketone (0.421 
g, 1.81 mmol) followed by purification by flash column chromatography (silica gel, 
hexanes:EtOAc, 4:1→1:1) afforded cis-diol 91 (0.282 g, 60% yield) [along with the 
corresponding trans-diol (0.097 g, 20% yield)] as a colorless amorphous solid.  91: Rf = 
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0.29 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3369 (br), 3005, 2965, 2933, 2873, 
1457, 1137, 1076 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.43–5.25 (m, 2 H), 4.06 (m, 1 H), 
3.95 (m, 1 H), 3.88 (m, 1 H), 3.51 (d, J = 4.0 Hz, 1 H), 3.00 (d, J = 2.0 Hz, 1 H), 2.11–
1.96 (m, 4 H), 1.87–1.38 (m, 6 H), 1.23 (d, J = 6.0 Hz, 3 H), 0.95 (t, J = 7.6 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 132.3, 128.2, 75.6, 68.7, 67.7, 40.2, 32.4, 26.6, 26.4, 24.1, 
20.5, 14.3; HRMS (FAB) calcd for C12H24ClO2 [M+H]+ 235.1465, found 235.1466. 
 83.  Prepared according to the procedures described above for the synthesis of 45.  
Cyclization of 91 (0.150 g, 0.64 mmol) at 130 °C for 12 h followed by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1→1:1) afforded the desired 
hydroxytetrahydrofuran (0.120 g, 95% yield) as a colorless viscous oil.  A portion of the 
cyclized product (0.060 g, 0.30 mmol) was taken forward to afford carbonate 83 (0.065 g, 
75% yield) after flash column chromatography (silica gel, hexanes:EtOAc, 19:1→4:1) as 
a colorless viscous oil.  83: Rf = 0.35 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 
2966, 2933, 2871, 1739, 1369, 1280, 1255, 1165 cm–1; 1H NMR (400 MHz, CDCl3) δ 
5.40–5.26 (m, 2 H), 5.16 (t, J = 4.0 Hz, 1 H), 4.31 (m, 1 H), 4.00 (m, 1 H), 2.18 (ddd, J = 
13.6, 6.0, 1.2 Hz, 1 H), 2.09–1.97 (m, 4 H), 1.77 (ddd, J = 14.4, 9.6, 5.2 Hz, 1 H), 1.65–
1.47 (m, 3 H), 1.48 (s, 9 H), 1.36 (m, 1 H), 1.23 (d, J = 6.0 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 153.3, 131.9, 128.7, 82.1, 80.7, 78.5, 72.9, 40.9, 28.8, 
27.8 (3 C), 27.1, 26.4, 21.3, 20.5, 14.3; HRMS (FAB) calcd for C17H31O4 [M+H]+ 
299.2222, found 299.2217. 
 85.  Prepared according to General Cyclization Procedure A described above.  
BDSB cyclization of 83 (0.0298 g, 0.100 mmol) followed by flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0→1:1) afforded 85 (0.0110 g, 34% yield) 
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as a colorless amorphous solid.  85: Rf = 0.48 (silica gel, hexanes:EtOAc, 7:3); IR (film) 
νmax 2969, 2939, 2876, 1799, 1748, 1379, 1243, 1199, 1121 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 4.97 (ddd, J = 11.6, 6.4, 2.4 Hz, 1 H), 4.82 (q, J = 6.8 Hz, 1 H), 3.94–3.83 (m, 2 
H), 3.53 (m, 1 H), 2.60 (ddd, J = 18.0, 11.6, 6.4 Hz, 1 H), 2.02–1.78 (m, 5 H), 1.75–1.60 
(m, 4 H), 1.34 (d, J = 6.4 Hz, 3 H), 1.06 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 154.6, 83.3, 80.9, 76.7, 73.9, 60.7, 33.9, 28.1, 27.1, 26.8, 21.7, 20.1, 12.5; 
HRMS (FAB) calcd for C13H22BrO4 [M+H]+ 321.0701, found 321.0704. 
 Diol Derivative of 85. Prepared according to the procedure described above for 
general acetate/carbonate hydrolysis.  Hydrolysis of 85 (0.011 g, 0.034 mmol) followed 
by purification by flash column chromatography (silica gel, hexanes:EtOAc, 4:1→0:1) 
afforded the diol derivative of 85 (7.4 mg, 74% yield) as a white crystalline solid.  
Crystals suitable for X-ray diffraction were grown by slow evaporation from a 
CH2Cl2:toluene mixture.  Rf = 0.20 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3375 
(br), 2966, 2926, 1461, 1331, 1076, 995 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.27 (m, 1 
H), 4.18 (m, 1 H), 3.92–3.83 (m, 2 H), 3.49 (ddd, J = 10.4, 4.4, 2.0 Hz, 1 H), 2.26 (ddd, J 
= 14.8, 9.6, 4.4 Hz, 1 H), 2.12 (br s, 1 H), 2.01–1.49 (m, 10 H), 1.28 (d, J = 6.8 Hz, 3 H), 
1.06 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 81.1, 73.5, 71.9, 70.7, 62.6, 
36.5, 30.9, 29.5, 270, 21.4, 20.4, 12.8; HRMS (FAB) calcd for C12H23BrNaO3 [M+Na]+ 




Synthesis of 87 and Cyclization to 9-endo Product 89 
 92.  Prepared according to a procedure adapted from Schmidt: Schmidt, B. J. Org. 
Chem. 2004, 69, 7672–7687.  A solution of allylmagnesium bromide (1.0 M in Et2O, 
12.0 mL, 12.0 mmol, 1.2 equiv) was added to a solution of hexanal (1.30 mL, 10.0 mmol, 
1.0 equiv) in Et2O (4.0 mL) at 0 °C.  After 30 min at 0 °C, the reaction contents were 
quenched by the addition of saturated aqueous NH4Cl (5 mL) and water (5 mL).  The 
layers were separated and the aqueous layer was extracted with additional Et2O (2 ×  10 
mL).  The combined organic layers were dried (MgSO4), filtered, and concentrated to 
yield a light yellow residue that was purified by flash column chromatography (silica gel, 
pentane:Et2O, 49:1→9:1) to afford 1-nonen-4-ol (0.81 g, 57% yield) as a colorless oil.  
Next, NaH (60% dispersion in mineral oil, 0.456 g, 11.4 mmol, 2.0 equiv) was added 
slowly to a solution of the newly formed 1-nonen-4-ol (0.810 g, 5.69 mmol, 1.0 equiv) in 
THF (19 mL) at 25 °C.  The mixture was carefully heated to reflux for 30 min, then 
cooled to 25 °C.  Allyl bromide (0.975 mL, 11.4 mmol, 2.0 equiv) was added, and the 
reaction contents were again heated to reflux for 45 min.  Upon completion, the colorless 
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solution was cooled to 25 °C, quenched by the addition of saturated aqueous NH4Cl (10 
mL) and water (10 mL), and extracted with Et2O (3 ×  10 mL).  The combined organic 
layers were dried (MgSO4), filtered, and concentrated to afford a light yellow residue that 
was purified by flash column chromatography (silica gel, hexanes:CH2Cl2, 9:1) to afford 
92 (0.820 g, 79% yield) as a colorless viscous oil.  92: Rf = 0.28 (silica gel, 
hexanes:CH2Cl2, 9:1); IR (film) νmax 3078, 2957, 2931, 2859, 1642, 1460, 1084, 916 cm–
1; 1H NMR (400 MHz, CDCl3) δ 5.97–5.77 (m, 2 H), 5.26 (dq, J = 17.2, 1.6 Hz, 1 H), 
5.14 (dq, J = 10.4, 1.2 Hz, 1 H), 5.11–5.02 (m, 2 H), 4.00 (qdt, J = 12.8, 5.6, 1.2 Hz, 2 
H), 3.35 (quintet, J = 5.6 Hz, 1 H), 2.32–2.21 (m, 2 H), 1.53–1.21 (m, 8 H), 0.88 (t, J = 
6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 135.6, 135.3, 116.9, 116.6, 78.7, 70.1, 38.5, 
33.9, 32.1, 25.2, 22.8, 14.2; HRMS (FAB) calcd for C12H21O [M–H]+ 181.1592, found 
181.1599. 
 93.  Prepared according to a procedure adapted from Schmidt: Schmidt, B. J. Org. 
Chem. 2004, 69, 7672–7687.  Grubbs catalyst (1st generation, 0.135 g, 0.163 mmol, 0.05 
equiv) was added to a solution of 92 (0.600 g, 3.29 mmol, 1.0 equiv) in toluene (13.2 
mL) at 25 °C.  After consumption of 92 was observed by TLC analysis (~30 min), 2-
propanol (3.3 mL) and NaOH (0.0330 g, 0.823 mmol, 0.25 equiv) were added 
sequentially in single portions.  The resultant brown solution was heated to reflux for 12 
h, then cooled to 25 °C and quenched with water (5 mL).  The crude product was 
extracted into Et2O (3 ×  5 mL), and the combined organic layers were dried (MgSO4), 
filtered, and concentrated.  The resultant brown residue was purified by flash column 
chromatography (silica gel, hexanes:CH2Cl2, 2:1) to afford the desired enol ether product 
(0.442 g, 87% yield) as a colorless viscous oil.  Next, PhI(OAc)2 (1.19 g, 3.40 mmol, 1.2 
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equiv) and BF3•OEt2 (0.088 mL, 0.570 mmol, 0.20 equiv) were added sequentially in 
single portions to a solution of the enol ether produced above (0.442 g, 2.90 mmol, 1.0 
equiv) in CH2Cl2 (22 mL) at –40 °C.  The reaction contents were stirred at –40 °C for 4 h, 
then pyridine (9 mL) and Ac2O (4.50 mL, 47.6 mmol, 16.4 equiv) were then added, and 
the reaction contents were warmed to 25 °C and stirred at that temperature for 12 h.  
Upon completion, the reaction mixture was quenched by the addition of water (20 mL) 
and extracted with EtOAc (3 × 10 mL).  The combined organic layers were washed with 
saturated aqueous NaHCO3 (20 mL), dried (MgSO4), filtered, and concentrated.  The 
resultant brown residue was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 2:1) to afford diacetate 93 as a colorless viscous oil contaminated with 
small amounts of inseparable impurities (estimated pure yield = 0.380 g, 49% yield).  
Stereochemistry was determined by COSY and NOESY NMR experiments (see attached 
spectra).  93: Rf = 0.44 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2932, 2861, 1747, 
1371, 1241, 1060, 949 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.61 (d, J = 8.4 Hz, 1 H), 
4.69 (m, 1 H), 3.54 (m, 1 H), 2.21 (m, 1 H), 2.10 (s, 3 H), 2.03 (s, 3 H), 1.72 (m, 1 H), 
1.63–1.20 (m, 10 H), 0.86 (t, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 169.9, 
169.5, 94.0, 77.0, 70.1, 35.1, 31.7, 29.6, 27.9, 25.2, 22.5, 21.1, 21.0, 14.0; HRMS (FAB) 















 94.  Prepared according to a procedure adapted from Danishefsky and co-workers: 
Wang, P.; Zhu, J.; Yuan, Y.; Danishefsky, S. J. J. Am. Chem. Soc. 2009, 131, 16669–
16671.  Allyltrimethylsilane (0.66 mL, 4.2 mmol, 3.0 equiv) was added to a solution of 
diacetate 93 (0.38 g, 1.4 mmol, 1.0 equiv) in CH2Cl2 (3.8 mL), at –78 °C.  Next, 
BF3•OEt2 (0.98 mL, 7.0 mmol, 5.0 equiv) was added dropwise over 5 min, and the 
resultant light yellow solution was allowed to slowly warm from –78 °C to 25 °C over 
the course of 12 h.  Upon completion, the reaction mixture was quenched by the addition 
of saturated aqueous NaHCO3 (10 mL), and the reaction mixture was extracted with 
CH2Cl2 (2 ×  20 mL).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated to yield a brown residue that was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 9:1) to afford the desired allylated product (0.26 g, 74% 
yield) as a colorless viscous oil.  Next, the Hoveyda–Grubbs catalyst (2nd generation, 
0.0195 g, 0.31 mmol, 0.03 equiv) was added to a solution of the allylated product 
generated above (0.264 g, 1.04 mmol, 1.0 equiv) in trans-3-hexene (5.00 g, 59.0 mmol, 
57 equiv) at 25 °C.  The resultant brown solution was stirred for 12 h at 25 °C, then 
filtered through a small plug of silica gel with hexanes:EtOAc (3:1, 100 mL) to generate 
the crude acetate 94.   
 87. This crude acetate 94 was concentrated and the resultant oil was dissolved in 
MeOH (50 mL) and cooled to 0 °C.  K2CO3 (1.44 g, 10.4 mmol, 10.0 equiv) was then 
added and the reaction mixture was stirred for 1 h at 0 °C.  Upon completion, the solution 
was quenched by the addition of saturated aqueous NH4Cl (10 mL) and water (50 mL), 
and extracted with EtOAc (3 ×  50 mL).  The combined organic layers were dried 
(MgSO4), filtered, and concentrated to yield an oil that was purified by flash column 
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chromatography (silica gel, hexanes:EtOAc, 1:0→4:1) to afford the alcohol derivative of 
94 (0.180 g, 72% yield over two steps) as a colorless viscous oil.  Rf = 0.33 (silica gel, 
hexanes:EtOAc, 4:1); IR (film) νmax 3403 (br), 2933, 2860, 1460, 1376, 1080, 966 cm–1; 
1H NMR (400 MHz, CDCl3) δ 5.57 (m, 1 H), 5.43 (m, 1 H), 3.77–3.69 (m, 2 H), 3.66 (m, 
1 H), 2.32 (m, 1 H), 2.22 (m, 1 H), 2.07–1.89 (m, 3 H), 1.85–1.64 (m, 4 H), 1.42–1.24 
(m, 8 H), 0.97 (t, J = 7.6 Hz, 3 H), 0.90 (t, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 
δ 134.7, 125.2, 73.0, 71.3, 67.3, 32.5, 31.9, 31.8, 26.9, 25.9, 25.8, 25.4, 22.8, 14.2, 13.9; 
HRMS (FAB) calcd for C15H29O2 [M+H]+ 241.2168, found 241.2172.  The next 
procedure was prepared according to the procedure described above for the synthesis of 
carbonate 45.  Carbonate formation on 0.36 mmol scale followed by flash column 
chromatography (silica gel, hexanes:EtOAc, 19:1→17:3) afforded 87 (0.095 g, 77% 
yield) as a colorless viscous oil. Stereochemistry was determined by COSY and NOESY 
NMR experiments (see attached spectra).  87: Rf = 0.58 (silica gel, hexanes:EtOAc, 9:1); 
IR (film) νmax 2958, 2933, 2859, 1739, 1369, 1278, 1255, 1165, 1086 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 5.52 (m, 1 H), 5.39 (m, 1 H), 4.69 (quintet, J = 4.0 Hz, 1 H), 3.85 
(quintet, J = 4.4 Hz, 1 H), 3.66 (m, 1 H), 2.39 (m, 1 H), 2.14 (m, 1 H), 2.01 (quintet, J = 
7.2 Hz, 2 H), 1.92–1.75 (m, 3 H), 1.58 (m, 1 H), 1.47 (s, 9 H), 1.40–1.20 (m, 8 H), 0.96 
(t, J = 7.6 Hz, 3 H), 0.88 (t, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.2, 
134.7, 124.8, 82.0, 72.5, 72.0, 70.0, 33.2, 32.0, 31.2, 28.0 (3 C), 27.6, 27.4, 25.8, 24.0, 




 89.  Prepared according to General Cyclization Procedure A.  BDSB cyclization 
of 87 (0.0341 g, 0.100 mmol) afforded 89 (0.0185 g, 51% yield) after flash column 
chromatography (silica gel, hexanes:EtOAc, 19:1→17:3) as a colorless viscous oil.  89: 
Rf = 0.23 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2934, 2861, 1805, 1363, 1186, 
1034 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.89 (m, 1 H), 4.75 (ddd, J = 9.2, 7.2, 1.6 Hz, 
1 H), 3.90 (ddd, J = 11.6, 9.2, 2.4 Hz, 1 H), 3.50 (quintet, J = 4.8 Hz, 1 H), 3.43 (m, 1 H), 
2.70 (m, 1 H), 2.56 (dt, J = 15.2, 2.0 Hz, 1 H), 2.10–1.94 (m, 4 H), 1.84–1.67 (m, 2 H), 
1.58 (m, 1 H), 1.44–1.20 (m, 7 H), 0.92 (t, J = 7.2 Hz, 3 H), 0.89 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 154.0, 84.7, 82.8, 82.1, 81.4, 49.6, 37.4, 34.5, 31.9, 30.3, 
26.4, 26.2, 24.8, 22.6, 14.0, 7.8; HRMS (FAB) calcd for C16H28BrO4 [M+H]+ 363.1171, 
found 363.1163. 
 Diol Derivative of 89.  Prepared according to the procedure described above for 
general acetate/carbonate hydrolysis.  Hydrolysis of 89 (0.0153 g, 0.0423 mmol) 
followed by purification by flash column chromatography (silica gel, hexanes:EtOAc, 
9:1→1:1) afforded diol derivative of 89 (0.0115 g, 81% yield) as a white crystalline 
solid.  Connectivity and stereochemistry were confirmed by COSY and NOESY NMR 
experiments (see attached spectra).  Rf = 0.20 (silica gel, hexanes:EtOAc, 7:3); IR (film) 




















4.27 (br s, 1 H), 4.04–3.92 (m, 2 H), 3.48 (dt, J = 10.0, 4.0 Hz, 1 H), 3.35 (m, 1 H), 2.58 
(ddd, J = 17.2, 11.2, 6.0 Hz, 1 H), 2.25 (ddd, J = 15.2, 3.6, 2.0 Hz, 1 H), 2.18–2.07 (m, 2 
H), 1.94–1.63 (m, 5 H), 1.55–1.35 (m, 3 H), 1.34–1.19 (m, 6 H), 0.91 (t, J = 7.6 Hz, 3 H), 
0.88 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 87.2, 85.1, 74.9, 73.3, 50.4, 
42.2, 36.6, 32.0, 30.6, 29.8, 26.5, 24.7, 22.6, 14.0, 7.1; HRMS (FAB) calcd for C15H29-
BrNaO3 [M+Na]+ 359.1198, found 359.1181.  
 
 































































































































































































Formal Total Synthesis of Laurefucin and Evaluation of the Proposed Biosynthesis 




 Having developed a method to transform diverse tetrahydrofurans and 
tetrahydropyrans into 8- and 9-membered bromoethers in good yield and as single 
diastereomers,1 we hoped to expand our model system explorations to the total synthesis 
of several natural products in the family.  Laurefucin (1, Figure 1)2 was initially chosen 
as an attractive testing substrate for its additional challenge of the bridging 5-membered 
ring, although we would not be pioneering its total synthesis, as Kim and coworkers have 
completed the target in 2008 through a route that encompassed 19 linear steps.3  Using 
our ring expansion strategy, we hoped to significantly decrease the step count of the Kim 
precedent due to the efficiency of the key step coupled with the abundant literature 
resources on preparation of stereochemically dense tetrahydrofurans.  Indeed, based on 
the findings of Chapter 4, the single step bromonium-induced ring expansion of the 
tetrahydrofuran precursor should be fully diastereoselective, rendering the overall 
approach as a rapid and concise way to generate a complex 8-membered bromoether. 
 This chapter will also discuss the biogenetic implications this ring expansion 
method has towards nature’s potential syntheses of these medium-sized bromoethers.  
While this idea is not the first proposed biosynthesis of these natural products,4 it is 
unique in its general conception of a ring expansion of a smaller ring system (a 
tetrahydrofuran) into a single medium sized ether.  Additionally, this hypothesis lays the 
groundwork to incorporate the synthesis of additional natural isolates with varying 





5.2  Formal Total Synthesis of Laurefucin 
 When comparing the products of our general ring expansion transformation from 
model compounds targeted to the natural isolate [i.e. laurefucin (1)], a few major 
challenges remained if success was to be achieved (Figure 1).  Laurefucin (1) and model 
system 2 differ in that laurefucin has an additional tetrahydrofuran bridging the C6 and 
C9 positions, an additional enyne side chain attached to the C6 position, and altered 
stereochemistry of the oxygen atom attached to C9.  With these differences in mind, we 
anticipated that the bridging tetrahydrofuran would need to be installed after the BDSB-
induced ring expansion, since the C9 position must contain the essential trapping group 
for the key ring expansion step (see compound 3).  Similarly, the enyne side chain would 
need to be installed after this process as well, as bromonium electrophiles are known to 
react with enyne functional groups,5 meaning that chemoselective engagement of the 
alkene could be difficult to achieve.  In addition, because the C6 methyl of the model 
system would be difficult to functionalize in its current state, an alternative group would 
need to be installed for late stage manipulation.  Finally, the alcohol stereochemistry at 
C9 would need to be inverted, either through the synthesis of a trans-cyclic carbonate 
along C9/C10 or via direct inversion of the cis-disposed carbonate post-cyclization.  
Globally, since 8-membered bromoethers of this class are prone to transannular 
rearrangements (something we observed in our model studies),6 we chose to install as 





 These general considerations led to the retrosynthesis of laurefucin shown in 
Scheme 1.  The last steps would be the installation of the reactive enyne side chain; Kim 
and co-workers installed this moiety as the last two steps of their synthesis of laurefucin 
via an olefin cross metathesis and Colvins alkyne synthesis from compound 4.3  In turn, 
the bridged tetrahydrofuran of 4 was proposed to derive from a simple etherification of 
the corresponding leaving group at C6 and alkoxide at C9 of substrate 5.  We elected to 
utilize functionality attached to C6 as the leaving group (over the alternative at C9), as 
transannular rearrangements of the 8-membered ring ether are typical when leaving 
groups are present at C9 or C10.6  Next, the 8-membered bromoether 5 was derived from 
common functional group manipulations to arrive at 6, a molecule we anticipated could 
be derived from the bromonium-induced ring expansion of tetrahydrofuran 7.  This 
material, in turn, would be generated from elaboration of tetrahydrofuran 8, itself 


























Putting these plans into action, the synthesis of meso-diol 9 was accomplished in 
three steps (Scheme 2).  As shown, 4-pentenal was alpha-benzoylated in 49% yield using 
a procedure developed by Tomkinson and co-workers.7  Then, aldehyde 10 was allylated 
and the benzoate protecting group was cleaved to afford the desired diol (9) in a 5:1 
mixture of trans:cis isomers.  Recrystallization in hot hexanes afforded pure trans-diol in 
55% overall yield.  It is worth noting that meso-diol 9 could also be synthesized in a 
single step from diallylation of glycol, though poor dr was observed for this process, 
rendering the route shown in Scheme 2 superior in terms of material throughput.8 
 
 The transformation of diol 9 into the functionalized tetrahydrofuran was 
accomplished next.  As indicated in Scheme 3, iodoetherification of 9 using I2 and 














































a. MeNHOBz•HCl b. AllylTMS, TiCl4
49% yield c. LiOH, MeOH
Reagents and Conditons: a. MeNHOBz•HCl (1.2 equiv), DMSO, 25oC, 5 h, 
49%; b. TiCl4 (1.2 equiv), allylTMS (1.2 equiv), CH2Cl2, -78 to -20
oC, 3 h;
LiOH (10 equiv), THF/MeOH/H2O, 25
oC, 2 h, 55%.
Scheme 2: Synthesis of meso-diol 9
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in a 1.2:1 ratio, slightly favoring the desired diastereomer (8b).  Numerous other 
haloetherification conditions were attempted with substrate 9, though these standard 
conditions ultimately proved optimal.  Of course, the generation of a mixture of 
diastereomers was not desired, yet the undesired diastereomer (8a) could potentially be 
deployed for the synthesis of a diastereomeric natural product.  Fundamentally, the 
synthesized compound (8b) differs from the previously used model compound with the 
methyl now functionalized with a halogen, allowing for further derivatization.  Pressing 
forward, cross metathesis with the Hoveyda-Grubbs second generation initiator and tert-
butyl carbonate formation yielded tetrahydrofuran derivative 11. 
 
 Our next goal, was the conversion of the primary iodine in 11 into an aldehyde.  
The simplest route to achieve this transformation, of course, would be to install an 
alcohol and then oxidize it directly.  Unfortunately, all attempted oxygen-based 
nucleophiles (Table 1) failed to effect the desired transformation or did so in insufficient 
yield (Entries 1-6), typically leading to decomposition through rearrangement or cleavage 
of the tert-butyl carbonate.  A thorough literature search unveiled an alternate three step 
method, which ultimately proved successful, one in which phenylsulfide displacement to 
12a (Entry 7) followed by oxidation and Pummerer rearrangement generated the desired 











9 8a, 34% yield 8b, 42% yield
b. HG II
    3-hexene






    87% yield
Reagents and Conditons: a. I2 (2 equiv), NaHCO3 (2 equiv), MeCN, 25
oC, 3 h; b. trans-3-hexene (6
equiv), Hoveyda-Grubbs second generation (0.008 equiv), CH2Cl2, 25
oC, 3 h, 78%; c. Boc2O (4 equiv), 
Et3N (1.5 equiv), DMAP (0.2 equiv), CH2Cl2, 25
oC, 5 h, then KOH (5 equiv), DMSO, 25oC, 3 h, 87%.




 With the key tetrahydrofuran 13 in hand, the stage was set for our bromonium-
induced ring expansion step.  Pleasingly, treatment of aldehyde 13 with 1.2 equiv of 
BDSB at -25oC generated the desired 8-membered bromoether core (6, Scheme 4) in a 
54% yield.  We found it was important to quench the reaction after only 2 min, as longer 
exposure to the reagents led to epimerization of the chiral center alpha to the aldehyde.  
Additionally, we were surprised this reaction proceeded without any additional 
bromination, as typically BDSB is competent in the alpha bromination of both aldehydes 
and ketones when these functionalities are present; clearly here the double bond proved 
to be more reactive.  Subsequently, allylation and mesylation produced the desired 
product (15), but with a 1:1 dr about the new center.  Even with use of alternate Lewis 
acids, no diastereoselectivity was observed.  We hypothesize that this outcome reflects 
the additional flexibility of the 8-membered rings over alternative smaller, more rigid 
ring sizes.  Given this lack of control, we decided to adjust the overall order of events in 





































    NaHCO3
71% yield




 Specifically, we believed that allylation at an earlier stage, with a tetrahydrofuran 
in place, had a greater potential to be diastereoselective.  In this next attempted route, we 
decided to allylate aldehyde 13 prior to the BDSB-induced ring expansion step.  Scheme 
5 demonstrates how using the Felkin-Ahn stereoselectivity model, each diastereomer of 
the allylated product could be generated selectively (17a or 17b) under the indicated 
conditions.10  Using a Lewis acid with only one site of coordination (BF3•OEt2), 17a was 
produced (this Lewis acid only assists in activation of the aldehyde within 13, i.e. via 
16a).  Alternatively, if a Lewis acid with multiple sites of chelation such as TiCl4, was 
























Reagents and Conditons: a. BDSB (1.2 equiv), MeNO2, -25
oC, 
2 min, 56%; b. BF3•OEt2 (5 equiv), allylTMS (5 equiv), -78 to
25oC, 2 h, 59%; c. MsCl (2 equiv), Et3N (4 equiv), CH2Cl2,
25oC, 1 h.
59% yield





 While an alcohol was installed through this process, this position ultimately 
needed to contain a leaving group to furnish the bridged tetrahydrofuran of laurefucin.  
Initially, we believed that any leaving group would not survive the ring expansion step, 
so we opted to attempt to protect the C9 alcohol prior to treatment with BDSB.   Indeed, 
prior studies revealed that BDSB (similar in structure to the active Swern oxidating 
reagent, chlorodimethylsulfonium chloride)11 was capable of reacting with free alcohols, 
an undesired transformation we hoped to discourage.  As indicated by Entries 1-3 of 
Table 2, efforts to install a silicon protecting group failed, leading to either 
decomposition or recovered starting material.  The introduction of a benzoate could be 
accomplished using standard conditions (Entry 4), though now cleavage between the 
benzoate and carbonate could be problematic post-cyclization.  Upon reflection, we then 









































































Scheme 5: Felkin-Ahn Model for Allylation of Aldehyde 13
Reagents and Conditons: a. BF3•OEt2 (5 equiv), CH2Cl2, -78
oC, 10 min; then allylTMS (5 equiv), -78 to -20oC, 
3 h; b. TiCl4 (5 equiv), CH2Cl2, -78







would survive through the key step.  Exploration of the conditions delineated in Entries 
5-7 all led to decomposition, though the bromide and mesylate derivatives were both 
synthesized successfully (Entries 8 and 9).    
 
Next, bromide 19 and mesylate 18b were tested using the standard ring expansion 
conditions, noting that these starting materials are much more complex than the 
previously studied model systems since they now include two alkenes and an allylic 
leaving group, both raising new chemoselectivity and functional group compatibility 
issues for the central bromonium-induced ring expansion step.  It was found that bromide 
19 rapidly decomposed with standard conditions, producing a variety of unidentified 
products.  Yet, mesylate 18b underwent the BDSB-promoted ring expansion cleanly to 
generate the 8-endo bromoether 15 in 72% yield as a single diastereomer (Scheme 6).  
BDSB was chemoselective for the more substituted, but also more hindered, alkene; no 
reactivity of the terminal olefin was observed.  In addition, the allylic mesylate remained 
intact, a functionality key for the completion of the natural product.  Mechanistically, we 






































quant. 19, R = Br







Table 2: Attempts to Transform Alcohol 17a into a Leaving Group
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generated oxonium 20, which, upon opening at the central position by the pendent tert-
butyl carbonate, yielded the desired product diastereoselectively.   
 
 With the 8-membered ring in place, the final steps were to cleave the carbonate 
and introduce the bridged tetrahydrofuran.  We were hopeful that only the C9 oxygen 
would form the tetrahydrofuran, as the C10 oxygen, potentially poised to generate a 6-
membered ether, is positioned trans to the leaving group.  Many conditions were 
explored for this event as shown in Table 3; as indicated, the use of common carbonate 
cleavage conditions led mostly to decomposition or diol 21 (Entries 1-3).  It was Entry 1, 
however, with the production of trace 4, which first gave us the idea to combine the 
originally proposed two step sequence into a single step.  This process was accomplished 
with the use of DIBAL-H in toluene in a 46% yield (Scheme 6 or Table 3, Entry 6).  It 
was found that both carbonate cleavage and cyclization occurred simultaneously most 
likely due to a chelation effect at the aluminum center.  Additionally, the unwanted 


































Reagents and Conditons: a. BDSB (1.5 equiv), MeNO2, -25 to 25
oC, 20 min, 72%; b. DIBAL-H 
(5 equiv), PhMe, -78 to 25oC, 6 h, 46%.
46% yield




compound 4 synthesized, we stopped our synthetic work here, though the formal total 
synthesis of laurefucin was thus completed by following Kim and co-workers’ final two 
steps.3   Our route to terminal alkene 4, the formal synthetic precursor to laurefucin, 
proceeded in 11 linear steps in 1.8% yield. Therefore, the overall total synthesis of 
laurefucin was 13 linear steps, the shortest synthesis of any Laurencia isolate to date, and 
six steps shorter than the Kim precedent for this specific substrate. 
 
 
5.3 Chemoselective Synthesis of the Core of 3E-Dehydrobromolaurefucin 
While we were able to install the 8-endo bromoether of laurefucin (1) 
diastereoselectively, it is worth noting that over a fourth of the medium-sized rings within 
this family lack this bromide, containing instead an alkene (i.e. 1 to 24, 22 to 25, or 23 to 
26, Figure 2).12  With the synthesis of laurefucin completed, simple elimination of the 
bromide could, in principle, complete the total synthesis of (3E)-dehydrobromolaurefucin 
(24).12a,b  Unfortunately, all attempts to effect this transformation were unsuccessful, 













































before, we have seen this problem of bromide elimination previously in the context of 
polyene cyclization, as described in Chapter 2.  To solve this difficulty, just as performed 
earlier, we turned to installation of an alternative halogen, an iodide. 
 
   Using our iodinating reagent, IDSI, compound 11, an intermediate in the 
previously described total synthesis of laurefucin, was smoothly expanded into 8-
membered iodoether 27 in 54% yield (Scheme 7).  Here, the addition of ICl across the 
alkene was the major by-product obtained from the event.  From 27, elimination of the 
secondary iodide with DBU provided the desired internal alkene without reacting at the 
primary iodide.  This chemoselectivity observed for the more substituted iodide likely 
reflects its orientation within the 8-membered ether, one that could align it anti-periplanar 
to an axial hydrogen, allowing for a facile E2 elimination.  By contrast, the primary 
iodide is proposed to be less accessible, with free rotation at its sp3 center in combination 
with the need for removal of a more hindered hydrogen making it harder to eliminate, as 
observed.  Next, treatment with K2CO3 in MeOH cleaved the carbonate backbone and in 
situ effected alcohol displacement of the primary iodide to afford the tetrahydrofuran in 
quantitative yield.  This cyclization from the diol intermediate to the bridged 




























tetrahydrofuran is likely an easier process than compared to that explored previously (see 
Table 3), as compound 28 lacks the allyl group (found in compound 4).  That extra side 
chain of atoms is oriented on the concave face of the bicyclic structure (4), making the 
synthesis of laurefucin more challenging in terms of generating the bridged 
tetrahydrofuran. 
 
 To conclude, these past two sections have demonstrated the generality of the 
bromonium-induced ring expansion method, one allowing for the use of additional 
functional groups including aldehydes, multiple alkenes, halides, and allylic leaving 
groups.  Additionally, it has led to the rapid and concise formal total synthesis of 
laurefucin (1), the shortest synthesis of any 8-membered isolate in the family.  The 
tetrahydrofuran template allows the use of robust, previously developed chemistry to 
assemble molecular complexity prior to ring expansion to the more reactive medium 
sized ethers.  And, using our iodonium reagent (IDSI) in this process instead, we were 
also able to synthesize the core of 3E-dehydrobromolaurefucin followed by a 
chemoselective elimination of the installed iodide.  The expediency of these syntheses is 
due to the ability to rapidly build complex tetrahydrofurans followed by a single 

















    92% yield
54% yield c. K2CO3, MeOH
    99% yield
Reagents and Conditons: a. IDSI (1.2 equiv), MeNO2, -25 to 25
oC, 25 min, 54%; b. DBU (5 
equiv), PhMe, 25oC, 24 h, 92%; c. K2CO3 (10 equiv), MeOH, 25
oC, 12 h, 99%.
Scheme 7: IDSI-Promoted Ring-expansion of Tetrahydrofuran 11
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5.4 Biosynthetic Hypothesis 
 The generality of the developed bromonium-promoted ring expansion strategy has 
allowed access to seven diastereomeric cores as well as the completion of formal total 
syntheses of laurefucin (described above) and (E)- and (Z)-pinnatifidenyne.13  Based on 
the breadth of this work accomplished to date, we believe the process may have 
biogenetic implications for the origin of these molecules in nature.  The general idea is 
drawn in Scheme 8, one in which laurediol (29a), upon treatment with a bromonium 
electrophile, would undergo a 5-endo bromoetherification to tetrahydrofuran 30.  Other 
electrophiles that could incorporate an H or OH in such an event could also be reasonable 
biosynthetic pathways for some targets which lack the bromide.  Critically, though, from 
30 specifically, a second bromocyclization with the tetrahydrofuran oxygen as the 
nucleophile would generate oxonium intermediate 31.  Opening of this material at the 
central position (i.e. C10) via loss of bromonium would yield deacetyllaurencin (32).14  
Overall, this process reflects events similar to the BDSB-promoted ring expansion 
without the use of a carbonate trapping group.  This proposed idea requires regioselective 
opening at the C10 position over the alternative C7 or C13 positions.  Obviously here 
other pathways could be present, since opening at the C7 or C13 positions could produce 
new tetrahydrofuran derivatives.  As circumstantial support, the second largest class of 
Laurencia natural isolates are tetrahydrofuran derivatives, the key intermediate proposed 




This biosynthetic hypothesis starting from linear precursors represents the first in 
which two smaller ring formations are prepared to account for the desired medium-sized 
bromoether.  As noted earlier, Murai and coworkers were the first to support the original 
proposal of the biogenesis of these medium-sized rings via a direct 8-membered 
bromoetherification (Scheme 9).4  As shown, their experimental results demonstrate that 
29a could be transformed into deacyllaurencin (32) using BPO (bromoperoxidase, the 
enzyme isolated from the same producing species as these natural products), hydrogen 
peroxide, and bromide anion.  These conditions were used to recreate the enzymatic 
conditions of the Laurencia red algae in a laboratory setting.  Similarly, its enantiomer 
(i.e. 29b) produced 8-exo prelaureatin (33)15 in trace yield under the same conditions.  
Yields here were very poor, with only small amounts of the desired 8-membered 
bromoether observed in both cases; this result, however, is not surprising as medium 
sized ether formation is both kinetically and thermodynamically disfavored.  Yet, for over 
20 years, this direct 8-membered bromoetherification from a linear precursor has been the 





























only accepted biosynthetic pathway for the generation of these natural isolates, probably 
because it was the only one with any modicum of support.   
 
 More recently, in 2012 (after the publication of our original work) Braddock and 
co-workers presented an alternate biosynthesis.16  Instead of laurediol cyclizing to 
medium-sized ethers, the hypothesized precursor to these diols, epoxide 34,17 could 
undergo a bromonium-induced cyclization (Scheme 10).  This route is then terminated by 
nucleophilic attack of either chloride or water, leading to a variety of substituted natural 
products.  This proposal relies on the idea that nature synthesizes these products without 
any true specificity, since variety of ring sizes are generated without any regio- or 
diastereocontrol; if the compounds are defensive in origin, that proposal could be 
reasonable.18  As a representative example, intermediate 35 could open at either the C6 or 
C7 positions to generate 8-endo bromoether 32 and/or 9-endo bromoether 37.19  Yet, 
intermediate 35 is just one of four possible intermediates that could arise from 
bromonium addition to epoxide 34, with each additional alternative capable of generating 
multiple isolates as well as non-natural structures.  Additionally, this proposal remains 























Scheme 9: Murai and Co-workers' Results for Cyclization of Linear Laurediol
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from a precursor with no additional elements of control, creating in the process an 
oxonium containing a strained 3-membered ring. 
 
While nature may not be selective in synthesizing each of these individually, we 
believe that pathways exist which could afford more control than the diversity-oriented 
synthesis proposal from the Braddock group.  Looking at the known laurediol precursors, 
numerous stereochemically distinct derivatives have been isolated (Figure 3).20  Each of 
these could be potential precursors for the synthesis of these medium-sized ethers, 
including both diol enantiomers (i.e. 29a and 29b or 38a and 38b), cis- or trans-C12/C13 
alkene geometry, as well as chlorohydrin derivatives (39a or 39b).21  While the 
chlorohydrin variant of 39b has not been isolated, it is probable that acetylated 39b 




Scheme 10: Braddock and Co-workers' Proposal for the Biosynthesis of 























 Putting each of these laurediol starting materials into our proposed biosynthesis 
scheme and focusing initially on only the 6R,7R-enantiomers, four distinct 8-endo 
bromoethers could be generated.  As shown in Scheme 11, starting with 29a, 38a, or 39a, 
a 5-endo bromoetherification would yield four possible diastereomers of the produced 
tetrahydrofuran ring system (30 and 40a-c).  Each of these materials, in turn, could 
undergo a second 5-endo bromocyclization to generate oxoniums 31 and 41a-c.  Based 
on our previous work with model systems in Chapter 4, only a single diastereomer of the 
generated oxonium should be observed.  These oxonium intermediates could then be 
opened in a variety of ways to produce a single diastereomer of the final bromoether 
products.  A single product is drawn in each case, here, focused on 8-membered ring 
formation, though multiple products with the same stereochemical array may exist in 
each case (i.e. 32 has nine additional matching natural isolates).22  Moreover, some 
pathways produce diastereomers that are non-natural, potentially isolates that have yet to 
be discovered (i.e. 44).  Following the same pathways, starting instead with 6S,7S-
Figure 3.  Isolated Laurediol Isomers and Derivatives






















laurediol derivatives, the enantiomers of the above products would be observed (i.e. 45-
48).23  Collectively, these comprise eight total diastereomers of the 8-endo bromoethers, 
which represent a majority of the natural isolates in the Laurencia family; four 
geometries are known (i.e. 32, 42, 43, and 46) and four are non-natural (44, 45, 47, and 
48).  Interestingly, over half of the 8-endo bromoethers contain a chloride at the C6 
position, an atom we believe is introduced in the starting material as shown in the 
synthesis of laurepinnacin (43).22b  Instead of starting with laurediol, chlorohydrin 39a 
could undergo the same desired transformation, now containing a chloride at C6 instead 




Critically, the proposed key bicyclic oxonium is unique in its ability to be 
transformed into a variety of natural isolates, including intermediates of different sizes.  
Scheme 12 demonstrates how oxonium 31 could be opened at the C7, C10, and C13 
















































































30 40a 40b 40c










38a: X = OH, 9Z,12Z,6R,7R-laurediol






while opening at C7 and C13 would generate new tetrahydrofuran derivatives, attack at 
C10 would produce an 8-membered ring.  Laurencin (49)24 could be derived from loss of 
bromonium of C9 and acylation, while the same intermediate 31 could yield laurefucin 
(1) from H2O attack at C10 and SN2 of the alcohol onto the C9 bromide.  Further support 
for this oxonium intermediate is in the generation of notoryne (51),25 via opening of 31 at 
C7 with a chloride nucleophile followed by an SN2 displacement of the bromide located 
outside of the tetrahydrofuran ring by the alcohol. 
 
Looking next in detail at proposals for 8-exo bromoether formation, a slightly 
different pathway would need to occur.  First, a 5-exo bromoetherification from the linear 
precursors would generate again four stereodistinct tetrahydrofuran intermediates (52a-d, 
Scheme 13).  Next, a second 5-exo bromocyclization would produce oxoniums 53a-d, 
which, upon opening, would lead to the desired 8-exo bromoether cores 54-57.  In this 
case, all of the stereoisomers derived from the 6R,7R-laurediols are not naturally 












































occurring (i.e. 54-57), while those derived from the 6S,7S-laurediols (8-exo products 33 
and 58-60) correspond collectively to at least 13 natural isolates.26 
 
 In addition to 8-membered bromoether cores, other medium-sized rings found in 
the same family include 7-exo and 9-endo bromoethers; there are no 7-endo or 9-exo 
isolates.  Using this same general idea, 7-exo derivatives could arise from an initial 5-
Br
5-exo














59: non-natural isomer 60: pinnatifidenyne2 natural products
52a 52b 52c 52d











































































endo bromoetherification of linear laurediol to 30 and 40a-c, followed by a 4-exo 
bromocyclization to overall generate 62 – 69 (Scheme 14).  As drawn, this pathway 
would allow access to at least seven of the ten total isolated compounds with a 7-exo ring 
system.27 
 
The 9-endo alternatives could be produced via a 5-exo etherification followed by 
a 6-endo bromonium-induced cyclization to oxonium intermediates 70a-d, which could 


















67: non-natural isomer 68: non-natural isomer 69: isoprelaurefucin
2 natural products






































































30 40a 40b 40c
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there are eight isolated 9-membered bromoethers; this proposed transformation accounts 
for the synthesis of seven of them along with three non-natural stereoisomers (72-74).   
 
These [2,3,0]- or [3,4,0]-oxonium intermediates, formed in these pathways 
leading to 7-exo or 9-endo systems, may not be as favored as the [3,3,0]-bicycle 
generated in the 8-membered rings synthesis, but they have been proposed by others, as 
intermediates previously to explain experimental results (Scheme 16).29  A [2,3,0]-
oxonium intermediate was first proposed by Howell and co-workers, when an 
unpredicted rearrangement occurred en route to their synthetic approach towards 
















76: un-named natural product
2 natural products










































Scheme 15: Proposed Biosynthesis of 9-endo Bromoethers















obtained in a 51% yield, presumably via the proposed oxonium intermediate 81.  The 
Howell group desired a direct 8-exo bromoetherification to occur with the free alcohol to 
generate 79, again providing further support for the unlikelihood of such an unfavorable 
event.  Additionally, as described in Chapter 4, in our own hands, a 6-exo 
bromocyclization of tetrahydrofuran 83 formed the [3,4,0]-oxonium species 84, which 
then generated 9-exo bromoether 85.1  
 
 This section has demonstrated how 7-exo, 8-endo, 8-exo, and 9-endo bromoethers 
can individually be generated from a linear laurediol precursor via a single biosynthesis 
hypothesis.  The 7-exo isolates are derived from 5-endo and 4-exo bromocyclizations, 
while the 8-endo molecules would be synthesized via two 5-endo bromonium-induced 
































































cyclizations.  Additionally, the 8-exo and 9-endo products arise via a 5-exo 
bromoetherification followed by either a 5-exo or 6-endo bromocyclization.  Based on 
further analysis of these medium-sized rings compared to the starting materials that they 
are derived from, it appears that the R-enantiomer of laurediol favors production of the 8-
endo bromoethers while the 8-exo derivatives are derived mostly from the 6S,7S-laurediol 
linear precursors (Table 4).  Interestingly, this idea is fully congruent with Murai and co-
workers’ results using enzymatic conditions as each enantiomer of laurediol only 
produced one 8-membered bromoether regioisomer (Scheme 9).4  Because of this, we 
believe the Laurencia red algae are more selective in generating a variety of natural 
isolates, potentially choosing a single pathway for synthesis of a selected array of natural 
products, rather than Braddock’s diversity-oriented hypothesis.16 
 
 
5.5 Additional Evidence to Support Proposed Biogenetic Hypothesis 
 To provide additional support for above proposed biosynthesis, we decided to 
investigate two key experiments, namely: a) mimic enzymatic conditions and b) obtain 
proof of the existence of the proposed oxonium intermediates.  The first follows the idea 
of Murai and co-workers using enzymes in a laboratory setting.4  Specifically, since the 
Murai group has shown that LPO (lactoperoxidase) transformed linear laurediol into a 5-
membered bromoether, we wished to examine the second half of our proposed 
Table 4: Analysis of all Medium Sized Bromoethers



























mechanism; that is, generation of the oxonium intermediate from the tetrahydrofuran 
followed by opening to the 8-membered bromoether.  Additionally, the Murai team used 
both BPO and LPO in their enzymatic studies, showing both react similarly, though BPO 
is the active enzyme isolated in the Laurencia red algae.  Since BPO is difficult to purify 
and LPO is commercially available, LPO was used for our studies in examining the ring 
expansion approach.   
 
 Treatment of alcohol-containing tetrahydrofuran 86 (synthesized using the same 
sequence as in Chapter 4)30 with LPO, hydrogen peroxide, and bromide anion did not 
generate any of the desired 8-membered bromoether (Scheme 17).  Instead, most of the 
mass balance was unreacted 86 with an isolable amount of bromohydrin generation about 
the lone alkene in 86.  While characterization of these bromohydrins was challenging as 
multiple regioisomers and diastereomers were formed, treatment of the same starting 















a Reagents and conditions: a. LPO (5 mg), H2O2, NaBr (1.0 equiv),
phosphate buffer (50 mM, pH 5.5, 30 mL), 25 °C, 24 h, 0% yield 88,
7% yield bromohydrin, 82% yield recovered 86; b. LPO (5 mg), H2O2,
NaBr (1.0 equiv), phosphate buffer (50 mM, pH 5.5, 30 mL), 25 °C, 24
h, 2% yield, 78% yield recovered 89; c. BDSB (1.5 equiv), MeNO2 (4.3 




















material (86) with NBS and water, a known procedure for bromohydrin generation,31 
produced the same 1H NMR spectra.  Since we previously learned that an intramolecular 
trap was necessary, tetrahydrofuran 89 was also tested, now producing 8-endo 
bromoether 90 in 2% yield along with mostly recovered 89.  To confirm this result, using 
our developed ring expansion method promoted by BDSB, 90 was generated in 68% 
yield as a single diastereomer.  While nature here most likely does not use a tert-butyl 
carbonate as a trapping group, it does show that the enzyme generates a bromonium 
electrophile, either in the form of BrOH or Br2, which is capable of performing the 
proposed transformation.32  Thus, some assistance in ring opening is likely required. 
 
 Next, we wondered how a linear source similar to laurediol without this directing 
group would behave in the presence of a bromonium electrophile(s) outside of enzymatic 
conditions.  With an eye towards a linear precursor for 8-endo generation, produced via 
two 5-endo bromocyclizations, alcohol 92 was synthesized as it contains the same 
substitution pattern of the alcohol and alkenes as laurediol. As shown in Scheme 18, cis-










    NaI
91
c. H2, Pd/BaSO4
    quinoline
   50% yield
OH
Reagents and Conditions: a. PBr3 (1.2 equiv), Et2O, 25
oC, 1 h; 
b. 4-pentyn-2-ol (1 equiv), allylic bromide (2 equiv), K2CO3 (4
equiv), CuI (4 equiv), NaI (4 equiv), DMF, 25oC, 12 h, 99%
yield; c. 5% Pd on BaSO4, quinoline (0.2 equiv), EtOAc, H2




2-Penten-1-ol was first transformed into its bromide and then used as an electrophile to 
generate enyne 91.33  Reduction of the alkyne yielded skipped diene 92, a compound that 
could not be transformed into the 5-endo bromoether despite the various conditions 
attempted.34  This problem was encountered previously in Chapter 4, as 5-endo 
bromoetherifications are known to be slow and very substrate specific. 
 
With problems arising for this 5-endo cyclization, the 5-exo alternative was also 
attempted to be as thorough as possible.  This linear starting material (94) would be 
poised for the generation of 8-exo bromoethers via two 5-exo cyclizations.  Here, 
alkylation of 4-pentyn-1-ol followed by oxidation and Grignard addition produced diyne 
93 in 58% overall yield (Scheme 19).  Stereoselective reduction of both alkynes using 
poisoned palladium catalyst (i.e. Lindlar’s catalyst) generated the desired skipped dieneol 
94,16 the substrate used to test our hypothesis.  Cyclization of linear precursor 94 using 
1.1 equivalents of TBCO, an electrophilic bromonium source, produced the desired 5-exo 
bromoether 95 in 85% yield with 2.5:1 dr about the methyl stereocenter (Scheme 20).  
Scheme 19.  Synthesis of Linear Skipped Diene Starting Material
a. CuI, Cs2CO3
    NaI, DMF





    59% yield
d. H2, Pd/BaSO4
    pyridine




Reagents and Conditions: a. 4-bromo-2-pentyne (1.1 equiv),
Cs2CO3 (2 equiv), NaI (2 equiv), CuI (1 equiv), DMF, 25
oC, 2
h, 99% yield; b. (COCl)2 (1.2 equiv), DMSO (2 equiv), Et3N (4
equiv), CH2Cl2, -78 to 0
oC, 3 h; d. MeMgCl (1.5 equiv), THF, -
78 to -20oC, 2.5 h, 59% yield; d. 5% Pd on BaSO4, pyridine,
cyclohexene, H2 balloon, 25
oC, 3 h, 19% yield.
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BDSB was not used here since it is generally incompatible with free alcohols.  Treatment 
of this new tetrahydrofuran 95 with another equivalent of TBCO in the presence of water 
produced dibromide 97 in 42% yield.  We believe this product reflects a 5-exo 
bromocyclization to oxonium intermediate 96, which, in the presence of water, opened at 
the least sterically hindered C2 position (over C5 or C8).  It seems as though only a single 
diastereomer of the starting 95 (the major diastereomer) underwent this transformation, as 
the other diastereomer (minor) placed the methyl substituent in the concave face of the 
oxonium intermediate, possibly destabilizing the generated intermediate, which led to 
decomposition.  Structural characterization of 97 was performed by 2D NMR 
spectroscopy, though additional structural conformation through derivatization to a 
crystalline solid and analysis by x-ray crystallography are in progress.  Alternatively, 
treatment of 5-membered 95 with BDSB generated the same oxonium 96, though now a 
bromide (from the SbBrCl5- anion of BDSB) opened at C2 in a similar fashion to yield 
13% of tetrahydrofuran 98.  It is likely here that a chloride is also opening the oxonium at 
C2 as numerous byproducts were detected using 1H NMR analysis of the crude product 




 Previously, only stepwise addition of a single equivalent of bromonium 
electrophile has been attempted; yet the overall transformation of linear alcohol 94 to 
tetrahydrofuran 95 underwent two 5-exo bromocyclizations, a new challenge we wished 
to probe directly.  Surprisingly, treatment of skipped diene 94 with 2.2 equivalents of 
TBCO in the presence of water generated the desired alcohol 97 in 50% yield.  This 
outcome suggests that this process could be completed in a single reaction pot, possibly 
something nature might also elect to deploy.  With these systems, opening at C5 was not 
observed; once again, this reveals the need for enzymatic assistance or other participation 
to control opening to 8-membered rings. 
 
 





















97, X = OH
98, X = Br
96
a Reagents and conditions: (a) TBCO (1.1 equiv), CH3CN (7.5 mL), -
25 °C, 20 min, 85%, 2.5:1 dr; (b) TBCO (1.1 equiv), CH3CN:H2O (5:1, 
11.2 mL), 25 °C, 15 min, 42% of 97; (c) BDSB (1.2 equiv), MeNO2
(13.8 mL), -25 to 25 °C, 20 min, 13% of 98; (d) TBCO (1.1 equiv),
CH3CN (4.8 mL), - 25 °C, 15 min, then TBCO (1.1 equiv), H2O (1.0




     TBCO











 The completed formal total synthesis of laurefucin has shown the effectiveness of 
our developed ring expansion strategy to transform easily prepared tetrahydrofuran 
derivatives into 8-membered bromoethers of the Laurencia family.  This total synthesis is 
the shortest of the over 30 syntheses of any 8-membered ring in this family, 
demonstrating the efficiency of the single diastereoselective step.  Due to the ability to 
synthesize complex tetrahydrofurans with great diastereocontrol, this transformation 
allows for the facile synthesis of stereochemically-rich medium-sized ethers.  
Additionally, the complexity of the derivatives used as starting materials in this chapter 
have shown the BDSB-promoted ring expansion step can encompass a variety of 
additional functional groups.  This full article was highlighted in the January 2013 issue 
of Synfacts35 and was also on the “Most Read Articles” list of JACS throughout 
November 2012. 
 Due to the ability to synthesize a variety of bromoether cores as well as three 
completed formal total syntheses, we believe this method may have implications in the 
biogenesis of these medium-sized bromoether isolates in nature.  Instead of a direct, 
unfavorable 8-membered bromoetherification, two smaller ring formation events could 
generate the same products.  We have been able to show that a tetrahydrofuran precursor 
was capable of transforming into an 8-membered ring under enzymatic conditions, albeit 
in trace yield.  Additionally, the transformation of a linear precursor with two equivalents 
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5.8  Experimental Section 
General Procedures.  All reactions were carried out under an argon atmosphere 
with dry solvents under anhydrous conditions, unless otherwise noted.  Dry methylene 
chloride (CH2Cl2), benzene, toluene, diethyl ether (Et2O) and tetrahydrofuran (THF) were 
obtained by passing commercially available pre-dried, oxygen-free formulations through 
activated alumina columns; nitromethane (MeNO2) and acetonitrile (MeCN) were stored 
over 3 Å molecular sieves, pyridine was distilled from CaH2 and stored over 3 Å 
molecular sieves; diisopropylamine (i-Pr2NH) was distilled from KOH and stored over 3 
Å molecular sieves; triethylamine (Et3N) was distilled from KOH; acetone, 
dimethylsulfoxide (DMSO), N,N-dimethylformamide (DMF), ethanol (EtOH), and 
methanol (MeOH) were purchased in anhydrous form from Sigma-Aldrich and used as 
received.  Yields refer to chromatographically and spectroscopically (1H and 13C NMR) 
homogeneous materials, unless otherwise stated.  Reagents were purchased at the highest 
commercial quality and used without further purification, unless otherwise stated.  
Lactoperoxidase (LPO) from Bovine Milk was purchased from MP Biomedicals, LLC 
and stored at 2 °C in a phosphate buffer (pH 5.5, 50 mM).  Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. 
Merck silica gel plates (60F-254) using UV light and/or I2 on silica as visualizing agents 
and an aqueous solution of phosphomolybdic acid and cerium sulfate or a solution of 
KMnO4 in aqueous NaHCO3 with heat as developing agents.  Preparative thin-layer 
chromatography was carried out on 0.50 mm E. Merck silica gel plates (60F-254).  
SiliCycle silica gel (60, academic grade, particle size 0.040–0.063 mm) was used for 
flash column chromatography.  NMR spectra were recorded on Bruker DRX-300, DRX-
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400, and 500 ASCEND instruments and calibrated using residual undeuterated solvent as 
an internal reference.  The following abbreviations were used to explain the 
multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, 
app = apparent.  IR spectra were recorded on a Nicolet Avatar 370 DTGS series FT-IR 
spectrometer. High-resolution mass spectra (HRMS) were recorded in the Columbia 
University Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB 
(Fast Atom Bombardment) and EI (Electron Ionization) techniques.   
 Abbreviations.  AcOH = acetic acid, BF3•OEt2 = boron trifluoride diethyl 
etherate, Boc2O = di-tert-butyl dicarbonate, DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene, 
DIAD = diisopropyl azodicarboxylate, DIBAL-H = diisobutylaluminum hydride, 4-
DMAP = 4-(dimethylamino)pyridine, MeMgCl = methyl magnesium chloride, 
MeNH(OBz)•HCl = N-(benzoyloxy)-methylamine hydrochloride, MsCl = 
methanesulfonyl chloride, NBS = N-bromosuccinimide, nBuLi = n-butyl lithium, NCS = 
N-chlorosuccinimide, TBCO = 2,4,4,6-tetrabromo-2,5-cyclohexadienone, TFAA = 
trifluoroacetic anhydride. 
 
Formal Total Synthesis of Laurefucin: 
9.  Prepared according to a procedure adapted from the work of Tomkinson and 
co-workers: a) Beshara, C. S.; Hall, A.; Jenkins, R. L.; Jones, T. C.; Parry, R. T.; 
Thomas, S. P.; Tomkinson, N. C. O. Chem. Comm. 2005, 1478; b) Beshara, C. S.; Hall, 
A.; Jenkins, R. L.; Jones, K. L.; Jones, T. C.; Killeen, N. M.; Taylor, P. H.; Thomas, S. 
P.; Tomkinson, N. C. O. Org. Lett. 2005, 7, 5729.  4-Pentenal (2.69 g, 32.1 mmol, 1.0 
equiv) was dissolved in DMSO (44 mL) at 25 °C, and then MeNH(OBz)•HCl (7.20 g, 
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38.5 mmol, 1.2 equiv) was added slowly.  The resultant reaction solution was then stirred 
at 25 °C for 5 h.  Upon completion (as monitored by 1H NMR analysis of small reaction 
aliquots), the reaction mixture was quenched with water (50 mL) and extracted with 
EtOAc (3 × 30 mL).  The combined organic layers were then washed with water (3 × 20 
mL), dried (MgSO4), filtered, and concentrated.  The crude residue was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 19:1→1:1) to afford the desired 
alpha-benzoylated aldehyde 10 as a light yellow solid (3.18 g, 49% yield).  Next, a 
portion of 10 (1.59 g, 7.80 mmol, 1.0 equiv) was dissolved in CH2Cl2 (94 mL) and cooled 
to –78 °C.  A solution of TiCl4 (1.0 M in CH2Cl2, 9.36 mL, 9.36 mmol, 1.2 equiv) was 
then added dropwise and the reaction was stirred for 15 min at –78 °C.  Next, 
allyltrimethylsilane (1.49 mL, 9.36 mmol, 1.2 equiv) was added, and the reaction solution 
was allowed to warm slowly to –20 °C over the course of 3 h.  Upon completion, the 
reaction mixture was quenched with saturated aqueous NH4Cl (100 mL) and extracted 
with CH2Cl2 (3 ×  30 mL).  The combined organic layers were dried (MgSO4), filtered, 
and concentrated.  The crude residue was then dissolved in a mixture of THF (47 mL) 
and MeOH (16 mL) at 25 °C.  A solution of LiOH (1.86 g, 77.7 mmol, 10 equiv) in water 
(16 mL) was added and the reaction solution was allowed to stir for 2 h at 25 °C.  Upon 
completion, the reaction mixture was quenched with water (100 mL) and extracted with 
EtOAc (3 ×  30 mL).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated.  The crude residue was purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 5:1→2:3) to afford 9 as a mixture of diastereoisomers (5:1 
trans:cis).  Recrystallization of this mixture from hot hexanes (20 mL) afforded the trans-
isomer of 9 (0.614 g, 55% yield over 2 steps) as a white crystalline solid.  9: Rf = 0.25 
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(silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3313 (br), 3077, 2901, 1053, 989, 915, 
869 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.85 (m, 2 H), 5.21–5.14 (m, 4 H), 3.67 (m, 2 
H), 2.36 (m, 2 H), 2.24 (m, 2 H), 2.06 (br s, 2 H); 13C NMR (100 MHz, CDCl3) δ 134.6 
(2 C), 118.4 (2 C), 72.6 (2 C), 36.4 (2 C); HRMS: No molecular ion peak was observed. 
8.  Prepared according to a procedure adapted from the work of Castillón and co-
workers: Díaz, Y.; Bravo, F.; Castillón, S. J. Org. Chem. 1999, 64, 6508.  To a solution 
of 9 (0.614 g, 4.32 mmol, 1.0 equiv) in MeCN (18 mL) at 25 °C was added solid 
NaHCO3 (0.726 g, 8.64 mmol, 2.0 equiv), and the resultant slurry was stirred for 10 min 
at 25 °C.   Solid I2 (2.19 g, 8.64 mmol, 2.0 equiv) was then added, and the reaction 
contents were stirred for an additional 3 h at 25 °C.  Upon completion, the reaction 
mixture was quenched with saturated aqueous Na2SO3 (10 mL) and the resultant biphasic 
mixture was stirred vigorously for 10 min at 25 °C.  The layers were then diluted with 
water (100 mL) and extracted with EtOAc (3 ×  30 mL).  The combined organic layers 
were dried (MgSO4), filtered, and concentrated, and the resultant crude residue was 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 9:1→7:3) to afford 
separable diastereomers 8a (0.389 g, 34% yield) and 8b (0.468 g, 42% yield).  8a: light 
yellow viscous oil; Rf = 0.38 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3392 (br), 
2929, 1431, 1102, 917, 750 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.85 (m, 1 H), 5.18–
5.09 (m, 2 H), 4.18 (quintet, J = 2.8 Hz, 1 H), 4.12 (m, 1 H), 3.91 (td, J = 6.4, 3.2 Hz, 1 
H), 3.31 (dd, J = 10.4, 4.4 Hz, 1 H), 3.25 (dd, J = 10.4, 6.4 Hz, 1 H), 2.38 (m, 1 H), 2.29 
(m, 1 H), 2.06 (ddd, J = 13.6, 6.4, 2.8 Hz, 1 H), 1.88 (ddd, J = 14.4, 8.8, 6.4 Hz, 1 H), 
1.65 (br s, 1 H); 13C NMR (125 MHz, CDCl3) δ 134.0, 117.8, 86.6, 77.3, 75.6, 41.2, 38.6, 
10.1; HRMS (FAB) calcd for C8H14IO2 [M+H]+ 269.0039, found 269.0054.  8b: light 
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yellow viscous oil; Rf = 0.56 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3412 (br), 
2927, 1429, 1062, 988, 918, 750 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.83 (m, 1 H), 
5.18–5.09 (m, 2 H), 4.23–4.15 (m, 2 H), 4.01 (dt, J = 6.8, 4.0 Hz, 1 H), 3.35 (m, 2 H), 
2.43 (quintet, J = 6.8 Hz, 1 H), 2.36–2.21 (m, 2 H), 1.86 (ddd, J = 13.6, 5.6, 5.2 Hz, 1 H), 
1.78 (d, J = 4.8 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 133.8, 117.8, 85.2, 77.4, 75.7, 
40.1, 37.7, 11.2; HRMS (FAB) calcd for C8H14IO2 [M+H]+ 269.0039, found 269.0038. 
 
11.  Prepared according to a procedure adapted from the work of Snyder and co-
workers: Snyder, S. A.; Treitler, D. S.; Brucks, A. P.; Sattler. W. J. Am. Chem. Soc. 2011, 
133, 15898 and Campagne and co-workers: Moreau, X.; Bazán-Tejeda, B.; Campagne, J.-
M. J. Am. Chem. Soc. 2005, 127, 7288.  To a solution of 8b (0.468 g, 1.80 mmol, 1.0 
equiv) in CH2Cl2 (23 mL) at 25 °C was sequentially added trans-3-hexene (1.34 mL, 10.8 
mmol, 6.0 equiv) and the 2nd generation Hoveyda-Grubbs (9 mg, 0.01 mmol, 0.008 
equiv). The resultant reaction contents were stirred for 3 h at 25 °C.  Upon completion (as 
monitored by 1H NMR analysis of small reaction aliquots), the reaction was concentrated 
directly, and the resultant crude residue was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 9:1→7:3) to afford the desired cross-metathesized product 
(0.371 g, 78% yield) as a light yellow oil.  Next, this newly synthesized material (0.371 g, 
1.40 mmol, 1.0 equiv) and Boc2O (1.22 g, 5.60 mmol, 4.0 equiv) were dissolved in 





















2.10 mmol, 1.5 equiv) were added sequentially at 25 °C.  The reaction solution was 
stirred at 25 °C for 5 h.  Upon completion, the reaction contents were concentrated, taken 
up in DMSO (1.4 mL), and then powdered KOH (0.392 g, 7.00 mmol, 5.0 equiv) was 
added at 25 °C.  This reaction mixture was then stirred vigorously for 3 h at 25 °C [this 
procedure was employed to remove the di-tert-butylcarbonate by-product] before being 
quenched with water (50 mL) and extracted with EtOAc (3 ×  25 mL). The combined 
organic layers were then washed with water (2 ×  25 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant crude residue was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 99:1→9:1) to afford 11 (0.479 g, 87% yield over 2 steps, 
contaminated with ~5% of an unknown side-product) as a colorless viscous oil.  11: Rf = 
0.63 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2974, 1738, 1369, 1278, 1163, 968 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.55 (m, 1 H), 5.36 (m, 1 H), 4.82 (dt, J = 6.4, 3.2 
Hz, 1 H), 4.27 (m, 1 H), 4.15 (td, J = 6.0, 2.8 Hz, 1 H), 3.29 (dd, J = 9.6, 5.6 Hz, 1 H), 
3.21 (dd, J = 9.6, 8.4 Hz, 1 H), 2.43 (quintet, 7.2 Hz, 1 H), 2.29–2.20 (m, 2 H), 2.05–1.95 
(m, 3 H), 1.46 (s, 9 H), 0.94 (t, J = 7.6 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 152.9, 
135.6, 123.3, 83.7, 82.4, 79.8, 78.3, 37.0, 36.3, 27.7 (3 C), 25.5, 13.6, 9.7; HRMS (FAB) 
calcd for C15H26IO4 [M+H]+ 397.0876, found 397.0884. 
13. Prepared according to a procedure adapted from the work of Fujioka and co-
workers: Fujioka, H.; Maehata, R.; Wakamatsu, S.; Nakahara, K.; Hayashi, T.; Oki, T. 
Org. Lett. 2012, 14, 1054.  Thiophenol (0.126 mL, 1.22 mmol, 2.0 equiv) was added 
dropwise to a suspension of NaH (60 % dispersion in mineral oil, 0.041 g, 1.2 mmol, 2.0 
equiv) in DMF (3.0 mL) at 0 °C.  The reaction flask was allowed to warm to 25 °C and 
maintained at that temperature for 1 h.  Next, a solution of 11 (0.240 g, 0.610 mmol, 1.0 
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equiv) in DMF (3.0 mL) was added.  After stirring for 4 h at 25 °C, the reaction contents 
were quenched with 1 M HCl (10 mL) and extracted with EtOAc (3 ×  10 mL). The 
combined organic layers were then washed with water (2 ×  10 mL), dried (MgSO4), 
filtered, and concentrated.  The resultant crude residue was purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 99:1→9:1) to afford the desired sulfide 
intermediate 12a (0.195 g, 85% yield) as a colorless viscous oil.  Moving forward, 12a 
(0.195 g, 0.520 mmol, 1.0 equiv) was dissolved in a mixture of THF (4.4 mL) and water 
(1.3 mL), cooled to 0 °C, and NCS (0.076 g, 0.57 mmol, 1.1 equiv) was added in a single 
portion.  The reaction contents were then allowed to warm slowly to 25 °C over 12 h with 
stirring.  Upon completion, the reaction mixture was quenched with saturated aqueous 
Na2SO3 (5 mL) and stirred vigorously for 10 min.  The contents were then diluted with 
water (10 mL) and extracted with EtOAc (3 ×  10 mL).  The combined organic layers 
were dried (MgSO4), filtered, and concentrated to afford the desired sulfoxide 
intermediate, which was carried forward without any additional purification.  Next, the 
newly prepared sulfoxide (0.520 mmol assumed) was dissolved in CH2Cl2 (4.5 mL) and 
cooled to 0 °C.  TFAA (0.253 mL, 1.82 mmol, 3.5 equiv) and 2,6-lutidine (0.212 mL, 
1.82 mmol, 3.5 equiv) were sequentially added dropwise.  The reaction contents were 
stirred for 10 min at 0 °C, then water (5 mL) and excess solid NaHCO3 were added at 0 
°C.  The resultant biphasic solution was stirred vigorously for 24 h at 25 °C, then poured 
into water (50 mL) and extracted with EtOAc (3 × 30 mL).  The combined organic layers 
were dried (MgSO4), filtered, and concentrated.  The resultant crude residue was purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 9:1→7:3) to afford 13 
(0.106 g, 71% yield over 2 steps, contaminated with ~5% of an unknown side product) as 
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a light yellow viscous oil.  13: Rf = 0.61 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 
2966, 2934, 1735, 1370, 1275, 1254, 1157, 1101 cm–1; 1H NMR (400 MHz, CDCl3) δ 
9.74 (d, J = 1.2 Hz, 1 H), 5.59 (m, 1 H), 5.40 (m, 1 H), 4.85 (dt, J = 6.2, 2.0 Hz, 1 H), 
4.39 (ddd, J = 9.6, 2.8, 1.2 Hz, 1 H), 4.24 (td, J = 6.4, 1.6 Hz, 1 H), 2.45 (ddd, J = 14.8, 
10.0, 6.0 Hz, 1 H), 2.28–2.21 (m, 3 H), 2.09–1.99 (m, 2 H), 1.46 (s, 9 H), 0.98 (t, J = 7.6 
Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 203.7, 152.7, 136.1, 123.1, 84.8, 82.8, 82.0, 
78.9, 36.7, 34.1, 27.7 (3 C), 25.6, 13.6; HRMS (FAB) calcd for C15H25O5 [M+H]+ 
285.1702, found 285.1693. 
 6. A solution of BDSB (0.066 g, 0.12 mmol, 1.2 equiv) in MeNO2 (0.5 mL) was 
added quickly via syringe to a solution of 13 (0.028 g, 0.10 mmol, 1.0 equiv) in MeNO2 
(4.5 mL) at –25 °C.  After stirring the reaction contents for 15 min at –25 °C, the flask 
was removed from the cooling bath and stirred at 25 °C for an additional 5 min.  At this 
time, the reaction mixture was quenched by the addition of water (10 mL) and the 
reaction contents were extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers 
were then dried (MgSO4), filtered, and concentrated.  Purification of the resultant crude 
residue by flash column chromatography (silica gel, hexanes:EtOAc, 7:3→2:3) afforded 
6 (0.017 g, 56% yield) as a light yellow viscous oil.  6: Rf = 0.35 (silica gel, 
hexanes:EtOAc, 1:1); IR (film) νmax 2936, 2882, 1802, 1737, 1207, 1057 cm–1; 1H NMR 
(500 MHz, CDCl3) δ 9.70 (s, 1 H), 4.72 (t, J = 9.5 Hz, 1 H), 4.56 (ddd, J = 11.5, 9.0, 3.0 
Hz, 1 H), 4.01 (ddd, J = 14.0, 10.0, 4.0 Hz, 1 H), 3.95 (dd, J = 12.0, 2.0 Hz, 1 H), 3.49 
(ddd, J = 9.5, 6.0, 3.0 Hz, 1 H), 3.02 (dd, J = 15.0, 4.0 Hz, 1 H), 2.53 (dt, J = 13.5, 2.5 
Hz, 1 H), 2.42 (m, 1 H), 2.11–2.00 (m, 2 H), 1.85 (septet, J = 7.0 Hz, 1 H), 1.00 (t, J = 
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7.5 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 199.1, 152.7, 90.6, 84.9, 83.1, 82.2, 47.3, 
43.3, 34.4, 27.5, 8.4; HRMS: No molecular ion peak was observed. 
15.  To a solution of 6 (0.012 g, 0.039 mmol, 1.0 equiv) in CH2Cl2 (0.52 mL) at –
78 °C was added BF3•OEt2 (0.030 mL, 0.20 mmol, 5.0 equiv).  After stirring for 10 min 
at –78 °C, allyltrimethylsilane (0.024 mL, 0.20 mmol, 5.0 equiv) was then added.  The 
reaction contents were then allowed to warm to –20 °C over the course of 3 h with 
stirring.  Upon completion, the reaction mixture was quenched with water (10 mL) and 
extracted with CH2Cl2 (3 ×  10 mL).  The combined organic layers were then dried 
(MgSO4), filtered, and concentrated.  The resultant crude residue was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 4:1→1:1) to afford the allylic 
alcohol intermediate (8 mg, 59% yield) as a colorless viscous oil. Moving forward, the 
allylic alcohol (8 mg, 0.023 mmol, 1.0 equiv) was dissolved in CH2Cl2 (0.1 mL) and 
cooled to 0 °C.  MsCl (5.2 mL, 0.069 mmol, 3.0 equiv) and Et3N (19 mL, 0.12 mmol, 6.0 
equiv) were added sequentially, and the reaction mixture was then allowed to warm to 25 
°C and was stirred at that temperature for 2 h.  Upon completion, the reaction mixture 
was quenched with water (2 mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined 
organic layers were then dried (MgSO4), filtered, and concentrated.  The crude residue 
was purified by flash column chromatography (silica gel, hexanes:EtOAc, 4:1→1:1) to 
afford 15 (8 mg, 59% yield, 1:1 d.r.) as a light yellow viscous oil. 
17a.  To a solution of 13 (0.050 g, 0.18 mmol, 1.0 equiv) in CH2Cl2 (2.4 mL) at –
78 °C was added BF3•OEt2 (0.11 mL, 0.90 mmol, 5.0 equiv).  After stirring for 10 min at 
–78 °C, allyltrimethylsilane (0.14 mL, 0.90 mmol, 5.0 equiv) was then added.  The 
reaction contents were then allowed to warm to –20 °C over the course of 3 h with 
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stirring.  Upon completion, the reaction mixture was quenched with water (10 mL) and 
extracted with CH2Cl2 (3 ×  10 mL).  The combined organic layers were then dried 
(MgSO4), filtered, and concentrated to provide the desired crude allyl alcohol 17a.  Only 
1H NMR was completed for characterization of 17a. 
17b.  To a solution of 13 (0.050 g, 0.18 mmol, 1.0 equiv) in CH2Cl2 (1.8 mL) at –
78 °C was added TiCl4 (1.0 M in CH2Cl2, 0.18 mL, 0.18 mmol, 1.0 equiv).  After stirring 
for 10 min at –78 °C, allyltrimethylsilane (0.034 mL, 0.21 mmol, 1.2 equiv) was then 
added.  The reaction contents were then allowed to stir at –78 °C for 20 min.  Upon 
completion, the reaction mixture was quenched with water (10 mL) and extracted with 
CH2Cl2 (3 ×  10 mL).  The combined organic layers were then dried (MgSO4), filtered, 
and concentrated to provide the desired crude allyl alcohol 17b.  Only 1H NMR was 
completed for characterization of 17b. 
19.  To a solution of the crude allylic alcohol 17a (0.019 g, 0.058 mmol, 1.0 
equiv) in Et2O (0.35 mL) at –20 °C was added PBr3 (2.7 µL, 0.029 mmol, 0.5 equiv).  
The reaction was allowed to stir at –20 °C for 30 min.  Upon completion, the reaction 
mixture was quenched with water (10 mL) and extracted with Et2O (3 ×  10 mL).  The 
combined organic layers were then dried (MgSO4), filtered, and concentrated to provide 
the desired crude allylic bromide 19.  Only 1H NMR was completed for characterization 
of 19. 
18b. Allyl alcohol 17a (0.18 mmol assumed, 1.0 equiv) was dissolved in CH2Cl2 
(0.52 mL) and cooled to 0 °C.  MsCl (0.041 mL, 0.53 mmol, 3.0 equiv) and Et3N (0.147 
mL, 1.06 mmol, 6.0 equiv) were added sequentially, and the reaction mixture was then 
allowed to warm to 25 °C and was stirred at that temperature for 2 h.  Upon completion, 
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the reaction mixture was quenched with water (10 mL) and extracted with CH2Cl2 (3 × 
10 mL).  The combined organic layers were then dried (MgSO4), filtered, and 
concentrated.  The crude residue was purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 9:1→7:3) to afford 18b (0.058 g, 81% yield over 2 steps, 
contaminated with ~5% of an unknown side product) as a light yellow viscous oil.  18b: 
Rf = 0.68 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2966, 1738, 1356, 1277, 1255, 
1170, 944, 915 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.81 (m, 1 H), 5.56 (m, 1 H), 5.35 
(m, 1 H), 5.20–5.14 (m, 2 H), 4.88–4.81 (m, 2 H), 4.14 (ddd, J = 10.4, 6.8, 4.0 Hz, 1 H), 
4.06 (td, J = 6.8, 3.2 Hz, 1 H), 3.07 (s, 3 H), 2.53–2.35 (m, 3 H), 2.22–2.10 (m, 3 H), 2.01 
(quintet, J = 7.6 Hz, 2 H), 1.48 (s, 9 H), 0.96 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 152.9, 135.8, 132.0, 123.3, 119.1, 83.0, 82.6, 82.1, 79.2, 77.5, 38.5, 36.8, 35.6, 
31.8, 27.7 (3 C), 25.6, 13.6; HRMS (FAB) calcd for C19H33O7S [M+H]+ 405.1947, found 
405.1961. 
15.  A solution of BDSB (0.037 g, 0.067 mmol, 1.5 equiv) in MeNO2 (0.23 mL) 
was added quickly via syringe to a solution of 18b (0.018 g, 0.045 mmol, 1.0 equiv) in 
MeNO2 (2.0 mL) at –25 °C.  After stirring the reaction contents for 5 min at –25 °C, the 
flask was removed from the cooling bath and stirred at 25 °C for an additional 10 min.  
At this time, the reaction mixture was quenched by the addition of 5% aqueous Na2SO3 
(3 mL) and saturated aqueous NaHCO3 (3 mL).  After stirring the resultant mixture 
vigorously for 5 min at 25 °C, the reaction contents were extracted with CH2Cl2 (3 × 10 
mL).  The combined organic layers were then dried (MgSO4), filtered, and concentrated.  
Purification of the resultant crude residue by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1→1:1) afforded 15 (0.014 g, 72% yield) as a colorless viscous oil.  
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15: Rf = 0.23 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2972, 1801, 1351, 1207, 
1173, 1056, 917 cm–1; 1H NMR (500 MHz, CDCl3) δ 5.77 (m, 1 H), 5.25–5.19 (m, 2 H), 
4.70–4.63 (m, 2 H), 4.53 (ddd, J = 11.5, 9.0, 3.0 Hz, 1 H), 4.02–3.92 (m, 2 H), 3.59 (dt, J 
= 10.0, 4.0 Hz, 1 H), 3.04 (s, 3 H), 2.98 (dd, J = 15.0, 3.5 Hz, 1 H), 2.53 (m, 1 H), 2.43–
2.32 (m, 2 H), 2.27 (m, 1 H), 2.10–1.90 (m, 3 H), 0.97 (t, J = 7.5 Hz, 3 H); 13C NMR 
(125 MHz, CDCl3) δ 152.8, 132.1, 119.8, 88.7, 83.3, 83.1, 82.3, 82.0, 46.4, 43.0, 38.8, 
34.8, 33.9, 26.1, 6.5; HRMS (FAB) calcd for C15H24BrO7S [M+H]+ 427.0426, found 
427.0437. 
4. A solution of 15 (6 mg, 0.014 mmol, 1.0 equiv) in toluene (0.14 mL) was 
cooled to –78 °C and DIBAL-H (1.0 M in toluene, 0.07 mL, 0.07 mmol, 5.0 equiv) was 
then added dropwise. The reaction contents were then allowed to warm to 25 °C over the 
course of 4 h with stirring, and then the maintained at that temperature for an additional 2 
h.  Upon completion, the reaction contents were quenched with 1 M aqueous 
sodium/potassium tartrate (1 mL) and the resulting biphasic solution was stirred 
vigorously for 2 h at 25 °C.  The layers were then separated and the aqueous fraction was 
extracted with EtOAc (3 ×  10 mL).  The combined organic layers were then dried 
(MgSO4), filtered, and concentrated.  Purification of the resultant crude residue by flash 
column chromatography (silica gel, hexanes:EtOAc, 9:1→1:4) afforded 4 (2 mg, 46% 
yield) as a colorless viscous oil, which was spectroscopically identical to the same 
intermediate obtained in the original total synthesis by Kim et al: Kim, B.; Lee, M.; Kim, 
M. J.; Lee, H.; Kim, S.; Kim, D.; Koh, M.; Park, S. B.; Shin, K. J. J. Am. Chem. Soc. 
2008, 130, 16807.  4:  Rf = 0.35 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3404 (br), 
2923, 1463, 1065, 969, 753 cm–1; 1H NMR (500 MHz, CDCl3) δ 5.82 (m, 1 H), 5.14 (d, J 
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= 17.5 Hz, 1 H), 5.07 (d, J = 10.5 Hz, 1 H), 4.18 (dd, J = 8.0, 3.5 Hz, 1 H), 4.03 (br s, 1 
H), 3.98 (br d, J = 8.5 Hz, 1 H), 3.87–3.82 (m, 2 H), 3.51 (t, J = 9.0 Hz, 1 H), 2.52 (d, J = 
14.0 Hz, 1 H), 2.46–2.35 (m, 3 H), 2.30–2.19 (m, 2 H), 2.09 (m, 1 H), 1.89 (ddd, J = 
14.0, 8.0, 2.0 Hz, 1 H), 1.48 (m, 1 H), 0.96 (t, J = 7.5 Hz, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 134.6, 117.2, 83.5, 83.2, 80.2, 77.8, 76.7, 53.0, 42.0, 34.2, 33.1, 28.2, 9.7; 
HRMS: No molecular ion peak was observed.  
Table S1. Spectral comparison of intermediate 4. 
1H NMR 
Kim et al Present Work 
5.82 (dddd, J = 17.2, 10.2, 7.0, 7.0 Hz, 1 H) 5.82 (m, 1 H) 
5.14 (dd, J = 17.1, 1.3 Hz, 1 H) 5.14 (d, J = 17.5 Hz, 1 H) 
5.07 (d, J = 10.2 Hz, 1 H) 5.07 (d, J = 10.5 Hz, 1 H) 
4.18 (dd, J = 8.0, 3.8 Hz, 1 H) 4.18 (dd, J = 8.0, 3.5 Hz, 1 H) 
4.03 (s, 1 H) 4.03 (br s, 1 H) 
3.98–3.96 (m, 1 H) 3.98 (br d, J = 8.5 Hz, 1 H) 
3.87–3.82 (m, 2 H) 3.87–3.82 (m, 2 H) 
3.51 (ddd, J = 11.0, 11.0, 2.1 Hz, 1 H) 3.51 (t, J = 9.0 Hz, 1 H) 
2.52 (d, J = 14.4 Hz, 1 H) 2.52 (d, J = 14.0 Hz, 1 H) 
2.46–2.37 (m, 2 H) 2.46–2.35 (m, 3 H) 
2.37 (dd, J = 9.8, 4.8 Hz, 1 H)  
2.30–2.25 (m, 1 H) 2.30–2.19 (m, 2 H) 
2.10–2.07 (m, 1 H) 2.09 (m, 1 H) 
1.89 (ddd, J = 14.3, 8.1, 2.3 Hz, 1 H) 1.89 (ddd, J = 14.0, 8.0, 2.0 Hz, 1 H) 
1.51–1.45 (m, 1 H) 1.48 (m, 1 H) 


















Synthesis of the Core of 3E-Dehydrobromolaurefucin: 
27.  A solution of IDSI (0.048 g, 0.060 mmol, 1.2 equiv) in MeNO2 (0.5 mL) was 
added quickly via syringe to a solution of 11 (0.020 g, 0.050 mmol, 1.0 equiv) in MeNO2 
(2.0 mL) at –25 °C.  After stirring for 15 min at –25 °C, the flask was removed from the 
cooling bath and then stirred at 25 °C for an additional 10 min.  At this time, the reaction 
mixture was quenched by the addition of 5% aqueous Na2SO3 (3 mL) and saturated 
aqueous NaHCO3 (3 mL).  After stirring the resultant mixture vigorously for 5 min at 25 
°C, the reaction contents were extracted with CH2Cl2 (3 ×  10 mL).  The combined 
organic layers were then dried (MgSO4), filtered, and concentrated.  The resultant crude 
residue was purified by flash column chromatography (silica gel, hexanes:EtOAc, 
9:1→3:2) to afford 27 (0.013 g, 54% yield) as a colorless viscous oil.  27:  Rf = 0.59 
(silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2964, 1801, 1354, 1208, 1050, 775 cm–1; 
1H NMR (500 MHz, CDCl3) δ 4.67 (t, J = 9.0 Hz, 1 H), 4.51 (ddd, J = 11.5, 9.5, 3.5 Hz, 
1 H), 4.07 (ddd, J = 14.5, 10.5, 4.0 Hz, 1 H), 3.62–3.55 (m, 2 H), 3.25 (dd, J = 10.5, 4.0 
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Hz, 1 H), 3.17 (dd, J = 10.0, 7.0 Hz, 1 H), 3.06 (dd, J = 15.0, 4.0 Hz, 1 H), 2.61 (ddd, J = 
13.0, 3.5, 2.0 Hz, 1 H), 2.52 (ddd, J = 21.5, 12.0, 9.0 Hz, 1 H), 2.12–2.02 (m, 2 H), 1.95 
(m, 1 H), 0.94 (t, J = 7.5 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 152.9, 89.0, 83.7, 
83.4, 80.0, 45.6, 38.9, 28.6, 26.0, 8.1, 7.5; HRMS (FAB) calcd for C11H17I2O4 [M+H]+ 
466.9216, found 466.9220. 
28.  DBU (0.014 mL, 0.095 mmol, 5.0 equiv) was added to a solution of 27 (9 
mg, 0.019 mmol, 1.0 equiv) in toluene (0.19 mL) at 25 °C, and the resultant solution was 
stirred at 25 °C for 24 h.  Upon completion, the reaction contents were purified directly 
by flash column chromatography (silica gel, hexanes:EtOAc, 9:1→3:2) to afford the 
desired olefin intermediate (6 mg, 92% yield) as a colorless viscous oil.  Next, this newly 
synthesized material (6 mg, 0.018 mmol, 1.0 equiv) was dissolved in MeOH (0.18 mL) 
and solid K2CO3 (0.025 g, 0.18 mmol, 10. equiv) was added at 0 °C.  The reaction 
contents were then allowed to warm to 25 °C and stirred for 12 h.  Upon completion, the 
reaction mixture was quenched with water (10 mL) and extracted with EtOAc (3 ×  10 
mL).  The combined organic layers were then dried (MgSO4), filtered, and concentrated.  
Purification of the resultant crude residue by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1→1:1) afforded 28 (4 mg, 99% yield) as a light yellow viscous oil.  
28:  Rf = 0.29 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3416 (br), 2935, 1120, 
1041, 855, 687 cm–1; 1H NMR (500 MHz, C6D6) δ 5.48 (ddd, J = 12.0, 4.5, 2.0 Hz, 1 H), 
5.16–5.10 (m, 2 H), 4.23 (dd, J = 7.0, 3.5 Hz, 1 H), 3.88 (d, J = 9.5 Hz, 1 H), 3.67 (t, J = 
2.0 Hz, 1 H), 3.53 (dd, J = 9.5, 3.0 Hz, 1 H), 3.33 (m, 1 H), 2.30 (d, J = 13.5 Hz, 1 H), 
2.02 (br s, 1 H), 1.41–1.34 (m, 2 H), 1.11 (ddd, J = 13.5, 7.0, 3.0 Hz, 1 H), 0.88 (t, J = 7.0 
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Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 133.6, 128.4, 86.1, 79.8, 78.8, 76.9, 73.8, 33.4, 
28.9, 10.1; HRMS (FAB) calcd for C10H17O3 [M+H]+ 185.1178, found 185.1181. 
 
Mimicking Enzymatic Conditions Results: 
 86.  To solution of alcohol precursor synthesized in Chapter 4 (0.224 g, 1.43 
mmol, 1.0 equiv) in toluene (14 mL) was added triphenylphosphine (0.563 g, 2.15 mmol, 
1.5 equiv).  The solution was cooled to 0 °C, and sequentially, AcOH (0.246 mL, 4.29 
mmol, 3.0 equiv) then DIAD (0.338 mL, 1.72 mmol, 1.2 equiv) were added dropwise.  
The solution was then heated to 40 °C for 4 hours.  Upon completion, the reaction was 
quenched with saturated aqueous NaHCO3 (5 mL) and extracted with Et2O (3 ×  5 mL).  
The combined organic layers were washed with H2O (5 mL), brine (5 mL), dried 
(MgSO4), filtered, and concentrated.  The resultant residue was purified by flash column 
chromatography (silica gel, hexanes:EtOAc 1:0 to 20:3) to afford the desired inverted 
acetylated alcohol (0.244 g, 80% yield) as a colorless viscous oil.  Next, K2CO3 (0.473 g, 
3.42 mmol, 3.0 equiv) was added to a solution of the newly prepared tetrahydrofuran 
(0.244 g, 1.14 mmol, 1.0 equiv) in MeOH (11.0 mL) at 25 °C.  The reaction mixture was 
stirred at 25 °C for 2 h.  Upon completion, the reaction mixture was quenched with water 
(5 mL) and saturated aqueous NH4Cl (5 mL), and extracted with EtOAc (3 × 5 mL).  The 
combined organic layers were washed brine (5 mL), dried (MgSO4), filtered, and 
concentrated.  Purification of the resultant oil by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:0 to 2:3) afforded the desired alcohol (0.188 g, 97% yield) as a 
colorless viscous oil.  86: Rf = 0.49 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3412 
(br), 2965, 2929, 1442, 1377, 1017, 966 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.58 (dt, J 
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= 15.2, 6.0 Hz, 1 H), 5.43 (dt, J = 15.2, 7.2 Hz, 1 H), 4.16 (sextet, J = 6.8 Hz, 1 H), 4.10 
(q, J = 6.0 Hz, 1 H), 3.82 (q, J = 6.8 Hz, 1 H), 2.36 (dt, J = 13.2, 6.8 Hz, 1 H), 2.30 – 2.12 
(m, 2 H), 2.02 (quintet, J = 6.8 Hz, 2 H), 1.79 (br s, 1 H), 1.56 (ddd, J = 12.8, 7.2, 6.0 Hz, 
1 H), 1.30 (d, J = 6.4 Hz, 3 H), 0.97 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
135.3, 124.3, 84.4, 76.3, 73.3, 42.1, 36.4, 25.6, 22.2, 13.8; HRMS (FAB) calcd for 
C10H17O2 [M–H]+ 169.1229, found 169.1225. 
 Enzymatic Results with 86.  Procedure adapted from the enzymatic work of 
Muria and coworkers: Fukuzawa, A.; Aye, M.; Nakamura, M.; Tamaura, M.; Murai, A. 
Chemistry Lett. 1990, 1287.  A solution of tetrahydrofuran 86 (0.0170 g, 0.100 mmol, 1.0 
equiv) in DMSO (0.2 mL) was added to a separate solution of phosphate buffer (pH 5.5, 
50 mM, 29.2 mL) containing NaBr (10.3 mg, 0.100 mmol, 1.0 equiv).  To the mixture 
was added an aliquot of each solution of H2O2 (30% in water, 0.8 nM in final solution, 91 
nL in 1.2 mL phosphate buffer) and LPO (5 mg in 1.2 mL phosphate buffer) divided into 
12 portions over 2 h (0.1 mL aliquots each every 10 min).  The reaction was stirred in the 
dark for 24 h at 25 °C.  The reaction contents were extracted with EtOAc (2 × 15 mL).  
The combined organic layers were washed with H2O (20 mL), dried (MgSO4), filtered, 
and concentrated.  The resultant residue was purified by preparative thin-layer 
chromatography (silica gel, hexanes:EtOAc 7:3) to afford the presumed bromohydrins of 
86 (2 mg, 7% yield) along with recovered tetrahydrofuran 86 (0.0140 g, 82% yield 
RSM).  An exhaustive characterization of the mix of regio- and diastereomeric 
bromohydrins was not completed, though the 1H NMR was compared to that of the below 
reaction.  Rf = 0.28 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3397 (br), 2964, 2926, 




 Bromohydrin Formation. To a solution of alcohol 86 (0.0100 g, 0.0588 mmol, 
1.0 equiv) in THF (0.5 mL) and H2O (0.1 mL) was added NBS (0.0126 g, 0.0706 mmol, 
1.2 equiv) at 25 °C.  The reaction was allowed to stir at 25 °C for 1 h.  Upon completion, 
the reaction mixture was quenched by the addition of a combination of saturated aqueous 
NaHCO3 and 5% aqueous Na2SO3 (1:1, 5 mL), and the resultant biphasic mixture was 
stirred vigorously for 20 min at 25 °C.  The reaction contents were added to brine (10 
mL) and extracted with EtOAc (3 × 15 mL).  The combined organic layers were washed 
with brine (20 mL), dried (MgSO4), filtered, and concentrated.  The resultant residue was 
purified by flash column chromatography (silica gel, hexanes:EtOAc 4:1 to 1:4) to afford 
the bromohydrins (0.010 g, 52% yield calculated without succinimide impurity).   
 89.  Alcohol 86 (0.056 g, 0.33 mmol, 1.0 equiv) was dissolved in THF (2.8 mL) 
and cooled to 0 °C.  nBuLi (2.5 M in hexanes, 0.13 mL, 0.33 mmol, 1.0 equiv) was added 
dropwise and the resultant solution was stirred at 0 °C for 5 min.  A solution of Boc2O 
(0.065 g, 0.30 mmol, 0.9 equiv) in THF (0.5 mL) was then added dropwise, and the 
resultant colorless solution was removed from the ice bath and stirred at 25 °C for 1 h.  
Upon completion, the reaction mixture was quenched with water (5 mL) and NH4Cl (5 
mL), and extracted with Et2O (3 ×  5 mL).  The combined organic layers were washed 
brine (5 mL), dried (MgSO4), filtered, and concentrated.  Purification of the resultant oil 
by flash column chromatography (silica gel, hexanes:EtOAc, 1:0 to 20:1) afforded the 
desired carbonate 89 (0.071 g, 80% yield) as a colorless viscous oil.  89: Rf = 0.65 (silica 
gel, hexanes:EtOAc, 4:1); IR (film) νmax 2971, 2933, 1737, 1254, 1109, 966 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 5.57 (td, J = 15.2, 6.4 Hz, 1 H), 5.41 (td, J = 15.2, 7.2 Hz, 1 
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H), 4.82 (quintet, J = 4.4 Hz, 1 H), 4.21 (sextet, J = 6.0 Hz, 1 H), 4.08 (td, J = 6.4, 3.2 
Hz, 1 H), 2.44 (dt, J = 14.0, 7.2 Hz, 1 H), 2.24 (t, J = 6.8 Hz, 2 H), 2.02 (q, J = 7.2 Hz, 2 
H), 1.67 (ddd, J = 13.6, 6.4, 4.4 Hz, 1 H), 1.48 (s, 9 H), 1.29 (d, J = 6.4 Hz, 3 H), 0.97 (t, 
J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.1, 135.2, 124.0, 82.3, 82.2, 80.8, 
73.7, 39.1, 36.2, 27.8 (3 C), 25.6, 21.7, 13.7; HRMS (FAB) calcd for C15H27O4 [M+H]+ 
271.1909, found 127.1922. 
 Enzymatic Results with 89.  Prepared according to the above enzymatic results 
procedure using tetrahydrofuran 89 (0.027 g, 0.10 mmol, 1.0 equiv).  The resultant 
residue was purified by preparative thin-layer chromatography (silica gel, hexanes:EtOAc 
7:3) to afford the desired 8-endo bromoether 90 (0.6 mg, 2% yield) as a colorless viscous 
oil along with recovered tetrahydrofuran 89 (0.021 g, 78% yield RSM). 90: Rf = 0.53 
(silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2971, 2929, 1780, 1203, 1045, 776 cm–1; 
1H NMR (400 MHz, CDCl3) δ 4.72 (t, J = 9.6 Hz, 1 H), 4.49 (ddd, J = 12.0, 9.2, 3.6 Hz, 
1 H), 3.89 (ddd, J = 11.6, 10.0, 4.0 Hz, 1 H), 3.67 (sextet of d, J = 6.0, 4.0 Hz, 1 H), 3.38 
(ddd, J = 9.6, 6.0, 3.2 Hz, 1 H), 2.94 (dd, J = 14.8, 4.0 Hz, 1 H), 2.38 (ddd, J = 21.6, 12.0, 
9.6 Hz, 1 H), 2.22 (ddd, J = 13.6, 3.2, 2.0 Hz, 1 H), 2.05 – 1.88 (m, 2 H), 1.71 (sextet, J = 
7.2 Hz, 1 H), 1.27 (d, J = 6.0 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 153.2, 88.2, 84.0, 82.6, 77.8, 48.4, 43.4, 41.3, 27.3, 23.0, 8.2; HRMS (FAB) 
calcd for C11H18BrO4 [M+H]+ 293.0388, found 293.0388. 
 Control Experiments:  The above enzymatic reaction was additionally performed 
exactly as above with these two variations: 
1. Same conditions as above without addition of the LPO.  This resulted in recovered 




2. Tetrahydrofuran 89 (0.022 g, 0.0822 mmol, 1.0 equiv) was dissolved in DMSO 
(0.16 mL).  To this solution, the phosphate buffer (pH 5.5, 50 mM, 24.0 mL) and 
Br2 (4.21 mL, 0.0822 mmol, 1.0 equiv) were added sequentially.  The reaction 
was stirred in the dark for 24 h at 25 °C.  The reaction contents were extracted 
with EtOAc (2 × 15 mL).  The combined organic layers were washed with H2O 
(20 mL), dried (MgSO4), filtered, and concentrated.  The resultant residue was 
purified by preparative thin-layer chromatography (silica gel, hexanes:EtOAc 7:3) 
to afford the desired 8-endo bromoether 90 (0.5 mg, 2% yield) along with 
recovered tetrahydrofuran 89 (0.017 g, 78% yield RSM). 
 Cyclization BDSB.  A cold (–25 °C) solution of BDSB (0.0701 g, 0.128 mmol, 
1.5 equiv) in MeNO2 (0.3 mL) was added rapidly via syringe to a solution of the 
cyclization precursor 89 (0.0230 g, 0.0851 mmol, 1.0 equiv) in MeNO2 (4.0 mL) at –25 
°C.  After stirring the resultant yellow solution for 15 min at –25 °C, the flask was 
removed from the cold bath and stirred for an additional 5 min.  Upon completion, the 
reaction mixture was quenched by the addition of a combination of saturated aqueous 
NaHCO3 and 5% aqueous Na2SO3 (1:1, 5 mL), and the resultant biphasic mixture was 
stirred vigorously for 20 min at 25 °C.  The reaction contents were added to brine (10 
mL) and extracted with EtOAc (3 × 15 mL).  The combined organic layers were washed 
with brine (20 mL), dried (MgSO4), filtered, and concentrated.  The resultant residue was 
purified by flash column chromatography (silica gel, hexanes:EtOAc) to afford the 
desired 8-endo bromoether 90 (0.017 g, 68% yield).   
 Diol Derivative of 90.  To a solution of cyclic carbonate 90 (0.017 g, 0.058 
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mmol, 1.0 equiv) in MeOH (2.1 mL) and H2O (0.23 mL) was added K2CO3 (0.080 g, 
0.58 mmol, 10. equiv) at 0 °C.  The reaction mixture was allowed to warm slowly to 25 
°C and monitored by TLC.  After 2 h, the reaction mixture was quenched with the 
addition of saturated aqueous NH4Cl (5 mL) and water (5 mL), and the crude product was 
extracted into EtOAc (3 × 10 mL).  The combined organic layers were washed with brine 
(10 mL), dried (MgSO4), filtered, and concentrated.  Purification by flash column 
chromatography (silica gel, hexanes:EtOAc 4:1 to 1:4) afforded the desired diol 
derivative of 90 (0.011 g, 71% yield) as white crystalline solid.  Recrystallization was 
performed by slow evaporation from a hexanes:CH2Cl2 mixture to afford single crystals 
suitable for X-ray diffraction. Rf = 0.38 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 
3372 (br), 2969, 2935, 1452, 1120, 1030, 690 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.98 – 
3.88 (m, 2 H), 3.80 – 3.70 (m, 2 H), 3.34 (td, J = 9.6, 2.0 Hz, 1 H), 2.83 (br s, 1 H), 2.71 
(br s, 1 H), 2.59 (m, 1 H), 2.34 (ddd, J = 16.0, 10.4, 6.0 Hz, 1 H), 2.12 – 2.11 (m, 2 H), 
1.73 (m, 1 H), 1.36 (m, 1 H), 1.25 (d, J = 6.4 Hz, 3 H), 0.96 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 86.1, 76.6, 75.5, 75.4, 53.8, 42.7, 40.9, 27.8, 22.6, 10.1; 
HRMS (FAB) calcd for C10H20BrO3 [M+H]+ 267.0596, found 267.0591. 
 
Results using Bromonium Electrophile with Linear Precursors: 
 92.  Prepared according to procedures adapted from the work of Taber and 








Snyder and coworkers: Snyder, S. A.; Brucks, A. P.; Treitler, D. S.; Moga, I. J. Am. 
Chem. Soc. 2012, 134, 17714.  A solution of cis-2-penten-1-ol (1.00 mL, 10.0 mmol, 1.0 
equiv) in Et2O (20 mL) was cooled to 0 °C and PBr3 (1.13 mL, 12.0 mmol, 1.2 equiv) 
was added dropwise.  The ice bath was removed and the solution was allowed to stir at 25 
°C for 1 h.  Upon completion, the reaction mixture was quenched with the addition of 
water (5 mL) and saturated aqueous NaHCO3 (5 mL) and the crude product was extracted 
into Et2O (3 ×  5 mL).  The combined organic layers were washed with brine (10 mL), 
dried (MgSO4), filtered, and carefully concentrated to afford the desired allylic bromide 
as a colorless oil, which was carried forward without any additional purification.  To a 
solution of the freshly prepared allylic bromide (10.0 mmol assumed, 2.0 equiv) in DMF 
(6.0 mL) was added 4-pentyn-2-ol (0.472 mL, 5.0 mmol, 1.0 equiv), K2CO3 (2.76 g, 20.0 
mmol, 4.0 equiv), CuI (1.90 g, 10.0 mmol, 2.0 equiv), and NaI (3.00 g, 20.0 equiv, 4.0 
mmol) sequentially.  The reaction was stirred for 12 h at 25 °C.  Upon completion, the 
reaction mixture was quenched with the addition of water (10 mL), and the crude product 
was extracted into EtOAc (3 × 10 mL).  The combined organic layers were washed with 
brine (10 mL), dried (MgSO4), filtered, and concentrated.  Purification by flash column 
chromatography (silica gel, hexanes:EtOAc 9:1 to 7:3) afforded the desired product 91 
(0.76 g, 99% yield, as a 4.7:1 desired:SN2’ alkylation) as a colorless viscous oil.  Lastly, a 
portion of 91 (0.400 g, 2.65 mmol, 1.0 equiv) in EtOAc (13.3 mL) was added to a 
solution of 5% Pd on BaSO4 (0.119 g) and quinoline (0.0626 mL, 0.530 mmol, 0.20 
equiv) in EtOAc (13.3 mL).  After the heterogeneous mixture was allowed to stirred for 5 
h at 25 °C, the reaction mixture was filtered through a pad of Celite and rinsed with 
EtOAc (10 mL).  The filtrate was washed with 1 M HCl (10 mL), dried (MgSO4), 
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filtered, and concentrated.  Purification by flash column chromatography (silica gel, 
hexanes:EtOAc 9:1 to 7:3) afforded the desired product 92 (0.225 g, 50% yield) as a 
colorless viscous oil (contaminated with ~10% of an inseparable, unidentified impurity). 
92: Rf = 0.42 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3340 (br), 2924, 2963, 2874, 
1457, 1375, 1077, 942, 731 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.60 – 5.32 (m, 4 H), 
3.81 (m, 1 H), 2.76 (t, J = 6.8 Hz, 2 H), 2.31 – 2.26 (m, 2 H), 2.04 – 1.93 (m, 2 H), 1.56 
(br s, 1 H), 1.20 (d, J = 6.0 Hz, 3 H), 0.96 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 132.7, 131.3, 126.9, 125.6, 67.6, 37.0, 30.5, 25.5, 22.8, 13.8; HRMS: no 
molecular ion peak was observed. 
93.  Prepared according to a procedure adapted from the work of Pivnitsky and 
coworkers: Lapitskaya, M. A.; Vasiljeva, L. L.; Pivnitsky, K. K. Synthesis 1993, 65.  1-
Bromo-2-pentyne (1.12 mL, 11.0 mmol, 1.1 equiv), Cs2CO3 (6.52 g, 20.0 mmol, 2.0 
equiv), NaI (3.00 g, 20.0 mmol, 2.0 equiv), and CuI (1.90 g, 10.0 mmol, 1.0 equiv) were 
added sequentially to a solution of 4-pentyn-1-ol (0.931 mL, 10.0 mmol, 1.0 equiv) in 
DMF (10. mL) at 25 °C.  The reaction was allowed to stir at 25 °C for 2 h, then quenched 
by the addition of saturated aqueous NH4Cl (10 mL) and extracted with EtOAc (2 ×  20 
mL).  The combined organic layers were then dried (MgSO4), filtered, and concentrated.  
The crude residue was purified by flash column chromatography (silica gel, 
hexanes:EtOAc 9:1 to 1:1) to afford the desired internal alkyne (1.50 g, 99% yield) as an 
orange oil.  Next, to a solution of oxalyl chloride (1.02 mL, 12.0 mmol, 1.2 equiv) in 
CH2Cl2 (90 mL) at –78 °C, DMSO (1.42 mL, 20.0 mmol, 2.0 equiv) was added dropwise 
over the course of 5 min, and the resultant colorless solution was stirred at –78 °C for 5 
min.  A solution of the freshly prepared alcohol (1.50 g, 10.0 mmol, 1.0 equiv) in CH2Cl2 
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(10 mL) was then added slowly over the course of 10 min, and the resultant colorless 
solution was stirred for an additional 5 min at –78 °C.  Finally, Et3N (5.58 mL, 40.0 
mmol, 4.0 equiv) was added slowly via syringe, and the reaction contents were allowed 
to warm slowly to 0 °C over the course of 3 h.  Upon completion, the reaction contents 
were quenched by the addition of water (40 mL) and extracted with CH2Cl2 (2 × 20 mL).  
The combined organic layers were then washed with 1 M HCl (20 mL), dried (MgSO4), 
filtered, and concentrated to afford the desired aldehyde as a light yellow oil, which was 
carried forward without any additional purification.  The freshly prepared aldehyde (10.0 
mmol assumed) was then dissolved in THF (50 mL), cooled to –78 °C, and MeMgCl (3.0 
M in THF, 5.0 mL, 15.0 mmol, 1.5 equiv) was added dropwise.  The reaction was 
allowed to warm slowly to –20 °C over the course of 2.5 h.  Upon completion, the 
reaction contents were quenched by the slow addition of water  (15 mL) and 1 M HCl (15 
mL), then extracted with EtOAc (2 ×  10 mL).  The combined organic layers were then 
dried (MgSO4), filtered, and concentrated.   The crude residue was purified by flash 
column chromatography (silica gel, hexanes:EtOAc 9:1 to 1:1) to afford the desired 
alcohol 93 (0.965 g, 59% yield over two steps) as a yellow oil.  93: Rf = 0.42 (silica gel, 
hexanes:EtOAc, 7:3); IR (film) νmax 3369 (br), 2972, 2935, 1320, 1127, 1078, 750 cm–1; 
1H NMR (400 MHz, CDCl3) δ 3.93 (sextet, J = 6.0 Hz, 1 H), 3.10 (sextet, J = 2.4 Hz, 2 
H), 2.31 – 2.26 (m, 2 H), 2.16 (qt, J = 7.6, 2.4 Hz, 2 H), 1.77 (br s, 1 H), 1.65 – 1.58 (m, 
2 H), 1.20 (d, J = 6.4 Hz, 3 H), 1.11 (t, J = 8.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
81.9, 79.8, 75.3, 73.6, 67.2, 37.6, 23.3, 15.4, 13.8, 12.3, 9.7; HRMS (FAB) calcd for 
C11H15O [M–H]+ 163.1123, found 163.1123. 
94. Prepared according to a procedure adapted from the work of Braddock and co-
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workers: Bonney, K. J.; Braddock, D. C. J. Org. Chem. 2012, 77, 9574.  To a solution of 
93 (0.965 g, 5.88 mmol, 1.0 equiv) in MeOH (26.5 mL) and cyclohexene (5.9 mL) was 
added quinoline (1.04 mL, 8.82 mmol, 1.5 equiv) and 5% Pd on BaSO4 (0.415 g) 
sequentially.  The heterogenous mixture was stirred at 25 °C for 10 min, a balloon of H2 
was added, and the reaction was allowed to stir at 25 °C for 3 h.  Upon completion, the 
reaction was filtered through a pad of Celite with EtOAc (30 mL) and then quenched by 
the addition of 1 M HCl (15 mL), then extracted with EtOAc (2 × 10 mL).  The combined 
organic layers were then dried (MgSO4), filtered, and concentrated.   The crude residue 
was purified by flash column chromatography (silica gel, hexanes:EtOAc 9:1 to 4:1) to 
afford the desired alcohol 94 (0.185 g, 19% yield) as a light yellow oil.  94: Rf = 0.55 
(silica gel, hexanes:EtOAc, 7:3); IR (film) νmax  3341 (br), 3010, 2965, 2930, 1458, 1128, 
1082, 719 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.43 – 5.26 (m, 4 H), 3.82 (sextet, J = 6.4 
Hz, 1 H), 2.80 (t, J = 6.4 Hz, 2 H), 2.23 – 2.12 (m, 2 H), 2.08 (quintet, J = 7.2 Hz, 2 H), 
1.58 – 1.49 (m, 2 H), 1.42 (br s, 1 H), 1.20 (d, J = 6.0 Hz, 3 H), 0.97 (t, J = 6.8 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 132.0, 129.4, 128.7, 127.2, 67.8, 39.0, 25.5, 23.7, 23.5, 
20.6, 14.3; HRMS (FAB) calcd for C11H20O [M]+ 168.1514, found 168.1524. 
95.  To a solution of alcohol 94 (0.076 g, 0.45 mmol, 1.0 equiv) in MeCN (7.5 mL) 
was added solid TBCO (0.204 g, 0.50 mmol, 1.1 equiv) at –25 °C.  The reaction was 
stirred at –25 °C for 20 min.  Upon completion, the reaction quenched by the addition of 
combination of saturated aqueous NaHCO3 and 5% aqueous Na2SO3 (1:1, 5 mL), and the 
resultant biphasic mixture was stirred vigorously for 20 min at 25 °C.  The reaction 
contents were added to brine (10 mL) and extracted with EtOAc (3 × 15 mL).  The 
combined organic layers were washed with brine (20 mL), dried (MgSO4), filtered, and 
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concentrated.  The resultant residue was purified by flash column chromatography (silica 
gel, hexanes:EtOAc) to afford the 5-exo bromoether 95 (0.095 g, 77% yield, 2.5:1 dr) as a 
colorless viscous oil (contaminated with ~10% of an inseparable, unidentified impurity).  
95: Rf = 0.46 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2966, 2872, 1458, 1090, 
883, 748 cm–1; Major diastereomer: 1H NMR (400 MHz, C6D6) δ 5.57 – 5.36 (m, 2 H), 
4.10 (m, 1 H), 3.93 (td, J = 7.2, 3.6 Hz, 1 H), 3.77 (td, J = 6.8, 3.2 Hz, 1 H), 2.71 (t, J = 
6.8 Hz, 2 H), 1.99 (quintet, J = 7.2 Hz, 2 H), 1.78 – 1.60 (m, 3 H), 1.13 (m, 1 H), 1.08 (d, 
J = 6.0 Hz, 3 H), 0.88 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 134.4, 125.2, 
80.5, 76.4, 59.5, 34.1, 33.0, 30.3, 21.1, 20.8, 14.0; HRMS (FAB) calcd for C11H18BrO 
[M–H]+ 245.0541, found 245.0532. 
 
97. Solid TBCO (0.124 g, 0.303 mmol, 1.1 equiv) was added to a solution of 
substrate 95 (0.0680 g, 0.275 mmol, 1.0 equiv) in MeCN (9.3 mL) and water (1.9 mL) at 
25 °C.  The reaction was stirred at 25 °C for 15 min.  Upon completion, the reaction 
quenched by the addition of combination of saturated aqueous NaHCO3 and 5% aqueous 
Na2SO3 (1:1, 5 mL), and the resultant biphasic mixture was stirred vigorously for 20 min 
at 25 °C.  The reaction contents were added to brine (10 mL) and extracted with EtOAc 
(3 × 15 mL).  The combined organic layers were washed with brine (20 mL), dried 
(MgSO4), filtered, and concentrated.  The resultant residue was purified by flash column 










as a colorless viscous oil (contaminated with ~10% of an inseparable, unidentified 
impurity).  97: Rf = 0.35 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3390 (br), 2966, 
2930, 2875, 1456, 1107, 1062, 802 cm–1; 1H NMR (400 MHz, C6D6) δ 4.19 (m, 1 H), 
3.95 (m, 1 H), 3.66 – 3.56 (m, 2 H), 3.42 (m, 1 H), 2.22 (ddd, J = 14.4, 9.6, 5.2 Hz, 1 H), 
2.04 (dd, J = 14.0, 4.0 Hz, 1 H), 1.95 – 1.73 (m, 2 H), 1.72 – 1.53 (m, 2 H), 1.40 – 1.32 
(m, 3 H), 1.01 (d, J = 6.4 Hz, 3 H), 0.88 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, C6D6) 
δ 83.6, 79.4, 67.3, 62.5, 56.3, 42.0, 36.0, 30.6, 29.5, 23.7, 12.8; HRMS (FAB) calcd for 
C11H21BrO2 [M+H]+ 342.9908, found 342.9895. 
98.  A solution of BDSB (0.181 g, 0.330 mmol, 1.2 equiv) in MeNO2 (1.8 mL) 
was added rapidly via syringe to a solution of the cyclization precursor 95 (0.0680 g, 
0.275 mmol, 1.0 equiv) in MeNO2 (12 mL) at –25 °C.  After stirring the resultant yellow 
solution for 10 min at –25 °C, the flask was removed from the cold bath and stirred for an 
additional 10 min.  Upon completion, the reaction mixture was quenched by the addition 
of a combination of saturated aqueous NaHCO3 and 5% aqueous Na2SO3 (1:1, 5 mL), 
and the resultant biphasic mixture was stirred vigorously for 20 min at 25 °C.  The 
reaction contents were added to brine (10 mL) and extracted with EtOAc (3 × 15 mL).  
The combined organic layers were washed with brine (20 mL), dried (MgSO4), filtered, 
and concentrated.  The resultant residue was purified by preparative thin-layer 
chromatography (silica gel, hexanes:EtOAc 9:1) to afford 98 (0.013 mg, 10% yield) as a 
colorless viscous oil (contaminated with ~25% of an inseparable, unidentified impurity).  
98: Rf = 0.46 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2968, 2929, 2877, 1441, 
1203, 1108, 904, 802 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.58 (m, 1 H), 4.47 (ddd, J = 
9.6, 6.4, 3.2 Hz, 1 H), 4.17 (m, 1 H), 3.98 – 3.91 (m, 2 H), 2.67 (ddd, J = 14.4, 9.6, 5.2 
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Hz, 1 H), 2.50 (dd, J = 14.0, 6.4 Hz, 1 H), 2.03 – 1.82 (m, 6 H), 1.73 (d, J = 6.4 Hz, 3 H), 
1.10 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 82.6, 79.2, 61.8, 55.1, 51.2, 
41.7, 37.6, 32.2, 28.9, 26.5, 12.7; HRMS (FAB) calcd for C11H18Br3O [M–H]+ 402.8908, 
found 402.8902. 
Double Bromonium Addition.  To a solution of alcohol 94 (0.0505 g, 0.300 
mmol, 1.0 equiv) in MeCN (4.8 mL) was added solid TBCO (0.135 g, 0.33 mmol, 1.1 
equiv) at –25 °C.  The reaction was stirred at –25 °C for 20 min.  Water (1.0 mL) and 
another portion of TBCO (0.135 g, 0.33 mmol, 1.1 equiv) were added to the reaction 
mixture at 25 °C.  The reaction was stirred at 25 °C for 30 min.  Upon completion, the 
reaction quenched by the addition of combination of saturated aqueous NaHCO3 and 5% 
aqueous Na2SO3 (1:1, 5 mL), and the resultant biphasic mixture was stirred vigorously 
for 20 min at 25 °C.  The reaction contents were added to brine (10 mL) and extracted 
with EtOAc (3 × 15 mL).  The combined organic layers were washed with brine (20 mL), 
dried (MgSO4), filtered, and concentrated.  The resultant residue was purified by flash 
column chromatography (silica gel, hexanes:EtOAc 9:1 to 7:3) to afford 97 (0.052 g, 
50% yield).   
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